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ABSTRACT 
The marine polychaete Nereis virens is an important species in estuarine sediments, which are often 
impacted by anthropogenic persistent compounds including polycyclic aromatic hydrocarbons 
(PAHs). Therefore, infaunal deposit-feeding invertebrates like Nereis virens can be extensively 
exposed to PAHs due to feeding activity and surface contact. The degree of systemic accumulation 
of PAHs depends on intake but also on efficiency of biotransformation by the organism. N. virens is 
known to extensively biotransform PAHs. In this study, in vivo and in vitro biotransformation 
studies were conducted using the model PAH pyrene. Assays were designed to characterise 
activities of phase I and II enzymes isolated from gut tissue by measuring the production of 1-
hydroxypyrene, pyrene-1-glucuronide, pyrene-1-sulfate and pyrene-1-glucoside by high-pressure 
liquid chromatography (HPLC). Formation of metabolites was used to estimate the activity of 
pyrene hydroxylase, glucuronosyl transferase, and sulfotransferase. Pyrene hydroxylase activity was 
determined to be cytochrome P450 (CYP) mediated and the prominent phase II pathway in this 
organism was glucuronidation. Pyrene hydroxylase activity was significantly induced after pre-
exposure to sediment associated pyrene (10 μg/g dry wt) whereas none of the phase II enzymes 
appeared inducible after pre-exposure to pyrene and B(a)A in the chosen concentrations. Apparent 
kinetic parameters were determined for all enzymatic reactions and glucuronidation was confirmed 
as being the prominent phase II reaction, based on its high apparent maximum velocity (Vmax(a)). 
However, sulfotransferase enzymes had the lowest apparent Michaelis constant (Km(a)), indicating 
high specificity of this enzymatic reaction. Apparent kinetic parameters for pyrene hydroxylase 
activity were changed after induction with pyrene. Induced worms showed increased Vmax(a) and 
decreased Km(a) compared to noninduced worms, indicating that the relative amount of the CYP 
enzyme(s) responsible for pyrene hydroxylation was increased. Since CYP enzymes catalyse the 
initial step in biotransformation of PAHs and the kinetic results indicate that this might be the rate-
limiting step in the overall biotransformation, further characterisation could be interesting. 
Therefore, complete cDNA sequences of two novel CYP genes were isolated from N. virens gut 
tissue. One was named CYP4BB1 and the other was named CYP342A1 by the Cytochrome P450 
nomenclature committee. The cDNA sequence of both genes was heterologously expressed and the 
proteins purified. Both CYP enzymes had monooxygenase activity and catalysed hydroxylation of 
pyrene to 1-hydroxypyrene. Furthermore, site directed mutagenesis replacing the conserved 
cysteine residue of the heme binding domain with a serine residue resulted in complete loss of 
monooxygenase activity of both CYP enzymes. This indicates that the cysteine residue is essential 
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for monooxygenase activity of invertebrate CYP enzymes, as has been well documented in 
vertebrates. The data on specific CYP enzymes in N. virens presented here contribute to the 
understanding of PAH biotransformation in this species, which is important in attempting to 
understand the differences in sensitivity towards PAHs among marine invertebrates.    
 
DANISH SUMMERY 
Den marine polychaete Nereis virens er en vigtig art i marine sedimenter, der ofte er påvirket af 
antropogene persistente forbindelser som polycycliske aromatiske hydrocarboner (PAHer).  
Infaunale sediment-ædende invertebrater som N. virens bliver i høj grad exponeret til PAHer via 
intagelse med føden og ved overførsel over epithelet. Graden af systemisk akkumulering af PAHer 
afhænger af optaget men ligeledes af effektiviteten af biotransformering i den pågældende 
organisme. N. virens er kendt for effektivt at biotransformere PAHer. I nærværende undersøgelse 
blev in vivo og in vitro biotransformerings undersøgelser foretaget med model-PAHen pyren. Der 
blev designet assay´s til karakterisering af fase I og fase II enzym aktivitet fra tarmvæv ved at måle 
produktion af 1-hydroxypyren, pyren-1-glucuronid, pyren-1-sulfat og pyren-1-glucosid ved High 
pressure Liquid Chromatography (HPLC). Produktion af metabolitter blev brugt til at estimere 
aktiviteten af pyren hydroxylase, glucuronosyl transferase og sulfotransferase. Pyren hydroxylase 
aktivitet blev bestemt til at være cytochrom P450 (CYP) medieret og den vigtigste fase II reaktion i 
denne organisme var glucuronidering. Pyren hydroxylase aktivitet var signifikant induceret efter 
præ-eksponering til pyren tilsat sedimentet (10 μg/g tørvægt) derimod var ingen af fase II 
enzymerne tilsyneladende inducerbare efter præ-eksponering til pyren og B(a)A i de anvendte 
koncentrationer. Kinetiske parametre blev bestemt for alle enzym reaktioner og glucuronidering 
blev bekræftet som værende den vigtigste fase II reaktion, baseret på dens høje tilsyneladende 
maksimum kapacitet (Vmax(a)). Sulfotransferase enzymer havde imidlertid den laveste Michaelis 
konstant (Km(a)), hvilket indikerer høj specificitet for denne enzymatiske reaktion. De kinetiske 
parametre for pyren hydroxylase var ændret efter induktion med pyren. Inducerede orme havde 
højere Vmax(a) og lavere Km(a) sammenlignet med ikke-inducerede orme, hvilket indikerer at den 
relative mængde af CYP enzymer involveret i pyren hydroxylering er øget. Eftersom CYP enzymer 
katalyserer det indledende trin i biotransformering af PAHer og kinetik resultaterne indikerer at 
dette kunne være det begrænsende trin i biotransformering vil yderligere undersøgelser af disse 
enzymer være interessant. Derfor blev komplette cDNA sekvenser for to nye CYP gener isoleret fra 
N. virens tarmvæv. CYP enzymerne er navngivet CYP4BB1 og CYP342A1 af cytochrome P450 
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nomenclatur komiteen. cDNA sekvensen fra begge gener blev heterologt udtrykt og proteinerne 
oprenset. Begge CYP enzymer havde monooxygenase aktivitet og katalyserer hydroxylering af 
pyren til 1-hydroxypyren. Derudover blev det konserverede cystein i hæm-bindings domænet 
erstattet med serin ved site-directed mutagenesis hvilket resulterede i komplet tab af 
monooxygenase aktivitet for begge CYP enzymer. Det indikerer at cystein er essentiel for 
monooxygenease aktivitet i invertebrat CYP enzymer, hvilket er dokumenteret i vertebrater. De 
data for specifikke CYP enzymer i N. virens der præsenteres her, bidrager til forståelsen af PAH 
biotransformering i denne art, hvilket er vigtigt i forståelsen af forskellene i sensitivitet overfor 
PAHer mellem marine invertebrater.              
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ABBREVATIONS: 
 
3-MC    3-methylcholanthrene  
AhR   aryl hydrocarbon receptor 
Arnt   aryl hydrocarbon receptor nuclear translocater 
B(a)A   benz(a)anthracene 
BAF   bioaccumulation factor 
B(a)P   benzo(a)pyrene 
BC   black carbon 
BSAF   biota to sediment accumulation factor 
CAR   constitutive androstane receptor 
cDNA   complementary deoxyribonucleic acid 
CYP   cytochrome P450 
DBD   DNA binding domain  
DD   dihydrodiol dehydrogenase 
DDE    dicholodiphenyldichloroethylene 
EH   epoxide hydrolase 
ER   endoplasmic reticulum 
GST   glutathione-S-transferase  
HPLC   high pressure liquid chromatography 
Hsp90   90 kDa heat-shock protein  
kDa   kilo Dalton 
Km(a)  apparent Michaelis-Menten constant for a substrate 
Km   Michaelis-Menten constant for a substrate 
LBD   ligand binding domain 
Log Kow   octanol-water partition coefficient 
mRNA   messenger ribonucleic acid 
NADPH   nicotinamide adenine dinucleotide phosphate  
NR   nuclear receptor 
PAH   polycyclic aromatic hydrocarbon 
PAP   adenosine´3´5 biphosphate 
PAPS   adenosine 3´-phosphate 5´phosphosulfate  
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PPAR   peroxisome proliferator activated receptor 
PPRE   peroxisome proliferator response element  
PXR   pregnane X receptor 
RXR   retinoid x receptor 
SULT   sulfotransferase 
TCDD   2,3,7,8-tetrachlorodibenzo-p-dioxin 
UDPGA   uridine diphosphoglucuronic acid 
UGT   uridine diphosphoglucuronosyl transferase 
Vmax(a)   apparent maximum reaction velocity 
Vmax   maximum reaction velocity 
Vmax/Km ratio  efficiency of catalysis 
XRE   xenobiotic response element 
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INTRODUCTION 
Polycyclic Aromatic Hydrocarbons (PAHs) are present in crude oil and are formed as by-
products from combustion processes. Due to their low aqueous solubility and hydrophobic 
character, PAHs in aquatic systems preferentially accumulate in sediments, where they may 
be ingested and accumulated by deposit-feeding benthic invertebrates (Ferguson & Chandler, 
1998). PAH exposure can pose a risk to benthic invertebrates both through acute and chronic 
toxicity (Farrington 1989). Benthic invertebrates are capable of biotransforming and excreting 
adsorbed PAHs. However, some intermediates of PAH biotransformation are very toxic and 
highly mutagenic and/or carcinogenic (Penning 1993). The biotransformation of PAHs by 
vertebrate species is fairly well characterised, whereas biotransformation by invertebrate 
species is less well understood. Although much remains to be elucidated about invertebrate 
biotransformation of PAHs, it appears to proceed in a manner similar to vertebrate species. 
Oxidized metabolites are produced by the cytochrome P450 enzyme (CYP enzyme) system 
similar to that in vertebrates. Following oxidation, the metabolites are conjugated by one of 
the several conjugation pathways catalysed by enzymes like sulfotransferase and glucuronosyl 
transferase. The PAHs are then eliminated by excretion of the water soluble conjugated 
metabolites.  
 
Polychaetes are richly abundant in various sediment and have been reported to constitute up 
to 50% of macrobenthic species by number in sediments (Reish and Gerlinger 1997). Deposit-
feeding polychaetes therefore constitute the dominant macrofauna in environments that tend 
to be depositional centers for organic matter and contaminants (Jumars et al. 1990). They are 
thus subject to an almost continuous exposure to PAHs that can be taken up and accumulated 
in the organism because they ingest large amounts of sediment. The polychaete Nereis virens 
is an important species for the soft bottom benthic community and is an important prey item 
for higher trophic level consumers like e.g. fish (Rust et al. 2004a). Furthermore, N. virens is 
known to extensively biotransform PAHs (McElroy 1985a; McElroy 1990). Therefore, it was 
chosen as model organism.  
 
Pyrene was chosen as model-PAH for several reasons. Pyrene is almost exclusively 
biotransformed to 1-hydroxypyrene by eukaryote CYP enzymes (Christensen et al. 2002a; 
Giessing et al. 2003a; de Knecht et al. 2001) reducing the number of phase II metabolites 
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thereby making identification of all the produced metabolites possible (this is an advantage 
over e.g. benzo(a)pyrene that is biotransformed to multiple phase I metabolites). Furthermore, 
pyrene is one of the more abundant PAHs found in marine environments polluted by 
industrial emissions (Stroomberg 2003). It is measured as part of many environmental 
monitoring programs and pyrene and its metabolites are considered to be low risk compounds 
and non-carcinogenic in mammalian species (Stroomberg 2003). Also, pyrene has a log Kow 
of 4-5 which makes it a potentially bioaccumulating PAH and several studies have found that 
pyrene is bioaccumulated in marine polychaetes (Christensen et al. 2002a; Timmermann and 
Andersen 2003).  
 
Analysis of the content of parent (non-metabolised) PAHs in different organisms as part of 
monitoring programs might not result in an accurate assessment of the risk associated with the 
PAH exposure in organisms efficiently biotransforming PAHs. Analysis of PAH metabolites, 
in addition to the parent PAHs, would provide information on biotransformation capacities 
and the potential for formation of toxic metabolites. Also, ratios between parent compound 
and metabolites could offer some indication of the intensity of internal exposure. Therefore, 
further knowledge on PAH biotransformation in benthic invertebrates is of major importance 
in order to gain a better understanding of effects of PAHs in the marine environment. This 
thesis addresses biotransformation of pyrene in the marine polychaete N. virens and the 
enzyme systems involved, in order to gain further knowledge about the underlying 
mechanisms of biotransformation in this species. This type of information from several key 
species in a given environment could contribute to the understanding of differences in PAH 
sensitivity between species and thereby improve the theoretical knowledge employed in 
ecotoxicological risk assessment in relation to environmental PAH pollution. This thesis 
employed two different approaches to gain information on mechanisms underlying 
biotransformation in N. virens; a biochemical approach, where enzymes involved in 
biotransformation of pyrene were identified, followed by investigation of their inducibility 
and enzyme kinetics, and a molecular approach, where two CYP genes were sequenced and 
further characterised to determine whether they could be involved in xenobiotic 
biotransformation by using the model PAH pyrene as substrate. 
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POLYCYCLIC AROMATIC HYDROCARBONS  
Polycyclic aromatic hydrocarbons (PAH) are a general class of persistent organic pollutants 
found in the marine and other ecosystems. PAHs in the environment may originate from 
natural sources (petroleum seeps, forrest fires etc.), anthropogenic sources (pyrogenic PAHs: 
combustion emissions from stationary and mobile sources, petrogenic PAHs: production, 
transport and uses of petrochemicals) (Meador et al. 1995b). Regardless of the source, PAHs 
occur as mixtures of compounds sharing similar characteristics (Neff 1985). They consist of 
multiple, fused aromatic ring systems solely containing carbon and hydrogen. PAHs are often 
divided into high molecular weight PAHs (>four fused benzene rings) and low molecular 
weight PAHs (< three fused benzene rings) (Cerniglia 1991). Due to their low aqueous 
solubility and hydrophobic character, PAHs are readily adsorbed to particulate matter after 
entering the aquatic ecosystem.  
 
In order to efficiently assess the potential effects of PAHs on an exposed organism, several 
factors have to be taken into account, environmental concentration, bioavailability, 
bioaccumulation potential, biotransformation capacity and toxicity. Of these factors, 
bioavailability, bioaccumulation and toxicity are discussed below and biotransformation in 
the next paragraph. 
 
BIOAVAILABILITY 
Bioavailability is a critical factor in determining the ecological risk of organic contaminants 
in sediments. In the case of sediment exposure, only a fraction of the total amount of a given 
contaminant in a sediment system is available for uptake by benthic organisms (Vinturella et 
al. 2004). The bioavailability of PAHs is determined both by PAH characteristics, life strategy 
of the organism and environmental factors. In sediment, pore water concentrations of PAH 
influence the exposure of infaunal organisms, making water solubility of the PAHs an 
important factor. Water solubility decreases with increasing molecular size of the PAH 
(Varanasi 1989). Another important factor is life strategy of the organism. For deposit feeding 
organisms ingesting large amounts of sediment, both PAHs dissolved in the pore water and 
PAHs bound to sediments are bioavailable to some degree. Factors that influence the 
bioavailability of sediment associated PAHs include quantity and quality of the organic 
content and age of the sediment, besides physicochemical characteristics of the PAHs (Forbes 
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et al. 1998). Thus, PAH bioavailability is affected by whether the PAH exist in solution 
(resulting in exposure over respiratory and body surfaces) or are primarily adsorbed to 
particle surfaces (resulting in exposure over digestive surfaces) (Simkiss 1996). The 
partitioning of PAHs between water and particles depends on a variety of factors including 
aqueous solubility and log Kow, affinity for sediment organic carbon and dissolved organic 
carbon and sediment grain size (Di Toro et al. 1991). Although PAHs are primarily associated 
to sediment in the marine environment, they are available to benthic organisms. However, the 
relationship between concentrations of PAH in the sediment and their bioavailability is not 
well understood. Timmermann & Andersen (2003) found that bioaccumulation of pyrene 
correlated with the amount of pyrene passing through the gut of the polychaete Arenicola 
marina, confirming the general notion that particle-associated pyrene is bioavailable for 
deposit feeding organisms.  
 
The bioavailability of PAHs to benthic invertebrates is complicated by the variety of ways 
that the PAHs are introduced to the marine environment (Rust et al. 2004c). The different 
origins result in variable sorption of PAHs between water and particles. This can lead to 
differences in bioavailability of PAHs from different sources and a distinction has been made 
between the bioavailability of PAHs from pyrogenic (high temperature combustion sources) 
and petrogenic (fossil fuel) sources, with pyrogenic PAHs considered much less bioavailable 
(Rust et al. 2004c). This is due to the fact that pyrogenic PAHs tend to arrive in the 
environment already tightly bound to carbonaceous particles (commonly referred to as black 
carbon) (Rust et al. 2004c). Black carbon (BC) is not suggested to be a permanent sink for 
PAHs; however, the bioavailability of sediment PAHs may be reduced short-term (Vinturella 
et al. 2004). 
 
BIOACCUMULATION 
Benthic invertebrates potentially accumulate PAHs from several routes: I) through direct 
contact with porewater/sediment II) through ventilation of overlying- or pore-water followed 
by diffusion over the body surface III) by ingestion of sediment or food particles and 
subsequent transfer over gut epithelium (Meador et al. 1995b). Different benthic invertebrates 
vary in important characteristics that may affect the extend of PAH bioaccumulation. This 
includes feeding behaviour (deposit feeders, filter feeders or carnivors), biotransformation 
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capacity, gut passage time, gut fluid surfactant strength and mediation of enhanced microbial 
degradation (Rust et al. 2004b). Deposit-feeding organisms may be exposed to high 
concentrations of sediment associated PAHs, since PAHs are often associated with organic 
matter in the sediment and most deposit feeders select for and process large quantities of fine-
grained and organic rich particles (Lopez and Levinton 1987). 
 
The potential influence of PAH biotransformation on bioaccumulation has long been 
recognised and therefore, only limited body burdens of PAHs can be expected in organisms 
efficiently biotransforming PAHs (Rust et al. 2004a). Christensen et al (2002a) investigated in 
vivo biotransformation and bioaccumulation of the PAH pyrene by two polychaetes, Nereis 
diversicolor and Arenicola marina. Body burdens were highest in Arenicola marina that has 
the lowest ability to biotransform pyrene (Christensen et al. 2002a). The pattern of 
bioaccumulation of PAHs in polychaete species is fairly well investigated, for example, 
bioaccumulation profiles obtained from laboratory experiment showed that the polychaete S. 
benedicti rapidly accumulated PAHs until about day 12, and afterwards the tissue 
concentration began to decrease (Ferguson and Chandler 1998). This is consistent with 
previous studies that have measured PAH bioaccumulation in polychaetes (Weston 1990; 
Forbes et al. 1996). Bioaccumulation in marine organisms is calculated as the 
bioaccumulation Factor (BAF) where the concentration of PAH in the organism is divided by 
the concentration of PAH in the sediment. However, since the partitioning between sediment 
and organism depends on the amount of organic carbon in the sediment and the lipid content 
in the organism, the BSAF have been introduced. BSAF is BAF normalised to organic- and 
lipid-content in sediment and organism, respectively. The octanol-water coefficient (Kow) of 
the particular PAH examined is also important to consider in bioaccumulation. Previous 
studies have shown that bioaccumulation of PAHs can generally be predicted by the log Kow 
value (Rust et al. 2004b). The correlations between log Kow and bioaccumulation of PAHs 
was found to be a bell shaped curve with a maximum bioaccumulation for compounds with 
log Kow values of approximately 5 to 5.5 (Landrum 1989). Reduced bioavailability and 
accumulation of high log Kow (>7-8) PAHs is observed and may be due to stronger sorption to 
the sediment (Landrum 1989; Rust et al. 2004b). Also, reduced accumulation of low log Kow 
PAHs has been observed and possible explanations include rapid uptake and elimination of 
compounds with low log Kow values (<2-3) (Landrum 1989; Meador et al. 1995a). 
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TOXICITY 
The toxicity of PAHs is exhibited through different modes of action (van Brummelen et al. 
1998) and examples of some of the most common toxic effects of PAHs follows. PAHs 
themselves are relatively inert molecules and it is generally accepted that besides from 
nonpolar narcosis due to incorporation of some PAHs in phospholipids bilayer of membranes 
after exposure to relatively high concentrations (Stroomberg 2003), toxic effects of PAHs are 
caused by their metabolites rather than by the parent compounds (Livingstone 1993). 
Biotransformation enzymes play a dual role of ridding the organism of parent PAH through 
modification and eventual excretion (further details of biotransformation follow in the next 
paragraph), but also of creating highly toxic metabolic intermediates that can have harmful 
effects. Metabolites of several PAHs have been found to be carcinogenic and mutagenic in 
mammalian species (Penning 1993). Besides mono-hydroxylation, biotransformation of PAHs 
can involve epoxidations both mediated by CYP enzymes (figure 1) (Penning 1993; James 
and Boyle 1998). Epoxides are highly reactive and can either spontaneously rearrange to 
aromatic monohydroxy compounds, react with nucleophilic centres in macromolecules, or 
react enzymatically catalysed with water (epoxide hydrolase in vertebrates) to form 
dihydrodiols. The dihydrodiols can be converted by enzyme dihydrodiol dehydrogenase to a 
stable diol that can be conjugated and excreted (Penning 1993). Some positions in larger 
PAHs are accessible for epoxidation but due to steric hindrance the epoxides formed are not 
accessible for hydrolysis by the epoxide hydrolase (bay region epoxides), thereby stable 
highly mutagenic and carcinogenic metabolites are formed (Chen et al. 1996).  
 
Another potentially toxic effect of PAHs is endocrine disruption. PAHs have been shown to 
influence endocrine functioning, although the evidence is limited due to the fact that only few 
PAHs have been studied so far (Santodonato 1997). Some PAHs or their metabolites bind to 
the estrogen receptor thereby either activating the receptor to produce an estrogen-mediated 
response or competing with estrogen for the receptor, thus inhibiting the estrogen response 
(Santodonato 1997). PAHs can also indirectly influence the endocrine functioning by their 
ability to induce cytochrome P450 enzymes (van Brummelen et al. 1998).           
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Figure 1. Biotranformation of benzo(a)pyrene in vertebrates. In the top of the figure is an 
example of mono-hydroxylation to 3-hydroxybenzo(a)pyrene. In the bottom is formation of 
epoxides. CYP: cytochrome P450, ST: sulfotransferase, UDPGT: glucuronosyl transferase, 
DD: dihydrodiols dehydrogenase, EH: epoxide hydrolase. From Stroomberg (2003).  
       
 
In benthic organisms, PAH exposure can also lead to reduced feeding-rates and irrigation-
rates. For example, A. marina reduced feeding rate by 50% as a response to fluoranthene 
exposure (Kure 1997). Also, pyrene exposure affected feeding-rates in A. marina as 
increasing sediment pyrene concentrations resulted in a decrease in feeding rate 
(Timmermann and Andersen 2003). In contrast, Capitella sp. I was found to initially increase 
the feeding rate when exposed to dissolved- and sediment-associated fluoranthene but after 
few days exposure the feeding rate decreased to the level of non-exposed worms (Selck 
2002). Changes in irrigation rates have also been observed after pyrene exposure in A. 
marina. Exposure to 10 μg/kg led to a small increase in irrigation whereas higher 
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concentrations (100, 1000 and 10.000 μg/kg) resulted in decreased irrigation rates 
(Timmermann and Andersen 2003).  
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BIOTRANSFORMATION 
Biotransformation is the principal route of elimination of xenobiotics like PAHs from an 
organism (James 1987). The xenobiotic biotransformation systems of both vertebrates and 
invertebrates comprise several phase I enzyme systems including the cytochrome P450 (CYP) 
enzymes as well as several phase II enzyme systems (James 1987). CYP enzymes are major 
players in the initial phase I metabolism where a functional group such as hydroxyl is 
introduced into the substrate (Werck-Reichart and Feyereisen 2000). In the subsequent phase 
II reaction, conjugating enzymes, most importantly acetyltransferase, glutathione-S-
transferases, glucuronosyl transferases and sulfotransferases attach endogenous substrates 
such as an acetyl group, glutathione, glucuronic acid or sulfate to a conjugatable position in 
the substrate generated by the phase I metabolism (de Knecht et al. 2001; Giessing et al. 
2003a). Solubility is only slightly increased in the phase I reaction whereas conjugation 
extensively increases solubility (Li and James 1993; van den Hurk and James 2000) allowing 
rapid excretion of the conjugates (Burchell and Coughtrie 1989; Livingstone 1998). 
 
PHASE I BIOTRANSFORMATION WITH EMPHASIS ON CYP ENZYMES 
Phase I biotransformation includes reduction, hydrolysis and oxidation, primarily mediated by 
CYP enzymes. The CYP enzymes constitute a superfamily of haem-thiolate containing 
proteins present in prokaryotes and throughout the eukaryotes. CYP enzymes are mono-
oxygenases, with functions ranging from the synthesis and degradation of endogenous steroid 
hormones, vitamins and fatty acid derivates (endobiotics) to the metabolism of foreign 
compounds such as environmental pollutants, drugs and carcinogens (xenobiotics) 
(Honkakovski and Negishi 2000). Generally, CYP enzymes primarily involved in xenobiotic 
biotransformation have broad substrate specificities, whereas CYP enzymes primarily 
involved in metabolism of endobiotics have narrower substrate specificity (Halkier 1996). 
The CYP enzymes are classified into families and subfamilies based on their amino acid 
sequence similarities (Nelson 1998), the root symbol “CYP”, denoting Cytochrome P450 and 
an Arabic number designating the family (e.g. CYP1). Members of the same family are more 
than 40% identical with respect to their amino acid sequence. If the sequence is more than 
55% identical, the enzyme belongs to the same subfamily, indicated by an additional letter 
(e.g. CYP1A). Finally, each individual enzyme is represented by an Arabic numeral (e.g. 
CYP1A1) (Nelson 1998).  Two different types of CYP enzymes exist. Mitochondrial CYPs 
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are located in the mitochondrial matrix and microsomal CYP located in the endoplasmic 
reticulum (ER). The two types of CYPs differ in the amino-terminal sequence, which 
determines the subcellular localisation and electron donor system (Omura 1999). 
Mitochondrial CYPs are primarily involved in metabolism of endogenous compounds 
whereas microsomal CYPs are involved in both endogenous and exogenous metabolism. 
Microsomal CYPs are terminal electron acceptors from NADPH via the closely associated 
NADPH- cytochrome P450 reductase. CYP enzymes and NADPH- cytochrome P450 
reductase are dissociated and independently anchored on the outer face of the ER by amino-
terminal hydrophobic anchors. An additional carboxy-terminally ER-anchored electron donor, 
cytochrome b5, which conveys electrons from NADPH, has been found to enhance the 
activity of some CYP enzymes (Werck-Reichart and Feyereisen 2000; Lewis 2003).  
 
CYP enzymes mediate the oxidative transformation of a large number of endogenous and 
exogenous substrates by the insertion of a single atom of oxygen (derived from O2) into a 
substrate. Depending on the CYP enzyme, different substrates can be oxygenated. As a result 
of the multiplicity of CYPs and their diverse and overlapping substrate specificities, the CYP 
enzymes are thus able to biotransform a wide variety of substrates via a multitude of 
oxidations (Simpson 1997; Maibeche-Coisne et al. 2005) e.g. C- and heteroatom 
hydroxylations and unsaturated bond epoxidation. The catalytic mechanism of CYP enzymes 
is presented in detail in figure 2. 
 
CYP enzymes are approximately 500 amino acids long with a molecular weight of 45-55 kDa 
and have several conserved domains (Feyereisen 1999). It appears that only sequences 
immediately surrounding two key residues in CYPs are absolutely conserved: the C-terminal 
cysteine residue in the heme binding domain that is located just before the L-helix, and the 
Thr (T) in the I-helix, which is involved in oxygen binding. The conserved heme binding 
region, FxxGxxxCxG (x representing any amino acid) is the signature sequence, which allows 
identification of CYP enzymes. In addition, most eukaryotic CYPs are associated with 
microsomal membranes and therefore often contain a cluster of prolines and glycines that 
form a hinge, preceded by a cluster of basic residues between the hydrophobic amino-terminal 
membrane anchoring segment of approximately 20 residues and the globular part of the 
protein (Figure 3) (Feyereisen 1999; Werck-Reichart and Feyereisen 2000). Furthermore, 
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there is a highly conserved ExxR motif in the K-helix probaly needed to stabilize the core 
structure (Werck-Reichart and Feyereisen 2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Catalytic mechanism of cytochrome P450 enzymes. CYP enzymes are mono-
oxygenases, catalysing the insertion of one of the atoms of molecular oxygen into a substrate, 
the second atom of oxygen being reduced to water. The most frequently catalysed reaction is 
hydroxylation. Mechanistically the substrate (R) binds to the CYP enzyme, leading to a 
change in oxidation status in the iron-group from Fe3+ to Fe2+ after receiving an electron from 
NADPH catalysed by NADPH-cytochrome P450 reductase. The reduced complex binds an 
oxygen molecule and accepts a second electron from NADPH. The second reduction activates 
the molecular oxygen in the enzyme-substrate complex, which leads to the formation of 
water, oxidised substrate and oxidised enzyme, the oxidised substrate is released from the 
enzyme that are now ready for the next cycle. Modified from Lewis (2003). 
 
The conserved region PERF is present in most identified CYPs, however, the functional 
significance is less clear. A WxxxR domain near the NH2-terminal located in the C-helix is 
considered to neutralise the charge of one of the side chains. In enzymes belonging to the 
CYP4 family, there is a 13-residue sequence in the I-helix region: EVDTFMFEGHDTT, 
which is also relatively conserved (Bradfield et al. 1991). The non-conserved or variable 
regions are usually associated with substrate binding. On the basis of sequence comparisons 
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between CYP genes with known crystal structures regions involved in substrate recognition 
have been identified and designated SRS (Graham and Peterson 1999) however, this type of 
prediction is only possible for well characterised CYPs (Werck-Reichart and Feyereisen 
2000). A very important feature for eukaryotic CYPs is that portions of the substrate binding 
site are flexible and will adjust its shape to accommodate its substrate (Graham and Peterson 
1999). 
  
 
Figure 3. Primary structure of CYP proteins. Typical features of an ER bound protein, the 
function of the different domain and regions indicated by colors are described in the text. 
Modified from Werck-Reichhart and Feyereisen (2000).   
         
 
PHASE II BIOTRANSFORMATION 
In phase II reactions either parent compounds or metabolites of phase I reactions are 
conjugated with one of several endogenous compounds via a functional group in the substrate. 
Phase II reactions are generally considered detoxification pathways rendering the substrate 
more polar and thereby more easy to excrete (Burchell and Coughtrie 1989). The most 
important phase II enzymes in marine invertebrates are apparently glucuronosyl transferases, 
glutathione-S-transferases and sulfotransferases (James 1987; de Knecht et al. 2001). In 
relation to pyrene biotransformation, glucuronosyl transferase and sulfotransferase enzymes 
are relevant, while glutathione-S-transferase is not due to the lack of formation of pyrene 
epoxides. 
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UDP-glucuronosyl transferase (UGT) enzymes catalyse one of the major phase II conjugation 
reactions in the conversion of both exogenous and endogenous compounds to polar, water-
soluble compounds (Tukey and Strassburg 2000). The glucuronosyl transferase enzymes 
constitute an enzyme superfamily that catalyses both glucuronidation and glucosidation 
(Tukey and Strassburg 2000). The enzymes exhibit broad substrate specificity and have 
evolved such that a wide range of structurally diverse substrates may be efficiently conjugated 
by distinct isoforms of UGT (Burchell and Coughtrie 1989). Based on evolutionary 
divergence of the proteins, at least two UGT subfamilies have been described: UGT1 and 
UGT2 (McKenzie et al. 1997). A nomenclature system similar to that for the CYP enzymes is 
used to name UGTs, i.e. using UGT as root symbol, representing UDP-glucuronosyl 
transferase, followed by an Arabic number denoting that within a family (e.g. UGT1), 
members have ≥45% amino acid identity and a letter designating the subfamily (e.g. 
UGT1A). Mammalian enzymes within the same protein subfamily have approximately 60% 
or more sequence identity. Finally, an Arabic number represents an individual enzyme within 
the subfamily (e.g. UGT1A1) (McKenzie et al. 1997). 
    
Glucuronidation reactions require uridine diphosphoglucuronic acid (UDPGA) as a co-
substrate, which functions as glucuronate donor (figure 4) (Tephly et al. 1989). Glucosidation 
reactions use UDP-glucose as co-substrate functioning as sugar donor. The UGTs are 
localized in the endoplasmic reticulum and the NH2-terminal region encodes an endoplasmic 
reticulum consensus signal sequence that facilitates the insertion of the protein into the 
membrane. UGTs have type I transmembrane topology, classified with the N-terminus and 
catalytic domain (active site) inside the lumen of the endoplasmic reticulum (Burchell and 
Coughtrie 1989).  
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Figure 4. UDP-glucuronosyl transferase activity. 1-hydroxypyrene is conjugated to pyrene-1-
glucuronide catalysed by UDP-glucuronosyl transferase enzymes. UDP-glucuronic acid is co-
substrate. Modified from Tephly et al. (1989). 
 
It is difficult to determine or predict the complete substrate profile of any glucuronosyl 
transferase because multiple transferase isoforms overlap in their substrate profile (Burchell 
and Coughtrie 1989; Tukey and Strassburg 2000). However, UGTs involved in xenobiotic 
biotransformation are generally considered inducible and regulation of their activity may be 
important in determination of xenobiotic detoxification and elimination (Jemnitz et al. 2000). 
The importance of glucuronidation in the detoxification process can be attributed to a 
significant biological parameter. Although there is some selectivity in substrate specificity 
between the different UGTs, there is also remarkable redundancy between them in their 
ability to accept similar compounds as potential substrates for glucuronidation (Tukey and 
Strassburg 2000). This assures that metabolic processes are in place to facilitate the process of 
detoxification regardless of the xenobiotic (Tukey and Strassburg 2000). Within insects and 
other invertebrates, glucosidation is considered a more important phase II conjugation 
pathway compared to glucuronidation that is most important in vertebrates. Glucosidation is 
involved in several processes, including detoxification of xenobiotics. In the terrestrial 
isopods P. scaber and O. asellus and in the shore crab C. maenas glucoside conjugates were 
identified, whereas glucuronide conjugates were not detected (de Knecht et al. 2001; Fillmann 
et al. 2004). It has previously been suggested that glucuronosyl transferase enzymes in marine 
invertebrates primarily use UDP-glucose as co-substrate whereas vertebrates primarily use 
UDP-glucuronic acid (James 1987). Also, Livingstone (1998) suggested that glucuronidation 
might be restricted to vertebrate species. However, Giessing et al. (2003a) found glucuronide 
conjugates to be the most prominent phase II metabolite in Nereis diversicolor and in 
manuscript I of this thesis we find that glucuronidation is the most prominent phase II 
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biotransformation pathway in N. virens, a nereid closely related to N. diversicolor. 
Accordingly, species differences appear to determine the co-substrate preference in 
glucuronosyl transferase reactions. 
  
Another major phase II reaction is sulfate conjugation catalysed by members of the 
sulfotransferase enzyme superfamily (Coughtrie et al. 1998; Lohr et al. 1998). An important 
characteristic of sulfotransferases, which have been well characterised, is that each enzyme 
can catalyse sulfation of both endogenous and exogenous compounds (Coughtrie et al. 1998; 
Nagata and Yamazoe 2000). A sulfotransferase classification and nomenclature system is not 
yet in general use, although SULT has been agreed on as acronym (Andersonn et al. 1998; 
Nagata and Yamazoe 2000). Based on amino acid sequence identity and substrate preferences 
the known sulfotransferases have previously been subdivided into two families, phenol 
sulfotransferases and hydroxysteroid sulfotransferases (Coughtrie et al. 1998). However, the 
mammalian cytosolic sulfotransferase enzyme family currently comprises over 44 different 
enzymes that based on amino acid sequence similarities are divided into five different 
families (Nagata and Yamazoe 2000). Recently, a nomenclature system for the 
sulfotransferase enzymes were suggested based on the cytochrome P450 nomenclature system 
(Nagata and Yamazoe 2000). On amino acid level SULT sequences with more than 40% 
sequence identity belong to the same SULT family (Nagata and Yamazoe 2000).  
 
Sulfotransferase enzymes are located in the cytoplasm. Adenosine 3´-phosphate 
5´phosphosulfate (PAPS) is co-substrate and functions as sulfate donor in the sulfation 
reaction (figure 5) (Coughtrie et al. 1998). Sulfotransferase enzymes exhibit relatively broad 
substrate specificity, allowing both endogenous and endogenous compounds to be substrates 
for this conjugation pathway. This raises the possibility for competition between the two 
classes of substrates for the conjugation reaction, as has been demonstrated in vitro 
(Coughtrie et al. 1998). Sulfation appears to be an important phase II conjugation pathway 
both in vertebrate and invertebrate species. An important factor determining the level of 
sulfation activity is substrate supply, since many substrates for sulfotransferase enzymes are 
also substrates for other enzymes e.g. the glucuronosyl transferases (Coughtrie et al. 1998). 
Furthermore, sulfate conjugation is regulated by co-substrate availability since the overall 
 22
 
 
 
 
activity of the sulfotransferase reaction depends on inorganic sulfate pool and the synthesis of 
PAPS (Lohr et al. 1998).  
 
OSO3OH
Sulfotransferase
PAPS PAP
1-hydroxypyrene Pyrene-1-sulfate  
 
Figure 5. Sulfotransferase activity. 1-hydroxypyrene is substrate for sulfotransferase enzymes 
leading to the formation of pyrene-1-sulfate. PAPS: adenosine 3´-phosphate 
5´phosphosulfate; PAP: adenosine 3´5´biphosphate. Modified from Coughtrie et al. (1998). 
 
ENZYME KINETICS 
To quantitatively characterise different biotransformation reactions, the kinetic parameters Km 
and Vmax can be determined for sets of enzymes and substrates (Houston 1994). Furthermore, 
the Vmax/Km ratio for a given substrate can be used to compare different enzymes, since it is 
used as a measure of the efficiency of catalysis (Houston 1994; Hlavica and Lewis 2001). 
CYP enzymes catalysed monooxygenations most often exhibit simple Michaelis-Menten 
kinetic with a hyperbolic relationship between the rate of metabolism of a substrate (velocity) 
and substrate concentration (Hlavica and Lewis 2001; Atkins 2004). However, the kinetic 
patterns of some CYP isoforms e.g. CYP3A4 deviate from the Michaelis-Menten model most 
often indicating allosteric activity regulation (Houston and Kenworthy 2000; Hlavica and 
Lewis 2001; Atkins 2004). CYP allosterism has been observed in vitro with only a few 
specific CYP isoforms; however, simultaneous binding of several ligands to the active site of 
CYP enzymes may be a general phenomenon (Houston and Kenworthy 2000; Hlavica and 
Lewis 2001; Atkins 2004). Most kinetic studies of CYP reactions used microsomes, which 
contain a mixture of several CYP isoforms, therefore the observed metabolic rates could 
reflect effects of several enzyme-substrate interactions. In some cases this may lead to a 
smoothing effect cancelling out different kinetic features and irregularities, and the resulting 
kinetics may appear hyperbolic (Houston and Kenworthy 2000). However, determination of 
kinetic parameters in microsome fractions is still considered a valuable tool in enzyme 
characterisation (Houston and Kenworthy 2000). Kinetic parameters for invertebrate CYP 
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enzymes are most often investigated using the classical B(a)P hydroxylation reaction thereby 
allowing comparison of apparent kinetic parameters between species (Buhler and Williams 
1989). Regarding phase II enzymes, both glucuronosyl transferase and sulfotransferase 
reactions most often display Michaelis-Menten kinetics (Pang 1990). Sulfation and 
glucuronidation are competing pathways for phenolic substrates, and enzyme kinetic 
experiments have been conducted to elucidate the principal relationship between them 
(Mulder et al. 1990). Generally, Km for sulfation is found to be significantly lower than for 
glucuronidation indicating that when small amounts of substrate are available, sulfation will 
be the dominant conjugation pathway (Pang 1990). With increasing substrate concentrations, 
glucuronidation will take over, partly due to a higher Vmax (Hakk et al. 2001), partly due to 
more rapid co-substrate (PAPS) depletion for sulfation than for glucuronidation (UDPGA) 
(Pang 1990; Coughtrie et al. 1998). Accordingly, increasing substrate availability, which 
could be due to induction of CYP mediated phase I metabolism, can result in disproportionate 
increases in glucuronidation rates relative to those seen at low substrate concentrations, giving 
a false impression of induction of the glucuronidation system (Pang 1990). Further, the 
intracellular localisation of the phase II pathways, the UGT active site being in the lumen of 
the endoplasmic reticulum and sulfotransferase enzymes being cytoplasmatic, might also 
affect the relative contributions of these competing pathways (Coughtrie et al. 1998). In 
conclusion, changes in activities of conjugation pathways should be interpreted cautiously.  
 
BIOTRANSFORMATION IN MARINE INVERTEBRATES  
CYP enzyme function and regulation have been investigated in polychaete species on a 
biochemical level. These previous studies primarily estimated CYP enzyme activity in 
relation to biotransformation of various compounds (Lee et al. 1979; Lee and Singer 1980; 
Lee 1981; Fries and Lee 1984; McElroy 1985b; McElroy 1990; Lee 1998). In the polychaete 
N. virens CYP enzyme activity has been found in the microsome fraction of gut tissue. The 
distribution of CYP enzymes varies greatly, with highest activity in the lower intestine, little 
activity in the upper portion of intestine and no activity in pharynx and oesophagus (Lee and 
Singer 1980). There has been no indication of mitochondrial CYP enzyme activity in N. 
virens (Lee and Singer 1980). Several studies have established that N. virens is capable of 
biotransforming PAHs such as B(a)P and benz(a)anthracene (B(a)A) via CYP enzyme 
catalysed reactions (Lee and Singer 1980; Lee 1981; McElroy 1985a; McElroy 1990). The 
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major metabolite produced by N. virens after exposure to B(a)P is 3-hydroxybenzo(a)pyrene, 
indicating a CYP catalysed hydroxylation (Fries and Lee 1984; Lee 1998).  
 
Investigations of polychaete CYP enzymes inducibility have lead to conflicting suggestions 
regarding whether or not the CYP enzymes responsible for PAH biotransformation are 
inducible or constitutively expressed. In the polychaete, Capitella capitata CYP enzyme 
activity could not be detected in unexposed animals but after exposure to B(a)A or crude oil 
for periods of 3 and 6 weeks, it was possible to measure CYP enzyme activity, indicating that 
B(a)A and crude oil induce CYP enzyme activity in this species (Lee et al. 1979; Lee and 
Singer 1980). Driscoll & McElroy (1996) investigated three polychaete species, 
Leitoscoloplos fragilis, Nereis diversicolor and Scolecolepides viridis and found species 
differences not only in their ability to biotransform B(a)P, but also in the inducibility of 
metabolic activity. The ability of L. fragilis to biotransform B(a)P was limited and not 
inducible, whereas N. diversicolor biotransformed B(a)P extensively but was not induced 
after exposure to 3-methylcholanthrene (3-MC) which is a potent inducer of PAH metabolism 
in vertebrates. In contrast, S. viridis extensively biotransformed B(a)P and 3-MC slightly 
induced B(a)P biotransformation (Driscoll and McElroy 1996). Previous experiments with N. 
virens showed that CYP enzyme levels and activity was increased after exposure to B(a)A 
indicating that CYP enzymes are inducible in this species (Lee and Singer 1980; Lee 1981). 
Furthermore, N. virens from an area heavily polluted with crude oil had significantly higher 
CYP enzyme activity than N. virens from a reference area (Lee and Singer 1980; Lee 1981) 
indicating inducibility. In contrast to these results, McElroy (1990) observed no increase in 
CYP enzyme activity in N. virens after exposure to 3-MC. However, the same author 
suggested in a later publication that 3-MC might not be a particularly good inducer of 
polychaete CYPs (Driscoll and McElroy 1997). In accordance, with Lee and Singer (1980) 
and Lee (1981) we found N. virens CYP enzyme induction after exposure to pyrene 
(Manuscript I). 
 
Regarding identification of phase II enzymes and specific phase II conjugates crustaceae is 
the most intensively investigated group of aquatic species. The dominant phase II pathways 
being glucosidation and sulfation (James 1987; Livingstone 1998). However, large species 
differences have been observed regarding which conjugates are produced in different 
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invertebrate species (Table 1). In the shore crab Carcinus maenas, biotransformation of 
pyrene resulted in formation of three major phase II metabolites; two of these are glucoside 
and sulfate. The third is unknown, but it was not a glucuronide conjugate (Fillmann et al. 
2004). In two species of marine clams Mya arenaria and Protothaca staminea exposed to 
pyrene and 1-hydroxypyrene for 10 days, pyrene-1-sulfate was identified as the major phase 
II metabolite (Simpson et al. 2002). In contrast, pyrene-1-glucuronide was the major phase II 
conjugate in the marine polychaetes N. virens and N. diversicolor, however, also pyrene-1-
sulfate and pyrene-1-glucoside were found in both species (Manuscript I; Giessing et al. 
2003a). The identification of pyrene-1-glucuronide as the most prominent phase II conjugate 
indicates that glucuronidation is not restricted to vertebrates as suggested by Livingstone 
(1998). In contrast to N. virens and N. diversicolor pyrene-1-sulfate and pyrene-1-glucoside 
were the most prominent metabolites in the marine polychaetes Capitella capitata and 
Arenicola marina, respectively (Giessing et al. 2003b). The results from the four marine 
polychaete species emphasizes the extensive inter-specific differences in phase II conjugation 
pathways even among closely related species. In the mollusk Mytilus galloprovincialis sulfate 
and glucuronide conjugates were identified (Michel et al. 1995) whereas in the terrestrial 
isopods Porcellio scaber and Oniscus asellus sulfate and glucoside conjugates were identified 
but not glucuronide conjugates (de Knecht et al. 2001). In lobster Homarus americanus 
sulfate and glucoside conjugates were found but not glucuronide conjugates (Li and James 
2000) whereas glucuronide, sulfate and glucoside conjugates were identified in catfish 
Ictalurus punctatus (James et al. 2001). This emphasise the differences conjugation pathways 
between different species, presently prohibiting more general conclusions on the relative 
importance of different phase II conjugation pathway in invertebrates.  
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Table 1. Identified phase II metabolites in invertebrate species, bold indicate that only the 
mentioned phase II metabolite was identified. * Manuscript I in this thesis.  
Species  Substrate Phase II metabolites identified Reference 
Carcinus maenas  1-hydroxypyrene Glucoside, sulfate, unknown Fillmann et al. 2004 
Mya arenaria  1-hydroxypyrene Sulfate, pyrenediol-hydrogensulfate Simpson et al. 2002 
Protothaca staminea  1-hydroxypyrene Sulfate, pyrenediol-hydrogensulfate Simpson et al. 2002 
Mytilus galloprovincialis  B(a)P metabolites Sulfate, glucuronide Michel et al. 1995 
Porcellio scaber  1-hydroxypyrene Glucoside, sulfate DeKnecht et al. 2001 
Oniscus asellus  1-hydroxypyrene Glucoside, sulfate DeKnecht et al. 2001 
Homarus americanus  9-hydroxy-B(a)P Glucoside, sulfate Li & James 2000 
Ictalurus punctatus  3-hydroxy-B(a)P Sulfate, glucuronide, unknown James et al. 2001 
Capitella capitata  1-hydroxypyrene Sulfate  Giessing et al. 2003b 
Arenicola marina  1-hydroxypyrene Glucoside Giessing et al. 2003b 
Nereis diversicolor  1-hydroxypyrene Glucoside, sulfate, glucuronide Giessing et al. 2003a 
Nereis virens  1-hydroxypyrene Glucoside, sulfate, glucuronide Jørgensen et al. 2005* 
 
In order to gain further knowledge about the phase II enzymes it is necessary to investigate 
other aspects, for example by determining enzyme kinetics and inducibility. The inducibility 
of phase II enzymes has been studied in few species only; de Knecht (2001) found no 
induction of glucosidation and sulfation in P. scaber and O. asellus. Further investigations of 
phase II enzyme inducibility in invertebrate species are necessary before any general 
suggestions can be made. In the two fish species channel catfish and mummichog inducibility 
of sulfotransferase and glucuronosyltransferase was investigated using 9-
hydroxybenzo(a)pyrene as substrate; both were significantly induced by 3-MC in channel 
catfish, whereas only glucuronosyltransferase enzymes were induced in mummichog 
(Gaworecki et al. 2004). Regarding apparent kinetic parameters for phase II enzymes, several 
investigations in different species are available (Table 2). The apparent kinetic parameters 
vary extensively among the invertebrate species shown here, but the differences in the 
substrates used are certainly responsible for some of the differences. Furthermore, species 
differences in the most prominent phase II metabolite are also reflected in these variations. If 
both the apparent kinetic parameters and the most prominent phase II metabolite are known 
for an investigated species, it is possible to suggest a prominent conjugation pathway in this 
species. The apparent kinetic parameters of these phase II enzymes are thoroughly discussed 
in manuscript I.       
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Table 2. Summary of apparent kinetic parameters determined for phase II enzymes.  
Enzyme Species Substrate Km
(μM) 
Vmax 
(nmol/min/mg) 
Reference 
Glucuronidation Nereis virens 1-hydroxypyrene 31.0 1.4 Jørgensen et al. (2005) 
Glucuronidation Homo sapiens 1-hydroxypyrene 6.9-8.6 4.9-6.6 Luukkanen et al. (2001) 
Glucuronidation Ictalurus punctatus B(a)P-7,8-dihydrodiol 23.4 0.3 van den Hurk & James (2000) 
Glucuronidation Ictalurus punctatus 3-hydroxy-B(a)P 1 1.1 James et al. (2001) 
Sulfation Nereis virens 1-hydroxypyrene 11.6 0.43 Jørgensen et al (2005) 
Sulfation Porcellio scaber 1-hydroxypyrene 0.3 0.3 De Knecht et al. (2001) 
Sulfation Oniscus asellus 1-hydroxypyrene 0.1 0.3 De Knecht et al. (2001) 
Sulfation Ictalurus punctatus B(a)P-7,8-dihydrodiol n.d. 0.002 van den Hurk & James (2000) 
Sulfation Ictalurus punctatus 3-hydroxy-B(a)P 0.4 1.61 James et al. (2001) 
Glucosidation Nereis  virens 1-hydroxypyrene 73.5 0.46 Jørgensen et al (2005) 
Glucosidation 
Glucosidation 
Porcellio scaber 
Oniscus asellus 
1-hydroxypyrene 
1-hydroxypyrene 
22.1 
8.1 
3.2 
6.2 
De Knecht et al. (2001) 
De Knecht et al. (2001) 
 
In polychaete species the major route of excretion of xenobiotics is assumed to be via the gut 
where chloragogen tissue has a function that resembles that of the vertebrate liver and also the 
highest biotransformation capacity has been found in gut tissue of N. virens (Lee and Singer 
1980). Elimination of conjugated metabolites through the gut is therefore expected. In 
accordance, Giessing et al. (2003a) found conjugates of pyrene in both gut fluid and 
defecation water from N. diversicolor, indicating that pyrene metabolites after phase I and II 
biotransformation are excreted via the gut in this organism. In an experiment comparing 
elimination rates of B(a)P between three different species of polychaetes, elimination of both 
parent compound and metabolites was faster in N. diversicolor and M. viridis that are able to 
biotransform B(a)P compared to L. fragilis that are not able to biotransform (Driscoll and 
McElroy 1997). However, elimination might also be affected by gut retention time and could 
be decreased by presence in the gut of de-conjugating enzymes like β-glucuronidase, leading 
to reabsorption analogous to vertebrate enterohepatic circulation (Mulder et al. 1990). This is 
described in the goldfish (Carassius auratus) for phenol glucuronide formed in the liver and 
excreted in bile but subsequently hydrolysed by intestinal β-glucuronidase. The phenol was 
reabsorbed and finally excreted in urine as a sulfate conjugate (James 1987). Interestingly, in 
a pilot experiment I was able to measure presence of pyrene conjugates in the overlying water 
of microcosmos with either N. virens or N. diversicolor exposed to pyrene contaminated 
sediment. The most prominent conjugate in the water was pyrene-1-sulfate despite the fact 
that the most prominent conjugate in both N. virens and N. diversicolor tissues was pyrene-1-
glucuronide (Manuscript I; Giessing et al. 2003a). This could indicate either that glucuronide 
conjugates might be de-conjugated by β-glucuronidase in these polychaete species or that 
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produced sulfate conjugates are more water soluble and therefore excreted from the 
polychaetes faster than the glucuronide conjugates.  
 
 
SPECIFIC CYP GENES 
The knowledge about specific CYP genes and their regulation and function is extremely 
limited in marine polychaetes. Only few specific CYP genes from polychaetes have been 
published and are available at the NCBI GenBank. Two partial CYP4 genes from N. virens 
have been published (Rewitz et al. 2004), and two complete CYP genes have been identified 
in the marine polychaete Capitella capitata sp. I (Li et al. 2004), assigned CYP4AT1 and 
CYP331A1 by the cytochrome P450 nomenclature committee. Sequencing of the two CYP4 
genes from N. virens is completed in Manuscript II in this master thesis.  
     
IDENTIFIED GENES IN MARINE INVERTEBRATES 
The hitherto reported specific CYP genes from the marine polychaetes and other marine 
invertebrates are summerised in Table 3. Most of them belong to the CYP4 family; however, 
specific CYP genes belonging to other CYP families have also been identified. In several of 
the articles in which the sequences have been published, transcriptional regulations of mRNA 
levels after exposure to exogenous or endogenous compounds have also been determined and 
a putative function of the CYP enzyme have been suggested based on these results. Only one 
of the identified CYP genes has been investigated on the protein level, CYP2L1 from the 
spiny lobster Panulirus argus was expressed in yeast and the enzyme activity determined 
(Boyle et al. 1998).  
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Table 3. Summery of specific CYP genes identified in marine invertebrate species.  
* Manuscript II.   
Species CYP 
isoform 
 Tissue Reference 
Nereis virens CYP4BB1 Complete sequence gut tissue Jørgensen et al. (2005*) 
Nereis virens CYP342A1 Complete sequence gut tissue Jørgensen et al. (2005*) 
Capitella Sp. I CYP331A1 Complete sequence whole worm Li et al. (2004) 
Capitella Sp. I CYP4AT1 Complete sequence whole worm Li et al. (2004) 
Haliotis rufescens CYP4C17 partial sequence digestive gland Snyder (1998a) 
Lytechinus anamesis CYP4C19 partial sequence pyloric caeca Snyder (1998a) 
Lytechinus anamesis CYP4C20 partial sequence pyloric caeca Snyder (1998a) 
Mytilus galloprovincialis CYP4Y1 partial sequence digestive gland Snyder (1998a) 
Mercenaria mercenaria 
Carcinus maenas 
Carcinus maenas 
Panilirus argus 
Orchonectes sapidus 
Penaeus setiferus 
Homarus americanus 
Homarus americanus 
CYP30 
CYP330A1 
CYP4C39 
CYP2L1 
CYP4C15 
CYP4C16 
CYP4C18 
CYP45 
Complete sequence 
complete sequence 
complete sequence 
complete sequence 
complete sequence 
partial sequence 
partial sequence 
complete sequence 
gonads 
hepatopancreas 
hepatopancreas 
hepatopancreas 
Y-organ 
hepatopancreas 
hepatopancreas 
hepatopancreas 
Brown (1998) 
Rewitz et al. (2003)  
Rewitz et al. (2003) 
James (1996)/Boyle et al. (1998) 
Dauphin-Villement et al. (1999) 
Snyder (1998a) 
Snyder (1998a) 
Snyder (1998b) 
 
 
CYP REGULATION  
CYP genes code for proteins that can be divided into constitutively expressed CYPs and 
inducible CYPs. Generally, inducible CYPs are thought to be involved in xenobiotic 
biotransformation (Whitlock 1986; Pang 1990). In many cases, inducers are also substrates 
for the CYP enzymes; therefore, CYP activity remains elevated only as needed (Whitlock 
1986). Induction usually enhances detoxification thus under most conditions, induction is a 
protective mechanism (Pang 1990). CYP gene families 1-4 encode enzymes that biotransform 
foreign compounds, environmental chemicals, drugs and other xenobiotics as well as 
endogenous compounds (Waxman 1999). CYP enzyme activities are regulated in a variety of 
ways and at multiple levels, however the most common and best understood means of 
regulation is transcriptional (Porter and Coon 1991; Denison and Whitlock 1995). However, 
post-transcriptional mechanisms include both mRNA and protein stabilisation that may be 
mediated through transacting regulators or through changes in the phosphorylation status of 
the enzyme (Figure 6). 
 
Many genes including CYP genes can be transcriptionally activated by endogenous or 
exogenous compounds that induce the gene expression through different receptor-dependent 
mechanisms (Waxman 1999; Xie and Evans 2001). The mechanism of transcriptional 
regulation is fairly well understood in vertebrates, but in invertebrate species not much is 
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Figure 6. Multiplicity in the regulation of CYP enzyme activity. There is considerable 
diversity in the mechanism of regulation in CYP enzymes and regulation can occur on levels 
indicated by the arrow. Modified from Porter & Coon (1991).  
 
known except that the CYP gene basic expression levels are low compared to those in 
vertebrates and that also the regulatory capacities of receptors controlling the expression of 
CYP genes are apparently much lower in marine invertebrates compared to vertebrates 
(Snyder 1998a; Rewitz et al. 2004). The regulation of expression of CYP genes involved in 
xenobiotic biotransformation in vertebrates is summarised below as the limited results from 
invertebrate species suggest that the basic mechanism is conserved between vertebrates and 
invertebrates (Butler et al. 2001; Mimura and Fujii-Kuriyama 2003).  
 
The most investigated regulatory mechanism of CYP enzymes in vertebrates is the aryl 
hydrocarbon receptor (AhR). The AhR is a ligand activated transcription factor involved in 
the regulation of several genes, including those for xenobiotic metabolising enzymes such as 
CYP1A and 1B forms (Hahn 1998; Denison and Nagy 2003; Mimura and Fujii-Kuriyama 
2003) and also genes encoding phase II enzymes e.g. glutathione-S-transferase and 
glucuronosyl transferase (Mimura and Fujii-Kuriyama 2003). Ligands for AhR include a 
variety of endogenous and especially exogenous compounds. Environmental contaminants 
including PAHs form the most extensively studied class of AhR ligands (Denison and Nagy 
2003). In the current model of AhR action (Figure 7), a ligand enters the responsive cell and 
binds with high affinity to the cytosolic AhR, which in un-ligated form exists as a 
multiprotein complex containing two molecules of 90-kDa heat-shock protein (Hsp90), co-
chaperone p23 and immunophilin-like protein XAP2 (also called AIP and ARA9) (Hahn 
1998; Denison and Nagy 2003; Mimura and Fujii-Kuriyama 2003). Following binding of a 
ligand the Hsp90 complex dissociates from AhR and is presumed to undergo a conformation 
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change that exposes a nuclear localisation sequence, resulting in translocation of the complex 
into nucleus (Denison and Nagy 2003). Inside the nucleus the ligand bound AhR will be 
released from its multiprotein complex and instead form a new complex with the 
heterodimerisation partner aryl hydrocarbon receptor nuclear translocater (Arnt). This 
converts the AhR to its high affinity DNA binding form and the heterodimer recognises an 
enhacer DNA element designated xenobiotic response element (XRE) which is a sequence 
located in the promoter region of target CYP genes (Denison and Nagy 2003; Mimura and 
Fujii-Kuriyama 2003). Binding of the AhR/Arnt heterodimer to XRE remodels the chromatin 
structure and facilitates the association of another transcription factor Sp1 to its recognition 
sequence in the promoter region. The AhR/Arnt heterodimer directly interacts with Sp1 and 
the two transcription factors enhance the expression of the CYP1A1 gene synergistically 
(Mimura and Fujii-Kuriyama 2003). Transactivation activity is transmitted to the general 
transcription factors in the nucleus and transcription is initiated (Mimura and Fujii-Kuriyama 
2003). 
 
Ligand
AhR AhR Arnt
XRE
Cytosol
Nucleus
Transcription mRNA Translation
Heterodimerisation 
with Arnt and 
binbing to XRE
CYP1
 
Figure 7. Mechanisms of transcriptional activation by AhR. The ligand enters the cell and 
binds to AhR in the cytoplasm. After being transported into the nucleus AhR heterodimerize 
with Arnt and the new complex binds to the xenobiotic response element (XRE) in the 
5´flanking region of the CYP1A1 gene that is transcribed. Modified from Mimura & Fujii-
Kuriyama (2003). 
 
 
CYP genes belonging to family 2, 3 and 4 are regulated by specific nuclear receptors (NR) 
(Waxman 1999; Xie and Evans 2001). The nuclear receptor, constitutive androstane receptor 
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(CAR) regulates CYP2 genes, the pregnane X receptor (PXR) (also called PAR or SXR) 
regulates CYP3 genes, and the peroxisome-proliferator activated receptor (PPAR) mediates 
regulation of CYP4 genes in vertebrates (Waxman 1999). The receptors are activated by 
lipophilic ligands with molecular properties similar to the compounds that are metabolised by 
the CYP enzymes. The DNA binding of PPAR, PXR and CAR requires the dimerisation of 
the specific receptor with the nuclear receptor retinoid X receptor (RXR) that functions as 
heterodimerisation partner for several nuclear receptors (Savas et al. 1999; Waxman 1999; 
Honkakovski and Negishi 2000). Differences in the spacing and orientation of the NR binding 
site contribute to NR specificity and prevent or reduce binding of other receptors. Although 
features of DNA response elements provide the means for targeting specific receptors to the 
genes that they regulate, competition with other NRs for the same binding site can occur 
(Savas et al. 1999).  
 
 
Ligand
PPAR PPAR RXR
PPRE
Cytosol
Nucleus
Transcription mRNA Translation
Heterodimerisation 
CYP4
with RXR and
binding to PPRE
 
Figure 8. Mechanism of transcriptional activation by NR in this example the peroxisome 
proliferator activated receptor (PPAR). Binding of a xenobiotic ligand to PPAR is followed 
by heterodimerisation with another nuclear receptor (RXR). The heterodimer binds to the 
peroxisome proliferator response element (PPRE) in the 5´flanking region of the CYP4 gene, 
which is then transcribed.  
 
The ligand-dependent activation of transcription by nuclear receptors is mediated through the 
ligand-binding domain (LBD) (Savas et al. 1999) and the binding of ligand-activated NRs to 
the hexameric NR core binding sequence in the response elements is mediated by a highly 
conserved DNA binding domain (DBD) (Honkakovski and Negishi 2000). According to the 
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current model of NR activation (Figure 8) using PPAR as example; ligand binding induces 
conformational change in the folding of the LBD, with AF-2 being repositioned forming a 
hydrophobic patch that is accessible to common co-activators and co-integrators such as 
p300/CBP, SCR-1 and TIF2 (Savas et al. 1999; Honkakovski and Negishi 2000). Co-
activators either possess intrinsic histone acetyltransferase activity or recruit additional 
histone acetyltransferases that relieve suppressive effects of the cromatin to activate 
transcription via the general transcription factors in the nucleus (Honkakovski and Negishi 
2000). When the NR ligand is released interaction with co-repressors such as N-Co and 
SMRT suppress gene transcription via recruitment of histone deacetylases (Honkakovski and 
Negishi 2000).  
 
CYP GENE REGULATION IN MARINE INVERTEBRATES 
Two partial CYP4 sequences from N. virens (Rewitz et al. 2004) were investigated regarding 
regulatory capacities by northern blot analysis after exposing individuals of N. virens to 
xenobiotics. The CYP4(1) gene was not inducible by the treatments in the experiment, but the 
CYP4(2) gene was 2-3 fold inducible (significantly) after exposure to crude oil, B(a)A or 
clofibrate. These results indicate that at least one of the N. virens CYP genes is 
transcriptionally inducible by PAHs and therefore might be involved in xenobiotic 
biotransformation (Rewitz et al., 2004). Also, the regulatory capacities of two CYP genes 
from Capitella sp. I (Li et al. 2004) were investigated by real-time PCR after exposing 
individuals of Capitella sp. I to sediment associated B(a)P, fluoranthene or 3-MC in different 
concentrations. CYP331A1 was 2 fold induced (significantly) by two concentrations of B(a)P 
and by one concentration of fluoranthene. However, mRNA levels of CYP331A1 were 
significantly lower after treatment with two concentrations of 3-MC. CYP4AT1 was not 
inducible by B(a)P or fluoranthene in any concentrations, but was significantly induced by 
one concentration of 3-MC (Li et al. 2004). The level of transcriptional regulation found in 
these two marine polychaetes is in the same order of magnitude as the CYP gene regulation 
observed in other marine invertebrates (Snyder 1998a; Rewitz et al. 2003). Interestingly, in 
contrast to Rewitz et al. (2004) who found that the CYP4(2) gene was induced after pre-
exposure to crude oil, Snyder et al. (1998a) found decreased mRNA expression of CYP4Y1 in 
mussel (Mytilus galloprovincialis) after pre-exposure to crude oil (and β-naphtaflavone).  
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HETEROLOGOUS EXPRESSION OF CYP GENES FROM INVERTEBRATES 
Based on the mRNA expression studies with the specific CYPs from N. virens and Capitella 
sp. I, putative functions were suggested to be involvement in xenobiotic detoxification (Li et 
al. 2004; Rewitz et al. 2004). However, in order to further characterise the identified CYP 
genes, functional studies of the corresponding enzymes by heterologous expression is 
necessary. Heterologous expression of CYP genes from marine invertebrates and 
determination of catalytic activity has been conducted in one experiment only, where 
CYP2L1 from the spiny lobster Panulirus argus was expressed in the yeast Pichia pastoris 
(Boyle et al. 1998). The catalytic activity was determined to 2.3 and 3.6 nmol/min/nmol with 
testosterone and progesterone as substrate, respectively (Boyle et al. 1998). The activities 
were re-calculated from nmol/min/mg using the content of 12.8 nmol CYP/mg protein stated 
in figure 1 of Boyle et al. (1998). In insect species, however, several CYP genes have been 
heterologously expressed and catalytic activity determined most often using insecticides as 
substrates. For example, the CYP6A2 gene from Drosophila melanogaster was heterologously 
expressed in lepidopteran cells by infecting the cells with a CYP6A2-recombinant 
baculovirus. The CYP6A2 protein produced in this system metabolised heptachlor and aldrin 
to their epoxides Activities of the epoxidation with added NADPH cytochrome P450 
reductase and cytochrome b5 were 1.04 and 2.53 nmol/min/mg protein with heptachlor and 
aldrin as substrates, respectively (Dunkov et al. 1997). In the house fly Musca domestica, the 
CYP6A1 gene was expressed in E. coli. In a reconstituted system the enzyme was catalytically 
active in epoxidation of the insecticides aldrin and heptachlor with turnover rates of 12 and 34 
min-1 (Andersen et al. 1994). Activity of CYP321A1 from the corn earworm Helicoverpa zea 
was determined in cell lysates prepared from Sf9 cells coexpresing CYP321A1 and house fly 
NADPH reductase. The metabolic  activity towards of the plant allelochemicals xanthotoxin 
and angelicin was 4.2 and 2.5 nmol/min/nmol P450, respectively (Sasabe et al. 2004). Also, 
the metabolic activity towards the insecticide α-cypermethrin was determined to 3.3 
nmol/min/nmol P450 (Sasabe et al. 2004). The activities of heterologously expressed CYPs 
are difficult to directly compare, since expression system, substrate, supply of NADPH 
cytochrome reductase, supply of cytochrome b5 and CYP isoforms differ between 
investigations. Also, it is expected that some CYP enzymes are specific with regard to one or 
few substrates and metabolise with a high activity whereas others are more general with a 
broader substrate specificity and a lower activity (Danielson et al. 1998). The activities 
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mentioned above is to illustrate the levels of activity that have previously been found in 
invertebrate species.      
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AIM OF STUDY 
Polychaetes like N. virens are important members of the benthic ecosystems in estuaries that 
are often impacted by organic contaminants like PAHs. Knowledge about the 
biotransformation of PAHs in this group of species is not extensive despite the importance of 
biotransformation for the toxicity of these compounds, as many of the toxic effects of PAHs 
are mediated by metabolites rather than parent PAHs. Further knowledge on PAH 
biotransformation in invertebrates may help understanding the mechanisms of PAH toxicity 
to these species. It is however important to understand not only the formation of the often 
reactive phase I metabolites but also the formation of phase II metabolites. Accordingly, the 
present study aims at: 
 
1) Identifying and characterising enzymes involved in biotransformation of the model PAH 
pyrene in N. virens including quantifying inducibility and apparent enzyme kinetic 
parameters.  
 
2) Sequencing as well as heterologous expression and purification of two novel CYP genes 
from N. virens that have previously been suggested to be involved in xenobiotic 
biotransformation, to evaluate the likeliness that these specific CYP enzymes are indeed 
involved in biotransformation of the model PAH pyrene.  
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EXPERIMENTAL WORK 
This thesis is based on: 
1. Previously published experiments leading to formulation of the work plan 
2. The two manuscripts, one in press and one submitted 
3. Supportive experimental work described below 
Unless anything else is mentioned, the experimental procedures are described in detail in the 
manuscripts.   
 
PREVIOUS WORK - SUMMERY 
K.F. Rewitz, C. Kjellerup, A. Jørgensen, C. Petersen, O. Andersen (2004). Identification of 
two Nereis virens (Annelida: Polychaeta) cytochromes P450 and induction by xenobiotics. 
Comparative Biochemistry and Physiology Part C 138: 89-96 – Appendix I 
 
Two partial sequences of CYP4 genes from N. virens gut tissue were identified after RT-PCR 
with degenerated primers designed from conserved regions of CYP4 genes. In order to 
investigate the expression of the two CYP genes, N. virens was exposed to different PAHs and 
known inducers of vertebrate CYP4 by intracoelomic injections. Expression of CYP4(1) and 
CYP4(2) mRNA in the gut tissue was quantified by Northern blot analysis. The expression of 
the CYP4(2) gene was significantly upregulated by clofibrate, B(a)A and crude oil exposure 
compared to the expression vehicle treated controls. In contrast CYP4(1) was not significantly 
induced by any treatment. These results indicate that CYP4(2) are transcriptionally regulated 
by xenobiotics and therefore might be involved in xenobiotic biotransformation.  
 
MANUSCRIPT I - SUMMERY 
A. Jørgensen, A.M.B. Giessing, L. Juel Rasmussen and O. Andersen (2005). 
Biotransformation of the polycyclic aromatic hydrocarbon pyrene in the marine polychaete 
Nereis virens. Environmental Toxicology and Chemistry 24 (11) In press. 
 
Biotransformation of the polycyclic aromatic hydrocarbon (PAH) pyrene was investigated by 
exposure of the marine polychaete Nereis virens to pyrene in laboratory microcosms. After 5 
days exposure, relative amounts of pyrene and pyrene derived metabolites in gut (intestinal 
and chloragogenic) tissue were: 65% pyrene-1-glucuronide, 12% pyrene-1-sulfate, 2% 
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pyrene-1-glucoside, 4% 1-hydroxypyrene and 17% pyrene, indicating that glucuronidation is 
the prominent phase II pathway in this organism. Assays were designed to characterise 
enzymes involved in this biotransformation. Formation of 1-hydroxypyrene, pyrene-1-
glucuronide, pyrene-1-sulfate and pyrene-1-glucoside appeared to be sensitive measures for 
the activity of pyrene hydroxylase, glucuronosyl transferase and sulfotransferase. Only pyrene 
hydroxylase activity was significantly induced after exposure to sediment associated pyrene 
(10 μg/g). Apparent kinetic parameters were determined for all enzymatic reactions, thereby 
glucuronidation was confirmed to be the prominent phase II reaction based on the highest 
Vmax(a) determined. Apparent kinetic parameters for pyrene hydroxylase activity were changed 
after induction with pyrene, induced worms showed increased Vmax(a) and decreased Km(a) 
compared to non-induced worms. This indicates that the relative contribution to total CYP 
protein of the CYP enzymes responsible for pyrene hydroxylation was increased. Altogether, 
our results indicate that N. virens has a high biotransformation capacity for PAHs, with 
inducible pyrene hydroxylase activity and that the most prominent phase II pathway in this 
organism is glucuronidation. 
  
MANUSCRIPT II - SUMMERY 
A. Jørgensen, L. Juel Rasmussen and O. Andersen (2005). Identification of two novel CYP4 
genes from the marine polychaete Nereis virens and their involvement in pyrene hydroxylase 
activity. Submitted, Biochem. Biophys. Res. Commun. 
 
The present study reports two CYP sequences identified in gut tissue from the marine 
polychaete N. virens. Based on known partial sequences the two genes were completely 
sequenced using RACE-PCR. The enzymes were named CYP4BB1 (encoding a 508 amino 
acid protein) and CYP342A1 (encoding a 508 amino acid protein). CYP4BB1 shared highest 
homology 41% to Mus musculus CYP4F15 whereas CYP342A1 was most identical with Mus 
musculus CYP4F14 with 34% homology. Both sequences contain the conserved CYP 
signature sequence, the CYP4 family invariant sequence and other conserved amino acid 
residues. Both CYP4BB1 and CYP342A1 were heterologously expressed in E. coli BL21 and 
purified. The catalytic activity of the two enzymes was determined after development of an 
activity assay measuring the formation of 1-hydroxypyrene with pyrene as substrate. Our 
results indicate that these two novel CYP proteins might be involved in xenobiotic 
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biotransformation. Furthermore, site directed mutagenesis of the conserved cysteine residue in 
the heme binding domain lead to complete loss of monooxygenase activity in both CYP4BB1 
and CYP342A1.     
 
UNPUBLISHED RESULTS:  
Effects of PAH exposure on enzyme activities 
The induction of pyrene hydroxylase activity by exposure to 10 µg/g pyrene in sediment was 
investigated in an independent experiment to ensure that the results found in manuscript I 
were reproducible, and to investigate if a concentration of B(a)A between the concentrations 
used in manuscript II would induce pyrene hydroxylase activity. In addition, pooled gut tissue 
were used in this experiment in order to reduce the variance due to variability between 
individual samples and investigate if this would influence the result from manuscript I, where 
inductions of phase II enzymes were not observed. The experiment consisted of five groups of 
8 individuals of N. virens that were exposed for 7 days to control sediment, sediment 
contaminated with 10 µg/g pyrene or 5 µg/g B(a)A. Gut tissue was isolated and pooled before 
preparation of a microsome fraction and a cytosolic fraction. Procedures were as described in 
manuscript I both regarding microsome and cytosole preparations, enzyme assays and HPLC 
analysis. As can be seen in Figure 9, exposure to 5 µg/g B(a)A, the concentration not used in 
the experiment in manuscript I, did not induce pyrene hydroxylase activity. As expected, 
exposure to 10 µg/g pyrene resulted in a significant induction of pyrene hydroxylase activity 
by a 3-fold. Also, none of the phase II enzyme reactions (glucuronidation, glucosidation or 
sulfation) were significantly induced after 7 days exposure to 10 µg/g pyrene or 5 µg/g B(a)A 
in this experiment. 
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Figure 9. Induction of pyrene hydroxylase, glucuronidation, glucosidation and sulfation 
enzyme activity by exposure of N. virens to pyrene 10 μg/g dry weight sediment or B(a)A 5 
μg/g dry weight sediment for 7 days. Enzyme activity was calculated as μg 1-
hydroxypyrene/min/mg protein and is shown in the table as relative activity compared to 
controls. In each exposure group, gut tissue from 8 animals was pooled. For all enzymatic 
measurements n=4 on the pooled homogenate. * Significantly different according to Turkey-
Kramer test (p< 0.05). 
 
Predicted secondary structure  
The secondary structures of N. virens CYP4BB1 and CYP342A1 were predicted using the 
Jpred submission (www.compbio.dundee.ac.uk/~www-jpred/submit.html). After 
submission of the deduced amino acid sequences, the server allows the sequences to be 
aligned to sequences from different secondary structure prediction algorithms. A consensus 
prediction is returned along with the results from the different secondary structure prediction 
algorithms.  The predicted secondary structures based on the deduced amino acid sequences 
of the two CYP4 genes are presented in figure 10. The deduced amino acid sequences of the 
two CYPs are only 35% identical. CYP proteins most often accommodate around four β 
sheets and 13 α helices defining two domains, one predominately comprised by β sheets and 
one predominately α helices (Graham and Peterson 1999; Werck-Reichart and Feyereisen 
2000). The first domain is often associated with substrate recognition, the second is the 
catalytic center (Werck-Reichart and Feyereisen 2000). Conserved domains in the primary 
structure are marked by greyscale in the figure. 
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Figure 10A - Predicted secondary structure of CYP4BB1 
 
AA         : 1---------11--------21--------31--------41--------51--------61--------71--------81--------91--------101-------111-------121------- 
OrigSeq    : MNSVTTSIAVVILLPVLYKVYQYLHWIYRTWFVIGTQVNKFPGEPLKWPYGNLHQNPGFNEKLNGYQKSMAAKYNRLWRMWFGPFVPFISLCHPDTIKILVKTEEPKFTDGNAGYLLAEPWLGNRLLLKC 
jalign     : ------------------------------------------------------------------------------EEEE------EEEE---HHHHHHHH-----------HHHHHH---------- 
jfreq      : ------HHHHHHHHHHHHHHHHHHHHHHHHHHHH----------------------EE------HHHHHHHHH----EEEEEE----EEEEE---HHHHHHHHH-------------EEE------EEE- 
jhmm       : ---HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-----------------------------HHHHHHHHHH----EEEEEE----EEEEE--HHHHHHHH-------------------------E-- 
jnet       : ------HHHHHHHHHHHHHHHHHHHHHHHHHHHH-------------------HHHHH-----HHHHHHHHHH----EEEEEE---EEEEEE--HHHHHHHHHH----------------------EEE- 
jpssm      : -----EEEHHHHHHHHHHHHHHHHHHHHHHHHHH--------------------HH-------HHHHHHHHHH-----EEEEE---EEEEEE---HHHHHHHHH---------------------EEEE- 
jpred      : ------HHHHHHHHHHHHHHHHHHHHHHHHHHHH-----------------------------HHHHHHHHHH----EEEEEE----EEEEE---HHHHHHHHH----------------------EEE- 
Jnet Rel   : 5511003579999999999999999999999986157888899999988641213323999873999999997089928997567117999618007977657179877898876642233478616851 
Putative helix 
 
AA         : 131-------141-------151-------161-------171-------181-------191-------201-------211-------221-------231-------241-------251-------
OrigSeq    : WTKVEEKQETPDTSFSFWHPQELHFCLQCGNRNSDEKSGQQKDRKERALTFRRIFRLCTLSIILRCAFSYDEKIQETGERHPYAVAVLDLSRLMVERAFNPFVRMSKFLYGLTANGRTFFKHCDYVHKVA 
jalign     : --HHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHHHH---------HHHHHHHH----H---------------------HHHHHHHHHH---------------------------HH------ 
jfreq      : ---HHHHHHHHHHHHH--HHHHHH---HHHHHHHHHHHHHHHH------H-HHHHHHHHHHHHHHHHHH-----------HHHHHHHHHHHHHHHH-----HHHHHHHHHH-----HHHHHHHHHHHHHH 
jhmm       : --HHHHHHHHHHHHH---------HHHHHHHHHHHHHHHHHH---------HHHHHHHHHHHHHHHHHH------------HHHHHHHHHHHHHHH--------------------HHHHHHHHHHHHHH 
jnet       : --HHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHH------E-HHHHHHHHHHHHHHHHHH-----------HHHHHHHHHHHHHHHHHH---HHHHHHHHH------HHHHHHHHHHHHHH 
jpssm      : --HHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHH------EEHHHHHHHHHHHHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHHHHHHHH-------HHHHHHHHHHHHHH 
jpred      : --HHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHH------E-HHHHHHHHHHHHHHHHHH-----------HHHHHHHHHHHHHHHH-----HHHHHHHH-------HHHHHHHHHHHHHH 
Jnet Rel   : 7448999999998750441467765367899999999999986179971220588988999998999971404677678849999999999999975110003223334314895589999999999999 
Putative helix C-helix 
 
AA         : 261-------271-------281-------291-------301-------311-------321-------331-------341-------351-------361-------371-------381------- 
OrigSeq    : ETVISQRRETLQENPDALEDR KYLDFLDILLQARDEDGTGLSDLEIRNEVDTFMFEGHDTTASGISWALYSLAKHPEFQKKAQQEIDELLADRKNKWIMWDDLNQLPYLTMCLKESMRLWCPVPVISRQ 
jalign     : -HHHHHH--------------------HHHH-------------HHHHHHHHHHH-------HHHHHHHHHHH------HHHHHHHH-------------------HHHHHHHHHHHHH----------- 
jfreq      : HHHHHHHHHHHHH----------HHHHHHHHHHH---------HHHHHHHHHHHHH------HHHHHHHHHHHH---HHHHHHHHHHHHE----------HHH----HHHHHHHHHHHH----------- 
jhmm       : HHHHHHHHHHH------------HHHHHHHHHHH---------HHHHHHHHHHHHH----HHHHHHHHHHHHHH---HHHHHHHHHHHHH------------------HHHHHHHHHH------------ 
jnet       : HHHHHHHHHHHHH----------HHHHHHHHHHH---------HHHHHHHHHHHHH-----HHHHHHHHHHHHH---HHHHHHHHHHHHH---------HHHHH---HHHHHHHHHHHH----------- 
jpssm      : HHHHHHHHHHHH-----------HHHHHHHHHHH---------HHHHHHHHHHHH-------HHHHHHHHHHHH------HHHHHHHHH----------------------------------------- 
jpred      : HHHHHHHHHHHH-----------HHHHHHHHHHH---------HHHHHHHHHHHHH------HHHHHHHHHHHH---HHHHHHHHHHHHH-----------------HHHHHHHHHHHH----------- 
Jnet Rel   : 9999998999862577788886569998888996268898884978887898885657522579999999988606837823778889865789999887120578417899888876256756656766 
Putative helix                                                 I-helix                                                   K-helix 
 
AA         : 391-------401-------411-------421-------431-------441-------451-------461-------471-------481-------491-------501----- 
OrigSeq    : LLNPITIDGVTLPPHTLFDINIIALHHNPTVWGEDHDEYKPERFLPENINKMDNFAFLFSAGPRNCIGQNFAFNEMKTTIARIIQRFDLSVDESHPVYPRPEVVTRAIHGIKLFMNPR 
jalign     : --------------------HHHH-------------------------------------------HHHHHHHHHHHHHHHHH---------------------------------- 
jfreq      : ---------EE-----EEEEEEEE-------------------------------E------------HHHHHHHHHHHHHHHHHHHH--------------EEE------EEEE--- 
jhmm       : ----------E-----EEEEE---------------------------------EEEE-------HHHHHHHHHHHHHHHHHHHH--------------------------EEEE--- 
jnet       : ---------EEE----EEEEEEEE-------------------------------EE-----------HHHHHHHHHHHHHHHHHH-----------------EE------EEEE--- 
jpssm      : ---------EEE----EEEEE----------------------------------E------------HHHHHHHHHHHHHHHH---EEE--------------------EEEEE--- 
jpred      : ---------EE-----EEEEEEEE-------------------------------E------------HHHHHHHHHHHHHHHHH--------------------------EEEE---  
Jnet Rel   : 6688532212713775688875422467888899987667765443356899981414888776413023799999999986426402027899998877861326889817888548  
Putative helix                                                                       L-helix 
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Figure 10B - Predicted secondary structure CYP342A1 
AA no.      : 1---------11--------21--------31--------41--------51--------61--------71--------81--------91--------101-------111-------121------- 
OrigSeq     : MGNAVSIVNEQVQPLLAKVSNLTALENVRKRDVISAILVAYGVYIGGSFIAKCYKIHRFRQKLEGIPNKPSVVMGNLSDFPGPGPEVFGWVQGKVNQYKKFYQFWVGPFSPMISLCHPETSQNHPEVIRT 
jalign      : -----------------------------------------------------------------------------------------------------EEEE------EEEE--------------- 
jfreq       : --------------------------HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-------------EE----E------- HHHHHHHHHHH---EEEEEE----EEEEE---HHHHHHHHHHH    
jhmm        : -----------------------HH-------HHHHHHHHHHHHHHHHHHHHHHHHHHH-------------------HH------HHHHHHHHHH-----EEEEE----EEEEE---HHHHHHHHHH-- 
jnet        : ---------------------HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---------------------------HHHHHHHHHH-----EEEE---EEEEEEE--EEHHHHHHHHHH- 
jpssm       : -------------------HHHHH---HHHHHH-----EEEE-----HHHHHHHHHHHEEE------------EEE-----------HHHHHHHHHHH----EEEE-----EEEEEHHHHHHHHHHHHHH 
jpred       : ---------------------------HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---------------------------HHHHHHHHHH-----EEEE-----EEEEE---EE-HHHHHHHHH 
Jnet Rel    : 0201223234212026444221231513578998766787777778899999999877415555555444332246892299999837888888744987033322110047544314415787777772 
Putative helix 
 
AA no.      : 131-------141-------151-------161-------171-------181-------191-------201-------211-------221-------231-------241-------251------- 
OrigSeq     : KVHLHRIWPVMLLLKEWLGDGLLLSSGSKWFRNRRLLTPAFHFRDSQTILRDLQSFSLTNSLTKCPLKEKMAKRVCPFILLSVFWRWILFYDVRSQMKRTYKFKGKMTHMWLQLLRSRTLLYKGFSILSC 
jalign      : ----------HHHHHH------------HHHHHH-------HHH------------------HHHHHH-------------- HHHHH-----H----------------HHHHHHHHHHHHHH------ 
jfreq       : H------------EE-------EEE----HHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHH---------HHHHHHHHHEEEEEEE-----------HHHHHHHHHHHHHHHH---HHH 
jhmm        : ----------------------E-----HHHHHHHHHHHHH--------HHHHHHHHHHHHHHHHHH----------E--HHHHHHHHHHHHHHHE------------HHHHHHHHHHHHH--------- 
jnet        : ---------HHHH---------EE---HHHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHH--------HHHHHHHHHHHHHHHHHHHHHHH 
jpssm       : E---HHHHHHHHHH-----------EEEE-HHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHH--------HHHHHHHHHHH---------- 
jpred       : -----------HHH---------E-----HHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHHHHH---------HHHHHHHHHHHHHHHH-----------HHHHHHHHHHHHHHHH---HHH 
Jnet Rel    : 5762554432333057888891316543788788878880222688888877878999999902124888731332243589776557534555541334456777337208877788822765456777 
Putative helix                                 C-helix 
 
AA no.      : 261-------271-------281-------291-------301-------311-------321-------331-------341-------351-------361-------371-------381------- 
OrigSeq     : TIRYYFTLAPLDVRIEERCSVYTKYHKKYYRNERSLWLRTQMHLKRDILISWTSFWLLEMRTEKVCLDREIRDEVDTFMFEGHDTTASGISWILYELSRHPEVQEQAGQEVIRVIGSQSDGTIEWSDLSR 
jalign      : -----------------HHHHHHHHHHHHHHHHHHHHH----------------HH-------------HHHHHHHHHHH-------HHHHHHHHHHH-----HHHHHHHHHHHH--------------- 
jfreq       : HHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHHH----------HHHHHHHHHHH--------HHHHHHHHHHHHH------HHHHHHHHHHHH---HHHHHHHHHHHHE----------HHHH- 
jhmm        : -----------HHHHHHHHHHHHHHHHHHHHHHHHH------------HHHHHHHHHH---------HHHHHHHHHHHHH----HHHHHHHHHHHHH----HHHHHHHHHHHHH---------------- 
jnet        : HHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHHH--------HHHHHHHHHHHH------HHHHHHHHHHHHHHH---HHHHHHHHHHHHHH----HHHHHHHHHHHHH--------HHHHHH-- 
jpssm       : HHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHHH---------HHHHHHHHHHHHH------HHHHHHHHHHHHH------HHHHHHHHHHHH------HHHHHHHHHH---------------- 
jpred       : HHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHHH----------HHHHHHHHHH---------HHHHHHHHHHHHH----HHHHHHHHHHHHH----HHHHHHHHHHHHH----------HHHH- 
Jnet Rel    : 8888876101411478899988888998989999999822334443159999958775176424113999986542654197146899999997484353288999999998454885265223554242 
Putative helix                                                                       I-helix                         K-helix 
 
AA no.      : 391-------401-------411-------421-------431-------441-------451-------461-------471-------481-------491-------501----- 
OrigSeq     : LPYLSQCIKEAMRVHPPVPFIGRQLSQDIIINGCTIPKDTICEVSIYGVHHNPEVWGKDHMEFKPERFHPDNMKDKDAFDYIPFSAGSRNCIGQNFALNEEKVVIRQGFAEVRITSGS 
jalign      : -HHHHHHHHHHHHH----------------------------EEEE----------------------------------E-------------HHHHHHHHHHHHHHHH-------- 
jfreq       : ---HHHHHHHHHHH--------------------EE-----EEEEEEEE-------------------------------EE------------HHHHHHHHHHHHHHHHHHH----- 
jhmm        : --HHHHHHHHHH----------------------------EEEEE----------------------------------EEEE-------HHHHHHHHHHHHHHHHHHHH-------- 
jnet        : --HHHHHHHHHHH---------------------E-----EEEEEEEEE-------------------------------E-----------HHHHHHHHHHHHHHHHHHHHHH---- 
jpssm       : ----------H--------HH---------------------------E------EEEEE---------------------------------------------HHHHHHHHH---- 
jpred       : ---HHHHHHHHHHH---------------------------EEEEE----------------------------------EE------------HHHHHHHHHHHHHHHHHHH----- 
Jnet Rel    : 5246678899084788730550012465578783277634566644453137886776673223688888899886657122588875430216667888888997899986204112 
Putative helix                                                                                                      L-helix
 
Figure 10. Prediction of secondary structure of CYP4BB1 and CYP342A1. H: indicate amino acid contributing to helix; E indicate amino acid 
contributing to β-strand; Jnet Rel indicate the number indicate the reliability of the predicted result. The higher number, the higher the reliability of the 
predicted result for each amino acid residue. The putative helix names are indicated for both CYP amino acid sequences after comparison of the 
location with the domains and secondary structure of other CYPs. 
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 DISCUSSION    
Polychaetes that inhabit polluted near-shore and estuarine areas are exposed to lipophilic 
xenobiotics that potentially affect their growth, reproduction and general fitness. Polychaetes (and 
other organisms) have evolved the two-phase biotransformation system previously described in this 
thesis as an adaptation to their needs for facilitating the excretion of both endogenous and 
exogenous compounds. In order to determine if invertebrate species efficiently biotransform PAHs, 
a good approach is to conduct both in vivo and in vitro studies in each species of interest (James 
1989). The studies described in the present thesis addressed the identification of CYP enzymes and 
various phase II enzymes with regard to their inducibility, capacity and relative importance for the 
metabolism of pyrene employed as PAH model compound. The simple metabolic pattern of pyrene 
allows determination of the enzymes that are important in pyrene biotransformation in this species. 
The approach employed in these studies is essential for a deeper understanding of the mechanisms 
of biotransformation in this invertebrate species. Determination of the pyrene metabolites present in 
N. virens gut tissue after 5 days exposure showed that more than 80% of the pyrene derived 
compounds were present as aqueous metabolites indicating that biotransformation is quite efficient 
in this species. This is in the same range as found in N. diversicolor where approximately 75% of  
total pyrene were present as pyrene-1-glucuronide (Giessing et al. 2003a). In another study with N. 
diversicolor and B(a)P, 75% was recovered as aqueous metabolites (Driscoll and McElroy 1996). 
Chistensen et al. (2002) found that 50% of total pyrene in N. diversicolor were water-soluble 
metabolites after 42 days whereas the same study found that in A. marina more than 80% were 
present as unmetabolised pyrene after 52 days. This is an interesting result in a risk assessment 
context, since most monitoring programs measure the presence of parent PAHs only. This practise 
could lead to underestimation of PAH exposure and presence in the environment if the monitoring 
organism used has a high biotransformation capacity. Measurements of PAH metabolites in 
monitoring organisms would provide additional information about the extend of exposure, as well 
as on the biotransformation capacity of the monitoring organisms (Stroomberg 2003). Also, this 
type of information could be used to identify sensitive species, which might improve the choice of 
model organism in different types of monitoring. In N. virens it was established that the phase I 
biotransformation activity measured was CYP enzyme mediated and that the most prominent phase 
II metabolite was pyrene-1-glucuronide. Two additional phase II metabolites of pyrene were 
produced in this species: pyrene-1-sulfate and pyrene-1-glucoside (manuscript I). The inducibility 
of N. virens pyrene hydroxylase activity, glucuronosyl transferase and sulfotransferase enzymes 
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 were investigated in manuscript I. As discussed in the manuscript and in the introduction of this 
thesis, inducibility of polychaete CYP enzymes have previously resulted in conflicting results. The 
induction of pyrene hydroxylase activity after pre-treatment with 10 μg/g pyrene found in 
manuscript I adds novel information to this discussion. Only very few studies have investigated the 
inducibility of glucuronosyl transferase and sulfotransferase enzyme activity in invertebrate species. 
However, in manuscript I we found that the phase II enzyme activities were not very inducible. This 
was further investigated in an experiment supplementing the data in manuscript I and presented in 
this thesis. The data from this experiment confirmed the approximately 3-fold inducibility of pyrene 
hydroxylase activity after exposure to 10 μg/g pyrene. Also, as shown in figure 9, the activity of the 
phase II enzymes were not inducible by pyrene and B(a)A in the concentrations used in these 
experiments. This finding is in agreement with the results from other studies previously discussed in 
the introductory chapters of this thesis. Regarding the kinetic experiment, the calculated kinetic 
parameters are compared and discussed in relation to values obtained from other invertebrates in 
manuscript I. The lowest capacity, Vmax(a), was determined for pyrene hydroxylase in control 
animals, which could indicate that hydroxylation is the rate-limiting step for the overall excretion of 
pyrene from N. virens. However, pyrene hydroxylase activity was significantly induced resulting in 
higher Vmax(a) and lower Km(a) values. In addition, none of the phase II enzymes appeared to be 
inducible and it does seem logic that only the rate-limiting step is inducible.   
     
The biotransformation pathway of pyrene in N. virens presented in manuscript I provides the first 
overall model for metabolites and enzymes involved in biotransformation in this species. Additional 
data on the excretion routes for different conjugates and especially on excretion directly to the water 
phase would provide further knowledge about the overall elimination kinetics, as the conjugate 
most prominent in gut-tissue may not necessarily be the one excreted directly to water, as has 
previously been demonstrated in Carrassius auratus (James 1987). Preliminary data seems to 
indicate that sulfate conjugates are present in higher concentrations in the water phase of 
microcosms with N. virens or N. diversicolor compared to the other phase II metabolites 
glucuronide and glucoside conjugates. This finding is in agreement with results from the flounder 
Paralictes lethostigma, where excretion rates of sulfate conjugates were higher than those of 
glucuronide conjugates (Foureman 1989). Such data could together with the already obtained 
biotransformation data allow modelling of biotransformation and excretion of pyrene in N. virens. 
A first order multi-compartment model has already been created for biotransformation and 
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 excretion of pyrene in the terrestrial model organism P. scaber (Stroomberg 2003). However, the 
first attempts to fit the model to data obtained in the field were not satisfactory, primarily due to an 
assumed constant food intake of the organism that seemed not to be correct. Despite these 
preliminary difficulties, such a model would be useful both to gain a better understanding of the 
factors influencing the effect of PAH exposure and in estimating the toxicity of the PAH since 
many of the toxic effects are mediated via metabolites rather than by the parent PAH (James 1989; 
Stroomberg 2003). Furthermore, it could be interesting to determine the excretion of pyrene 
metabolites in N. virens since a previous study with N. diversicolor and A. marina showed 
differences in removal paths of pyrene from the sediment between the two polychaete species 
(Christensen et al. 2002b). The major pathway for removal of pyrene from the sediment with N. 
diversicolor was release of water-soluble metabolites to the water phase whereas the major pathway 
with A. marina was flushing of unmetabolised pyrene due to bioturbation (Christensen et al. 
2002b). However, in experiments with A. marina also stimulated microbial degradation and release 
of water-soluble metabolites contributed to removal of pyrene from the sediment (Christensen et al. 
2002b). Also, previous investigations have indicated that the rate of elimination of B(a)P 
metabolites in Marenzellaria viridis and N. diversicolor appeared to be slower than elimination of 
the parent compound (Driscoll and McElroy 1997). This result agrees with the general notion that 
apparently, PAH metabolites are eliminated inefficiently by aquatic invertebrates (James 1989). 
 
PAHs are primarily excreted from eukaryote organisms in the form of conjugates, and the 
environmental fate of these conjugates is presently unknown. It has been speculated that after 
elimination from the organism, bacteria will further degrade the conjugated PAHs. Generally, 
microbial degradation of parent PAHs is rapid for low molecular weight PAHs whereas high 
molecular weight PAHs appear to be more persistent to microbial degradation (Cerniglia 1991). 
Since the eukaryotic PAH metabolism does not introduce ring opening (Giessing 2002), the 
mineralisation to CO2 of PAH metabolites excreted from eukaryotic organisms must be conducted 
by bacteria (Cerniglia and Heitkamp 1989). It has been suggested that after excretion to the 
environment, the endogenous groups of the conjugated PAHs are readily hydrolysed from the 
aromatic ring structure releasing phase I metabolites (Giessing and Johnsen 2005), analogous to the 
hydrolysis of biliarily excreted conjugates by intestinal flora in mammals. Recently, Giessing and 
Johnsen (2005) showed that marine pyrene degrading bacteria did not degrade pyrene metabolites 
excreted from N. diversicolor whereas pyrene was indeed degraded. Furthermore, six isolated 
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 bacterial strains known to degrade pyrene were tested for metabolic capacity for 1-hydroxypyrene 
in a growth assay and in a respiration assay. None of the strains could utilise 1-hydroxypyrene as 
their sole carbon and energy source. In addition, 1-hydroxypyrene reduced the respiration rates of 
all six strains. This suggests a direct toxic effect of 1-hydroxypyrene and supports the negligible 
degradation of pyrene metabolites excreted from N. diversicolor (Giessing and Johnsen 2005). 
Since bacteria conceivably are unable to degrade phase I metabolites of some PAHs, their fate is 
currently unknown and remains to be elucidated.  
 
Another aspect of the environmental kinetics of PAHs, that is often discussed but not very well 
investigated, is the trophic transfer of toxic metabolites that are potentially mutagenic or 
carcinogenic. As marine polychaetes are an important feeding source for several fish species like 
flatfish, cod and trout, PAH metabolites formed in the polychaetes might be transferred to the next 
trophic level (McElroy and Sisson 1989). Since the biotransformation capacity of fish and 
vertebrate organisms is considered to be larger than that of invertebrates, transferred phase I 
metabolites might be further oxidized by CYP catalysed reactions which might lead to formation of 
metabolites that can react with DNA (James 1989). This has been investigated in few experiments. 
Rice et al. (2000) investigated growth, CYP1A expression and DNA adduct formation in juveniles 
of the flatfish (Pleuronectes vetulus) fed the polychaete Armandia brevis exposed to harbour 
sediment or sediment contaminated with B(a)P, Arochlor 1254 or dichlorodiphenyldichloroethylene 
(DDE) (Rice et al. 2000). The growth of P. vetulus fed exposed worms was slower than of those fed 
non-exposed worms. Also, fish fed exposed worms all showed increased expression of CYP1A, 
whereas hepatic PAH-DNA adducts were found only in fish exposed to B(a)P-exposed polychaetes 
(Rice et al. 2000). Palmqvist et al. (personal communication) investigated the trophic transfer to N. 
virens of 14C-labelled fluoranthene from two Capitella sibling species differing in their ability to 
biotransform. N. virens fed Capitella Sp. I (effective biotransformator) accumulated higher levels of 
fluoranthene derived compounds than did Capitella Sp. S (poor biotransformator). This is in 
agreement with the general finding that PAH metabolites are eliminated inefficiently by aquatic 
invertebrates and, thus, certain invertebrates exposed to PAHs could be dietary sources of 
potentially toxic PAH metabolites, even when the parent PAH has allready been eliminated from 
the organism (James 1989). There were however, no indications of DNA damage in N. virens fed 
Capitella Sp. S or Capitella Sp. I (Palmqvist et al. personal communication). Also, McElroy and 
Sisson (1989) demonstrated transfer of metabolites of 14C-labelled B(a)P formed by N. virens via 
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 the diet to winter flounder Pseudopleuronectes americanus, resulting in the presence of phase I and 
phase II metabolites in liver and intestine. This indicates that transfer of PAH metabolites between 
trophic levels might have effects on different levels to the predator organism. 
  
The use of pyrene as a model PAH offers the advantage of the formation of only one phase I 
metabolite, facilitating identification of all formed phase II metabolites. There were no indications 
of further CYP mediated oxidation of 1-hydroxypyrene in N. virens in manuscript I, in agreement 
with previous studies not finding further oxidation of 1-hydroxypyrene (de Knecht et al. 2001; 
Giessing et al. 2003a; Giessing et al. 2003b; Fillmann et al. 2004). In one study, Simpson et al. 
(2002) found further oxidation of 1-hydroxypyrene to pyrenediol-hydrogensulfate but only after 
exposure of Mya arenaria and Protothaca staminea to 1-hydroxypyrene and it appeared that 
conjugation of 1-hydroxypyrene pre-dominated over this further oxidation (Simpson et al. 2002). 
There are, however, also disadvantages with the use of pyrene as model PAH. The lack of pyrene 
epoxide formation precludes evaluation of the importance in the phase II PAH biotransformation of 
the normally highly important glutathione-S-transferase (GST) enzyme activity (James 1987; 
Livingstone 1998). GST-metabolites of other PAHs have previously been identified in several 
invertebrate species (Livingstone 1998). Despite this limitation in model biotransformation, the 
results in this study, presenting a detailed biotransformation pathway for pyrene in N. virens, 
contribute to the understanding of a significant part of the biotransformation involved in excretion 
of PAHs from this organism. 
 
 
In order to increase the mechanistic understanding of the CYP enzymes mediating the first step of 
biotransformation in N. virens, two CYP genes were sequenced. CYP4BB1 and CYP342A1 
presented in manuscript II are among the first CYP genes reported in polychaetes. N. virens 
CYP342A1 shares less than 40% amino acid identity with other CYP enzymes and was therefore 
assigned to a new family, which is closest related to members of the CYP4F family. The other 
identified N. virens gene CYP4BB1 was assigned to a new subfamily, but was also closest related 
to CYP4F. Compared to vertebrates, the invertebrate CYP4 family is more diverse comprising 
numerous members even within a single species. In vertebrates, CYP4 enzymes are primarily 
involved in fatty acid metabolism, but some enzymes are also recognised for their involvement in 
metabolism of exogenous compound (Kikuta et al. 1999). It has been suggested that CYP4 enzymes 
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 in vertebrates function at the interface between metabolism of endogenous and exogenous 
substrates (Fischer et al. 1998). In insects the CYP4 family has been suggested to be involved in 
toxin metabolism (Scott et al. 1994; Dunkov et al. 1996). This is supported by the greater number 
and broader sequence diversity of CYP4 sequences in insects which indicate that these enzymes 
could have a similar role as vertebrate CYP2, that are involved in drug metabolism (Dunkov et al. 
1996). This hypothesis is supported by Danielson et al. (1998) who relates strong and highly 
specific upregulations of CYP4 mRNA expression after barbiturate exposure to a pattern of 
xenobiotic responsiveness more similar to vertebrate drug metabolising enzymes than to putative 
vertebrate CYP4 homologs (Danielson et al. 1998). The suggested function of insect CYP4 
enzymes in biotransformation of exogenous compounds is primarily based on the general thought 
that CYPs involved in biotransformation of exogenous compounds are often transcriptionally 
inducible by substrates upon which they act (Whitlock 1986). Therefore most investigations have 
used mRNA expression studies to determine inductions after exposure to xenobiotics and thereafter 
suggested involvement in xenobiotic biotransformation (Carino et al. 1994; Snyder et al. 1995; 
Danielson et al. 1998; Snyder 1998b; Tares et al. 2000). However, upregulation of transcription 
does not necessarily result in an increased amount of produced enzyme, therefore, experiments on 
the enzyme level are also necessary. In vivo experiments employing enzyme activities as markers of 
induction at the enzyme level can be used to study relationship between inducers and substrate, 
however, it is seldom possible to separate activities contributed by different CYP isoforms, limiting 
the value of this approach. Metabolic studies with specific CYP isoforms are necessary to 
demonstrate that the inducing pesticide or other exogenous compound is in fact substrate for the 
enzyme. Therefore, heterologous expression of CYP genes is a valuable tool for investigating if the 
substrate in question is metabolised by the specific CYP enzyme. This type of metabolic studies 
with CYP4 enzymes is needed to directly demonstrate catalytic activity and involvement in 
xenobiotic biotransformation. Such investigations have successfully been conducted with CYP6 
enzymes from insects as described in the introductory sections of this thesis and in manuscript II.  
 
In marine polychaetes and more general in marine invertebrates less research on specific CYP 
isoforms has been conducted compared to insects. Identified CYP genes from marine invertebrates 
have primarily been investigated with regard to possible functions by mRNA expression studies. In 
the supporting article (Appendix I) of this thesis, northern blot analysis showed induction of 
CYP4(2) (CYP342A1) by crude oil, B(a)A and CF (Rewitz et al. 2004). CYP4(1) (CYP4BB1) gene 
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 expression was not induced by any of the treatments, including CF, which is a known inducer of 
CYP4F in vertebrate species (Simpson 1997). Based on the transcriptional upregulations by 
xenobiotics found with the N. virens CYPs, it was suggested that the CYP genes might be involved 
in xenobiotic biotransformation (Rewitz et al. 2004). Also, CYP4AT1 and CYP331A1 from 
Capitella capitata sp. I were investigated by real-time PCR after exposure to sediment associated 
PAHs (Li et al. 2004). CYP4AT1 was not induced except after exposure to one concentration of 3-
MC whereas CYP331A1 was induced by B(a)P and fluoranthene (Li et al. 2004). However, the 
authors suggest that the two CYPs are relatively constitutively expressed. In the shore crab Carcinus 
maenas CYP4C39 and CYP330A1 were identified, a Northern blot experiment showed that 
CYP4C39 was not induced by xenobiotics and ecdysteroids whereas CYP330A1 was induced by 
B(a)P, phenobarbital, ecdysone and ponasterone A (Rewitz et al. 2003). The induction levels found 
in marine invertebrates appear to be lower compared to insects, which could indicate that CYP4 
enzymes in marine invertebrates are not involved in xenobiotic biotransformation. However, it 
could also indicate that the CYP enzymes responsible for xenobiotic biotransformation in marine 
invertebrates have broader substrate specificity due to a diverse exposure to xenobiotics. In contrast, 
insects seem to have specialised CYPs since most exposure is to a certain plant toxin, and the 
involved CYP plays an important role in the maintenance of a specific insect-host plant relationship 
(Danielson et al. 1998).      
 
The relatively unknown function of specific CYP enzymes in marine invertebrates is due to the fact 
that most investigations conducted mRNA expression studies in addition to publishing of the 
sequence. CYP2L1 from the spiny lobster P. argus is currently the only CYP from marine 
invertebrates that has been heterologously expressed and investigated for catalytic activity. In 
insects several investigators have expressed CYP proteins and measured the catalytic activity using 
mostly insecticides as substrates. Results from these studies are discussed and compared to the 
activity of CYP4BB1 and CYP342A1 in manuscript II. The differences in CYP family, substrate 
and expression system makes it difficult to directly compare catalytic activities. However, the 
comparison is conducted in order to relate the determined CYP activities to other CYP enzymes 
from invertebrates and thereby establish if they are in the same range. The activity of 
heterologously expressed eukaryotic CYP is often limited by the ability of endogenous cytochrome 
P450 reductase and cytochrome b5 to act as co-enzymes to the expressed CYP proteins (Korytko et 
al. 2000). This could explain the limited activity of CYP4BB1 and CYP342A1, that might be due in 
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 part to suboptimal interactions of the two CYPs with the co-factors cytochrome P450 reductase and 
cytochrome b5 that were from human in the experiment in manuscript II. Also, the lack of 
endoplasmic reticulum membrane and post-translational modifications of the protein when using E. 
coli as expression system might lead to changes in the stability, folding and activity of the protein. 
However, it was possible to express both CYP4BB1 and CYP342A1 in E. coli. This has been 
difficult to achieve with some CYP isoforms in previous studies, due to differences between E. coli 
and eukaryote 5´ regions (Friedberg and Wolf 1996). Apparently, some CYP isoforms can be 
readily expressed in E. coli whereas NH2–terminal modifications are required for expression of 
other CYP isoforms (Kagawa et al. 2003). The NH2–terminal modifications that have successfully 
been used were replacement of the second codon to alanine (Licad-Coles et al. 1997; Feyereisen 
1999), fusion of the NH2–terminal to a bacterial leader sequence (Pritchard et al. 1997) and 
replacement of the NH2–terminal region with one from a CYP that can be expressed in E. coli 
(Kagawa et al. 2003). In addition, the characterisation of specific CYP isoforms can be further 
complicated by the fact that even though the majority of reactions catalysed by CYP enzymes are 
hydroxylations, the reactions can be extremely diverse (Werck-Reichhart and Feyereisen 2000). 
Certain CYP isoforms produce only a single metabolite from a given substrate, while other CYPs 
can produce multiple metabolites (Scott 1999).  
    
The secondary structure of CYP enzymes is important for the activity of the enzyme; even 
modification of one or few amino acid residue might lead to alterations of enzyme activity. 
Depending on the localisation of the modified amino acid it can result in complete disruption of 
enzyme activity or changes in substrate specificity of the enzyme (Feyereisen 1999).  Site-directed 
mutagenesis of the completely conserved cysteine residue in the heme-binding domain of 
CYP4BB1 and CYP342A1 resulted in complete loss of pyrene hydroxylase activity. This is in 
accordance with Vatsis et al. (2002) who found complete loss of monooxygenase activity in 
CYP2B4 from Oryctolagus cuniculus (rabbit) when cysteine in the heme-binding domain was 
substituted with serine. This particular cysteine residue is suggested to be involved in cleavage of 
molecular oxygen (Werck-Reichart and Feyereisen 2000), which could explain the lack of 
monooxygenase activity in CYP enzymes that are mutated in this residue. Other researchers have 
replaced cysteine from the heme binding domain with histidine (Shimizu et al. 1988; Yoshioka et 
al. 2000) or tyrosine (Shimizu et al. 1988). They also found these amino acid substitutions to 
destroy heme structure and catalytic activity (Shimizu et al. 1988; Yoshioka et al. 2000). Shimizu et 
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 al. (1988) introduced several different amino acid substitutions in the heme-binding domain of rat 
liver P450d and found that conserved hydrophobic amino acids near the heme-binding site are also 
essential for holding and incorporation of the heme and suggested that also mutations around the 
cysteine residue might influence the electron transfer process (Shimizu et al. 1988). In agreement 
Yoshioka et al (2000) found that substitution of leucine, that were the amino acid following 
cysteine, with proline in P450cam from Pseudomonas putida (bacteria) affected the proton transfer 
during catalysis.  
 
The mechanism of CYP gene regulation is not yet elucidated in invertebrates. However, there have 
been few studies and both metal responsive transcription factor MT1 acting on metal responsive 
promoter elements (Zhang et al. 2001) as well as hormone receptors and hormone responsive 
elements (Wu et al. 2004) similar to those in vertebrates have been demonstrated in invertebrate 
species. Furthermore, in the nematode C. elegans the nhr-8 nuclear receptor is required for 
resistance to the toxins colchicines and chloroquine, indicating that nuclear receptor activity is a 
conserved function (Lindblom et al. 2001). Also, AhR and Arnt homologs have been identified in 
invertebrate species, both in Drosophila melanogaster and Caenorhabditis elegans, and the 
complex binds to a XRE domain as in vertebrate species (Mimura and Fujii-Kuriyama 2003). 
However, it remains unknown whether or not these invertebrate AhR homologs can mediate the 
toxicological effects of xenobiotics, because neither Drosophila melanogaster nor Caenorhabditis 
elegans AhR homologs appear to exhibit binding of TCDD or β-naphtoflavone (Mimura and Fujii-
Kuriyama 2003). Furthermore, an AhR homolog has been identified in the soft-shell clam Mya 
arenaria (Butler et al. 2001). The in vitro expressed clam AhR exhibited sequence specific 
interaction with a mammalian xenobiotic response element. However, the clam AhR homolog binds 
neither TCDD nor β-naphtoflavone, which is consistent with results from Drosophila melanogaster 
and Caenorhabditis elegans (Butler et al. 2001; Mimura and Fujii-Kuriyama 2003). This might 
indicate a property shared by invertebrate AhR homologs distinguishing them from vertebrate AhRs 
(Butler et al., 2001). Therefore, transcriptional regulation of CYP gene expression is likely to 
resemble that in vertebrates regarding the overall mechanism, but there seem to be differences in the 
mechanism compared to vertebrates.  
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 CONCLUSION AND PERSPECTIVES 
This thesis addresses biotransformation of pyrene in the marine polychaete N. virens with focus on 
the mechanisms behind biotransformation. Experiments were designed to investigate this both on a 
biochemical level and on a genetic level. The first aim of this thesis, identification and 
characterisation of enzymes involved in biotransformation of pyrene in N. virens is presented in 
manuscript I. It appears that biotransformation of PAHs in invertebrates does not differ much in a 
mechanistic perspective compared to vertebrates, except for a lower response level regarding 
presence of biotransformation enzymes, induction and enzyme kinetic parameters. The second aim 
of the thesis, sequencing, heterologous expression and determination of pyrene hydroxylase activity 
is presented in manuscript II. The experiments here show that pyrene is hydroxylated by the two 
sequenced CYP genes after heterologous expression and protein purification. This indicates that 
CYP4BB1 and CYP342A1 are conceivably involved in xenobiotic biotransformation. In addition, 
mutation of the conserved cysteine residues in the heme binding site resulted in complete loss of 
monooxygenase activity. In conclusion, the results presented in this thesis do contribute to a further 
understanding of biotransformation of pyrene in the marine polychaete N. virens. Among future 
approaches, is on the biochemical level determination of the dominant excretion routes of the three 
pyrene conjugates. Based on these excretion data and the current data on biotransformation, 
development of a kinetic compartment model for biotransformation and excretion of pyrene in N. 
virens is of high importance. It is vital to increase our understanding and prediction of 
biotransformation in marine organisms in order to assess the potential effects of xenobiotics in risk 
assessment. Furthermore, it is important search for and characterise additional phase II enzymes e.g. 
GST enzymes that have not yet been identified due to the limitations of pyrene as model PAH. 
Also, the presence of de-conjugating enzymes like β-glucuronidase and arylsulfatase in N. virens 
gut tissue should be investigated to clarify their role in overall PAH excretion and expand the 
preliminary conclusion that sulfate is the most prominent conjugate in the water phase, likely due to 
a more direct excretion. On the genetic level, determination of the catalytic activity of the two 
specific CYP proteins with other substrates, both exogenous and endogenous is relevant, to 
establish the functional role of these enzymes and to determine their activity with a perhaps more 
suitable substrate. To facilitate this work with (hopefully) higher reconstituted enzyme activity, it is 
important to investigate the activity of CYP4BB1 and CYP342A1 in a mammalian expression 
system, preferably Chinese Hamster V79 cells that are primarily used for investigation of activity of 
specific CYP enzymes, since these cells does not contain any cytochrome P450 genes (or 
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 sulfotransferase and glucuronosyl transferase genes). This minimises background problems and 
facilitates identification of phase I metabolites from a transfected expression vector containing 
either CYP4BB1 or CYP342A1. Finally, it could be interesting to further investigate the 
consequence on the catalytic activity of other mutations in the heme binding domain and in 
substrate recognition sites (if they can be identified based on knowledge from other CYP proteins).  
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Abstract— In vivo and in vitro biotransformation of the polycyclic aromatic hydrocarbon (PAH) pyrene was 
investigated in the marine polychaete Nereis virens.  Assays were designed to characterize phase I and II enzymes 
isolated from gut tissue. High-pressure liquid chromatography (HPLC) measurement of 1-hydroxypyrene, pyrene-1-
glucuronide, pyrene-1-sulfate, and pyrene-1-glucoside appeared to be a sensitive method for estimating the activity of 
pyrene hydroxylase, glucuronosyl transferase, and sulfotransferase. Total pyrene in gut tissue after a 5-d exposure to 10 
μg/g dry weight pyrene constituted 65% pyrene-1-glucuronide, 12% pyrene-1-sulfate, 2% pyrene-1-glucoside, 4% 1-
hydroxypyrene, and 17% pyrene, indicating that glucuronidation is the prominent phase II pathway in this organism. 
Only pyrene hydroxylase activity was significantly induced after pre-exposure to sediment associated pyrene (10 μg/g 
dry wt). Apparent kinetic parameters were determined for all enzymatic reactions. Glucuronidation was confirmed as 
being the prominent phase II reaction, based on its high apparent maximum velocity (Vmax(a)). Sulfation had the lowest 
apparent Michaelis constant (Km(a)), indicating high specificity. Apparent kinetic parameters for pyrene hydroxylase 
activity were changed after induction with pyrene. Induced worms showed increased Vmax(a) and decreased Km(a) 
compared to noninduced worms, indicating that the relative amount of the cytochrome P450 (CYP) enzyme(s) 
responsible for pyrene hydroxylation is increased. Our findings show that N. virens has a high biotransformation 
capacity for PAHs, with inducible pyrene hydroxylase activity, and that the most prominent phase II pathway in this 
organism is glucuronidation. 
 
Keywords—Polycyclic aromatic hydrocarbon, Polychaetes, Pyrene hydroxylase, Glucuronosyl transferase, 
Sulfotransferase 
 
 
INTRODUCTION∗
 
     Polycyclic aromatic hydrocarbons is a 
group of contaminants that have been shown 
to accumulate and persist in marine sediments 
[1]. Due to their lipophilic character, PAHs 
can be taken up and accumulated by benthic 
organisms both by ingestion and diffusion 
across the epithelium. Such accumulation is 
counteracted in organisms efficiently 
biotransforming PAHs. In the present study, 
the objective was to characterize the enzymes 
involved in biotransformation of the model 
PAH pyrene in the marine polychaete Nereis 
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(annejoer@ruc.dk). 
virens.  Special emphasis was put on 
developing and optimizing a sensitive method 
to measure enzyme activities, determining the 
metabolites produced, as well as investigating 
enzyme induction and kinetic parameters. 
Since the only phase I metabolite of pyrene 
produced by CYP enzyme activity in 
eukaryotes is 1-hydroxypyrene, the number of 
phase II metabolites is limited, making 
identification of the produced metabolites 
possible. The inducers pyrene and 
benz[a]anthracene (BaA) were chosen based 
on Rewitz et al. [2], who found that BaA 
induces specific CYP genes in N. virens. 
Along these lines, higher CYP protein content 
was found in N. virens after BaA exposure 
[3]. Furthermore, the transcription of genes 
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 for specific CYP enzymes involved in 
xenobiotic biotransformation is often 
upregulated by substrates upon which the 
enzymes act [4]; we therefore used pyrene as 
a substrate as well as inducer. Several studies 
have demonstrated biotransformation of 
PAHs in marine polychaetes [3, 5-13].  
Production of hydroxylated intermediates 
indicating CYP activity has previously been 
demonstrated in the marine polychaetes 
Nereis virens [6, 12,13] and Nereis (Hediste) 
diversicolor [10, 11]. Furthermore, CYP 
proteins have previously been quantified in 
several polychaetes by carbon monoxide 
difference spectrum analysis [8, 9, 14].  
     The expression of CYP genes in 
invertebrates seems to be lower and less 
variable than in vertebrates, where 10-  to100-
fold induction has been found after PAH 
interaction with the aryl hydrocarbon-receptor 
[15-17]. Conflicting results have led some 
authors to suggest that marine polychaete 
CYPs are constitutively expressed [6, 7, 18], 
whereas others have reported induction of 
CYP enzymes [3, 19]. A 2- to 3-fold 
upregulation of transcription was observed for 
specific CYP genes studied in the marine 
polychaetes N. virens and Capitella sp.I [2, 
20], which is in the same order of magnitude 
as the CYP gene regulation observed in other 
marine invertebrates [15]. The mechanism of 
CYP gene expression regulation has not yet 
been elucidated in invertebrates. However, 
CYP gene expression regulation is likely to 
resemble that in vertebrates, as both metal 
responsive transcription factor MT1 acting on 
metal responsive promoter elements [21], as 
well as hormone receptors and hormone 
responsive elements [22] similar to those in 
vertebrates, have been demonstrated in 
invertebrates.  
     Few studies on the capacity of phase II 
enzymes in marine invertebrates are available 
[23-27], and knowledge about specific 
conjugates is limited, as many studies merely 
characterize fractions with different aqueous 
solubility without characterizing the 
contributing chemical species [6, 10, 28]. In 
other types of studies, phase II metabolites 
were enzymatically deconjugated with 
glucuronidase or glucosidase to the phase I 
metabolites, which were quantified [29].  
Quantification of specific phase II metabolites 
in marine invertebrates (mainly crustaceans) 
indicates that the most prominent conjugation 
pathways in marine invertebrates are 
glucosidation and sulfation, whereas 
glucuronidation is less common [15, 29]; 
however, species-specific differences are 
considerable. Giessing et al. [13] identified 
pyrene-1 glucuronide as the most prominent 
phase II metabolite in N. virens and N. 
diversicolor, whereas pyrene-1-sulfate and 
pyrene-1-glucoside were the most prominent 
metabolites in Capitella capitata and 
Arenicola marina, respectively [13]. This 
indicates that even among marine 
polychaetes, large species-specific differences 
exist. To our knowledge, further 
characterization of the phase II enzymes 
regarding induction and enzyme kinetic has 
not previously been investigated in marine 
polychaetes. 
 
MATERIALS AND METHODS 
 
Chemicals 
     Pyrene (98%), 1-hydroxypyrene (98%), 
benz[a]anthracene (BaA) (98%), ammonium 
acetate (>99%), 1-aminobenzotriazole (ABT), 
cumene hydroperoxide (CHP), uridine 
diphosphate glucose  (UDPG), uridine 
diphosphate glucuronic acid (UGPGA), 
adenosine 3´-phosphate 5´phosphosulfate, 
reduced nicotinamide adenine dinucleotide 
phosphate (NADPH), acetic acid, 
triethylamine, dithiothreitol, 
phenylmethylsulfonylfluoride, and 
ethylenediaminetetraacetate were purchased 
from Sigma Aldrich (Copenhagen, Denmark). 
Potassium chloride, potassium phosphate, and 
sucrose were from Merck (Darmstadt, 
Germany). Gentest UGT reaction mix A and 
B from BD Bioscience (San Jose, CA, USA), 
glucuronidase-arylsulfatase enzymes (from 
Helix pomatia 134.300 U/ml), and 
glucosidase enzymes (from almond, 14.3 
U/mg) were from Sigma Aldrich. 
Acetonitrile, methanol, acetone, and hexane 
(all HPLC grade) were purchased from Lab 
Scan (Dublin, Ireland). 
 65
  
Microcosms and test animals 
     Sediment for microcosms was collected at 
Store Havelse in Roskilde fjord, Denmark, 
sieved through a 1mm mesh sieve, and frozen 
at -20°C for 5 d in order to kill macro- and 
meiofauna. Thawed sediment was spiked with 
pyrene or BaA by adding the desired amount 
of pyrene or BaA dissolved in a minimum of 
acetone to a fraction (0.5 kg) of sediment. 
Seawater was added to form a slurry, which 
was mixed in an electrical mixer for three h. 
The rest of the sediment was placed on an 
upright power drill fitted with a mudslinger, 
and the contaminated slurry was added and 
mixed continuously for 24 h. The 
contaminated sediment was then allowed to 
settle, the water removed, and the sediment 
kept at 5°C for 5 d before being used. 
Nominal sediment concentrations were 1 and 
10 μg/g sediment dry weight for pyrene, and 1 
and 10 μg/g sediment for BaA. Furthermore, 
uncontaminated control sediment was treated 
similarly except for the addition of PAHs. 
     Specimens of the marine infaunal 
polychaete Nereis virens collected in the 
Netherlands and purchased from a local bait 
dealer were acclimatized for three weeks 
before use at 15 ºC in large containers with 
fresh uncontaminated sediment overlaid by 
aerated 18‰ salinity seawater. The animals 
were fed twice a week with frozen shrimps 
and fish food pellets. For experimentation, 
individuals of N. virens were randomly 
selected and placed separately in 1.1 L plastic 
containers with 0.6 L sediment and 0.5 L 
aerated 18‰ salinity seawater. 
 
Pyrene and metabolites in gut tissue 
     Ten individuals of N. virens were exposed 
to 10 µg/g dry weight pyrene in sediment for 
5 d and allowed to purge their guts in Petri 
dishes with 10 ml 18‰ salinity seawater for 
12 h. Then gut tissue was isolated by 
dissection and homogenized in 2 ml methanol 
using a Tissue-Tearor™ (Biospec Products, 
Bartlesville, OK, USA) at full speed for 1 min 
and followed by sonication of samples for 10 
min on ice. Samples were then centrifuged at 
420 g for 10 min to precipitate any debris, and 
500 µl supernatant was filtered through a 0.22 
µm syringe filter, transferred directly to 
brown HPLC vials, and stored at -80°C until 
further analysis. 
     Glucuronic acid-, glucoside-, and sulfate-
conjugates of 1-hydroxypyrene in the samples 
were quantified by HPLC before and after 
enzymatic de-conjugation to determine 
quantitative relationships (conversion factors) 
between conjugate and 1-hydroxypyrene peak 
areas in chromatograms. By using such 
conversion factors, a 1-hydroxypyrene 
standard curve can be used to quantify phase 
II metabolite peaks. Samples with only one of 
the conjugates present were used to determine 
specific conversion factors for each 
conjugate. Glucuronidase-arylsulfatase 
enzymes were used to hydrolyze both 
glucuronide and sulfate conjugates, whereas 
glucosidase enzymes were used to hydrolyze 
glucoside conjugates. Assay samples (100 µl) 
with a protein content of 9.8 to 28.3 µg were 
incubated for 4 h at 37°C with 1.3 U of the 
respective enzymes. The reaction was stopped 
by addition of 500 µl ice-cold 100% ethanol. 
The samples were centrifuged at 3000 g for 5 
min to precipitate denatured protein. The 
supernatants were transferred to brown HPLC 
vials and stored at -80°C until further 
analysis.  
 
Chromatography 
     Total metabolite pattern were analyzed on 
a Dionex (Sunnyvale, CA, USA) HPLC 
system with a RF2000 fluorescence detector 
using the method of Giessing et al. [11]. A 
Supelcosil LC-PAH column (25 cm × 4,6 mm 
inner diameter; Supelco, Bellafonte, PA, 
USA) was used. The acetonitrile buffer (10 
mM ammonium acetate, 5 mM triethylamine, 
pH 5) gradient profile went linearly from 5:95 
to 90:10 (volume/volume [v/v]) over 40 min 
and then held at 90:10 for 10 min at a flow 
rate of 0.8 ml/min. Detection was by 
absorbance at 339 nm, and fluorescence at 
λEX/EM (i.e., λexcitation/emission) was 346/384 nm 
for metabolites/conjugates and 333/384 nm 
for parent compound. Injection volume was 
50 µl and column temperature was kept at 
28°C.  
 
Pyrene and benz[a]anthracene pretreatment 
     Five groups of 10 randomly selected 
individuals of N. virens were exposed to 
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 control sediment or sediments with either 1 or 
10 µg/g dry weight pyrene or BaA. Five 
individuals from each experimental group 
were taken after 3 d and 7 d of exposure, 
respectively, for analysis as described below.  
 
Preparation of microsomes and cytosolic 
fractions 
     Individuals of N. virens were placed on a 
frozen foam brick to avoid enzymatic 
degradation, cut open with a pair of small 
dissecting scissors (Fine Science Tools, 
Heidelberg, Germany), and the gut tissue cut 
free from the somatic tissue. The gut-tissue 
was homogenized in 2 volumes of ice-cold 
homogenization buffer (100 mM potassium 
phosphate, pH 7.4, 150 mM potassium 
chloride, 1 mM ethylenediaminetetraacetate, 
1 mM dithiothreitol, and 0.2 mM 
phenylmethylsulfonylfluoride) using a Tissue-
Tearor™ (Biospec Products) at full speed for 
1 min. The homogenate was centrifuged at 
12,500 g for 20 min at 4°C. The fatty layers 
were removed, and the obtained supernatant 
was centrifuged at 100,000 g for 60 min at 
4°C in a DuPont Sorvall RC 28s ultra 
centrifuge (Newtown, CT, USA). The 
microsomal pellet was used for pyrene 
hydroxylase assay, glucoside transferase 
assay, and glucuronosyl transferase assays 
after resuspension in ice-cold assay buffer 
(100 mM potassium phosphate, pH 7.4, 1 mM 
ethylenediaminetetraacetate, 0.25 M sucrose, 
1 mM dithiothreitol, and 0.2 mM 
phenylmethylsulfonylfluoride). The 
supernatant (cytosolic fraction) was used for 
sulfotransferase assay. All subcellular 
fractions were frozen with liquid nitrogen and 
stored at -80°C until further analysis. None of 
the enzymes showed loss of activity when 
stored at this temperature for several weeks.   
 
Pyrene hydroxylase assay 
     Pyrene hydroxylase activity was assayed 
using a modified aryl hydrocarbon 
hydroxylase assay by a method modified from 
DeKnecht et al. [26]: Reaction tubes 
contained 400 μl microsomal fraction 
containing 12.7 to 31.7 μg protein, 40 μM 
pyrene, 1 mM NADPH (electron donor), and 
1.5 μM MgCl2, in a final volume of 500 μl. 
The enzymatic reaction was started by 
addition of NADPH, and the tubes were 
incubated at 37°C for 5 min. The reaction was 
stopped by adding 1.5 ml of an 
acetone:hexane (1:3) mixture and by thorough 
vortex mixing. When the phases were stable, 
the upper phase was transferred to a test tube. 
The extraction was repeated twice to a total 
volume of 4.5 ml. The combined supernatants 
were evaporated to dryness with nitrogen, re-
dissolved in 500 μl nitrogen saturated 
acetonitrile, transferred to brown HPLC vials 
and stored at -80°C until further analysis. 
 
Glucuronosyl transferase assay 
     The glucuronosyl transferase activity was 
measured in 142 μl microsomal fraction 
containing 5.0 to 11.3 μg protein using 
Gentest UGT reaction mix A (25 mM uridine 
5´diphospho-glucuronic acid in water) and B 
(250 mM Tris-HCl, 40 mM MgCl2, 0.125 
mg/ml alamethicin in water). The reaction 
was initiated by adding 500 μM 1-
hydrozypyrene to a final reaction volume of 
200 μl. After 5 min incubation at 37 °C, the 
reaction was terminated by adding 100 μl 
acetonitrile/acetic acid (94/6), and by 
thorough vortex mixing. After centrifugation 
for 3 min at 10,000 g the supernatant was 
transferred to brown HPLC vials and stored at 
-80°C until further analysis.       
 
Glucoside transferase assay 
     The glucoside transferase activity was 
measured in 142 μl microsomal fraction 
containing 5.0 to 11.3 μg protein using 25 
mM UDPG and Gentest UGT reaction mix B 
(250 mM Tris-HCl, 40 mM MgCl2, 0.125 
mg/ml alamethicin in water). The reaction 
was initiated by adding 500 μM 1-
hydrozypyrene to a final reaction volume of 
200 μl. After 5 min incubation at 37 °C, the 
reaction was terminated by adding 100 μl 
acetonitrile/acetic acid (94/6), and by 
thorough vortex mixing. After centrifugation 
for 3 min at 10,000 g, the supernatant was 
transferred to brown HPLC vials and stored at 
-80°C until further analysis. 
 
Sulfotransferase assay 
     Sulfotransferase activity was measured 
with 1-hydroxypyrene as substrate using a 
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 method modified from DeKnecht et al. [26]: 
The reaction mixture contained 280 μl 
cytosolic fraction containing 9.3 to 26.2 μg 
protein, 350 μM adenosine 3´-phosphate 
5´phosphosulfate, and 500 μM 1-
hydroxypyrene to a final volume of 300 μl. 
The reaction was started by adding 1-
hydroxypyrene. After 5 min incubation at 
37°C, the reaction was stopped by adding of 
an equal volume of ice-cold ethanol and by 
vortex mixing. After centrifugation, the 
supernatant was transferred to brown HPLC 
vials and stored at -80°C until further 
analysis.        
 
Modification of pyrene hydroxylation activity 
     To establish that the phase I 
biotransformation observed was in fact CYP-
mediated, three different experiments were 
conducted. The effect of the CYP enzyme 
inhibitor ABT [30] on 1-hydroxypyrene 
production was studied. Also, denaturation of 
microsomal proteins and CHP mediated 
electron transfer to CYP were investigated. 
All experiments were conducted with pooled 
microsome preparations from five control 
individuals and with pooled microsome 
preparations from five pyrene pre-exposed 
worms. For inhibition, 12.5 µM ABT was 
added before starting the assay. As an 
alternative electron donor, 100 µM CHP was 
added to start the assay. To denature 
microsomal proteins, the microsome 
preparations were boiled at 100°C for 15 min 
before addition to the assay. 
 
Determination of apparent kinetic parameters 
(Vmax(a) and Km(a)) 
     The kinetic parameters for the four 
enzymatic reactions were determined using 
microsome and cytosolic fractions from gut 
tissue from 15 individuals of Nereis virens. 
The substrate concentrations were: 1 to 80 
µM pyrene in the pyrene hydroxylase assay, 
0.5 to 500 µM 1-hydroxypyrene in the 
glucuronide and glycoside assays, and 0.005 
to 500 µM 1-hydroxypyrene in the 
sulfotransferase assay. The variation of the 
substrate concentration was the only 
parameter changed from the procedure 
described above. Preliminary experiments 
indicated that the initial velocity of the 
reactions could be determined during an 
incubation time of 5 min. Kinetic parameters 
were estimated by nonlinear fitting of the rate 
data as a function of the substrate 
concentration curve in the Michaelis-Menten 
equation by the least squares method using 
GraphPad Prism® software (San Diego, CA, 
USA).   
  
Protein determination 
     Protein content was determined according 
to the Bradford method using the Bio-Rad 
protein assay (Hercules, CA, USA) for 
microassay for microtiter plates with bovine 
serum albumin as a standard. Both the 
microsome and the cytosolic fractions were 
diluted (1:10).   
 
Statistical analysis 
     All data were normally distributed with 
similar variance. Therefore, experimental 
groups data were analyzed for significant 
difference (p<0.05) using one-way analysis of 
variance followed by Turkey-Kramer test.   
 
RESULTS 
 
Relative amounts of pyrene and pyrene 
metabolites in gut tissue 
     Figure 1 shows a HPLC chromatogram 
indicating the separation of pyrene and its 
metabolites and the relative amounts of the 
various compounds: Pyrene-1-glucuronide 
constituted 65% of pyrene-derived 
metabolites in gut tissue, 12% were present as 
pyrene-1-sulfate, and only 2% was present as 
the last phase II metabolite pyrene-1-
glucoside, indicating that glucosidation is a 
less prominent phase II pathway in N. virens. 
Approximately 4% were present as 1-
hydroxypyrene, indicating that 1-
hydroxypyrene is further biotransformed via  
one of the two important phase II reactions. 
Seventeen percent of all pyrene-derived 
compounds were present as pyrene itself after 
5 d exposure. Our results suggest that pyrene-
1-glucuronide is the most prominent phase II 
metabolite of pyrene in N. virens gut tissue.   
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 Fig. 1. (A) High-pressure liquid chromatogram of pyrene and 
metabolites from Nereis virens gut-tissue samples. Peak: 15 min is 
pyrene-1-glucuronide, peak: 17 min is pyrene-1-sulfate, peak: 20 min  
is pyrene-1-glucoside, peak: 33 min is 1-hydroxypyrene, and peak: 
42 min is pyrene. The peak present at 4 min is the injection peak. (B) 
Distribution of pyrene present in Nereis virens after 5 d exposure to 
sediment-associated pyrene (10 µg/ g sediment dry wt). 10 
individuals were analyzed separately and results are ± standard 
deviation.        
 
Modification of pyrene hydroxylation activity  
     To establish that the observed pyrene 
hydroxylation   was   due   to   CYP    enzyme 
activity, specific CYP inhibitors and inducers 
were used as  shown in  Table 1.   Preliminary 
induction experiments (data not shown) 
indicated that pyrene is likely to be an inducer 
of hydroxylation of pyrene itself. Pyrene 
hydroxylation activity (putative CYP activity) 
was significantly (p< 0.05) induced in gut 
tissue after exposing individuals of N. virens 
to 10 µg/g dry weight pyrene in sediment. 
Addition of the specific CYP-inhibitor ABT 
to the CYP enzyme assay significantly (p< 
0.05) inhibited the enzyme activity both in 
microsomes from control worms and from 
pyrene induced worms. Also, boiling of 
microsomes to denature proteins before their 
addition to the assay abolished pyrene 
hydroxylation activity. Cumene 
hydroperoxide has previously been reported 
to support CYP catalyzed reactions without 
involvement of NADPH [26]. In agreement 
with this, we found that CHP supported 
pyrene hydroxylation without addition of 
NADPH. However, CHP was significantly 
(p< 0.05) less effective in stimulating pyrene 
hydroxylase activity than NADPH (Table 1). 
Pyrene hydroxylation assays were also 
conducted with the cytosolic fraction instead 
of the microsome fraction and with 
microsomes without addition of NADPH; in 
both cases, no pyrene hydroxylation activity 
was detected. Together, these results indicate 
that the pyrene hydroxylation observed in 
vivo is primarily CYP-mediated. 
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Table 1. Modification of pyrene hydroxylation activity (considered to 
be cytochrome P450-mediated). Pooled gut microsomes from five 
individuals of Nereis virens not exposed or pre-exposed to sediment 
associated pyrene (10 µg/g dry wt) for 7 d were used. For each 
treatment three separate measurements were conducted. * 
Significantly different from control or pyrene treatment according to 
Turkey-Kramer test (p< 0.05)  
 
Treatment Activity ± SD 
(ng/min/mg 
protein) 
Ratio between 
treatment  
and control (A)  
or pyrene (B) 
Control 66.1 ± 8.8 1 
Pyrene 138.8 ± 15.2 1 
Control + ABT 32.4 ± 1.9 0.49 * (A) 
Pyrene + ABT 72.4 ± 8.3 0.52 * (B) 
Control boiled 2.9 ± 0.1 0.04 * (A) 
Pyrene boiled 3.3 ± 0.5 0.02 * (B) 
Control + CHP ÷ NADPH 37.1 ± 4.7 0.56 * (A) 
Pyrene + CHP ÷ NADPH 41.3 ± 7.9 0.30 * (B) 
Control ÷ NADPH 3.7 ± 1.1 0.06 * (A) 
Pyrene ÷ NADPH 3.8 ± 0.9 0.03 * (B) 
 
 
The in vitro enzyme assay were modified with the following 
treatments; ABT: 12.5 μM 1-aminobenzotriazole added, boiled: 
microsomes were boiled for 10 min, CHP: 100 μM cumene 
hydroperoxide were added and no nicotinamide adenine dinucleotide 
phosphate (NADPH) were added and finally ÷ NADPH: no addition 
of NADPH. 
 
 
Pyrene and benz[a]anthracene pretreatment  
     Figure 2 shows effects of induction by 
pyrene and BaA on the activity of the four 
enzymatic   reactions:    Pyrene   hydroxylase, 
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Fig. 2. Induction of pyrene hydroxylase, glucuronidation, 
glucosidation, and sulfation enzyme activity by exposure of Nereis 
virens to pyrene or benz[a]anthracene (BaA) for 3 d (Fig. 2A) or 7 d 
(Fig. 2B) at two different concentrations. Enzyme activity was 
calculated as μg 1-hydroxypyrene/min/mg protein and is shown in 
the figure as fold activity relative to control. In each exposure group 
n=5 and all measurements in this experiment are on individual 
worms. * Significantly different according to Turkey-Kramer test (p< 
0.05).  
 
glucuronidation, glucosidation, and sulfation. 
The enzyme activity is presented as the 
relative activity in exposed animals compared 
to control animals. Exposure of N. virens to 
10 µg/g dry weight pyrene in sediment for 3 d 
and 7 d significantly (p<0.05) induced pyrene  
hydroxylase activity, whereas none of the 
other treatments significantly induced the 
pyrene hydroxylase activity. Exposure to 10 
µg/g dry weight BaA in sediment for 7 d 
significantly (p<0.05) reduced the pyrene 
hydroxylase activity compared to the control 
treatment.  
     Among phase II enzymes, glucuronidation 
activity was significantly (p<0.05) induced 
after 3 d exposure to 1 μg/g dry weight BaA. 
Glucosidation was not induced by any of the 
treatments in this experiment. 
Sulfotransferase activity was significantly 
(p<0.05) induced after 3 d exposure to 1 μg/g 
dry weight pyrene. However, since the 
inductions found for the phase II enzymes are 
quite small, with the highest relative increase 
in activity being 1.7, the biological relevance 
might not be strong.  
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Kinetic analysis of the four enzymatic 
reactions 
     The four enzymatic reactions were further 
investigated by kinetic analysis and 
determination of the apparent kinetic 
parameters, as shown in Figure 3. For pyrene 
hydroxylation, kinetic analysis was performed 
on gut microsomes from unexposed animals 
(control treatment), as well as from animals 
exposed to 10 µg/g dry weight pyrene for 7 d 
(pyrene treatment). This was to determine if 
the apparent kinetic parameters were 
influenced by the induction. Microsomes 
from control animals had the lowest capacity, 
Vmax(a) of the enzymes in this experiment, 
which could indicate that hydroxylation is the 
rate-limiting step for the overall excretion of 
pyrene from N. virens. However, the pyrene 
hydroxylation activity was inducible and the 
induced hydroxylase activity had a higher 
Vmax(a) and a lower Km(a), indicating specific 
upregulation of one or few isoforms of CYP 
relative to the total amount of CYP protein 
present. The determined Vmax(a)/ Km(a) ratio for 
induced gut microsomes is approximately 10 
times higher than the Vmax(a)/Km(a) ratio for 
control gut microsomes, conceivably 
indicating extensive and specific upregulation 
of few CYP isoforms.  
     The sulfotransferase enzymes have a quite 
low Km(a), indicating relatively high 
specificity. However, the Vmax(a) is not 
particularly high. This finding is expected 
since sulfotransferases are generally 
characterized as having a high affinity and 
low capacity [28]. Glucuronosyl transferase 
enzymes   are   generally   characterized     by  
having   a   relatively  low  affinity  and a high 
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Fig. 3. Kinetic analysis of pyrene hydroxylase (control) (A); pyrene hydroxylase (induced) (B); glucuronidation (C); glucosidation (D); and sulfation 
(E). Microsome and cytosolic fractions isolated from Nereis virens gut tissue was used. For each kinetic experiment n=15 and for all enzyme activity 
measurements n=3. Apparent maximum velocity (Vmax(a)) values of the enzymes: nmol 1-hydroxypyrene/min/mg protein. Apparent Michaelis constant 
(Km(a)) values are expressed as µM and the Vmax(a)/Km(a) ratio: (nmol 1-hydroxypyrene/min/mg protein)/µM. The apparent Km and Vmax values were 
obtained using Michaelis-Menten curve fitting (± standard error). 
 
capacity. The apparent kinetic parameters 
determined in this experiment confirm this 
when glucuronic acid is used as substrate, 
with a high Vmax(a) and a relatively high Km(a) 
value. With glucoside as substrate for 
glucuronosyl transferase enzymes, the kinetic 
data indicate capacity in the same range as for 
sulfotransferase, and the Km(a) for glucoside is 
very high compared to all other enzymes 
investigated in this study, indicating that this 
enzyme is not specific with regard to 
glucoside as substrate. The Vmax(a)/Km(a) ratio 
for the sulfotransferase enzymes is in the 
same range as for the pyrene hydroxylase 
(control) and for glucuronidation. The Vmax(a)/ 
Km(a) ratio for glucuronosyl transferase 
enzymes is 7.5 times higher with glucuronic 
acid as substrate than with glucoside as 
substrate, indicating a much higher catalytic 
efficiency with glucuronic acid as substrate. 
 
Biotransformation pathway for pyrene 
     The biotransformation of pyrene is 
relatively simple, as 1-hydroxypyrene is the 
only phase I metabolite generated in 
eukaryote species including N. virens, 
allowing identification of all phase II 
metabolites produced. Glucuronide, sulphate, 
and glucoside conjugates were identified as 
pyrene metabolites in N. virens gut tissue, 
which is in accordance with previous work 
[29]. These results were confirmed by the 
three phase II assays employed in the present 
study, where microsomal and cytosolic 
fractions were incubated with 1-
hydroxypyrene and UDPGA, UDPG, or 
adenosine 3´-phosphate 5´phosphosulfate to 
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 produce the conjugates separately. 
Furthermore, the three conjugates from 
pyrene exposed N. virens were hydrolyzed 
with glucuronidase-arylsulfatase and 
glucosidase enzymes to ensure that only 1-
hydroxypyrene and pyrene were present. 
Based on these results, we propose a pathway 
for biotransformation of pyrene in N. virens, 
shown in Figure 4.           
 
 
 
Fig. 4. Proposed biotransformation pathway of pyrene in Nereis 
virens. CYP450: Cytochrome P450 enzymes, ST: Sulfotransferase 
enzymes, UDPGT: urinidinediphosphosphateglycuronosyl 
transferase enzymes. 
 
DISCUSSION 
 
     We here present data on phase I and phase 
II biotransformation of pyrene in N. virens, 
developing and employing highly specific and 
sensitive assays. Previous studies clearly 
demonstrated a high capacity of nereids for 
PAH hydroxylation, confirmed in the present 
study using pyrene as model substrate. The 
question of polychaete CYP inducibility has 
been somewhat controversial due to 
conflicting results. The present study reports a 
3-fold induction of pyrene hydroxylase 
activity in N. virens after exposure to 10 μg/g 
dry weight sediment-associated pyrene. This 
is in accordance with previous results where 
N. virens mixed function oxygenase activity 
was induced in worms fed BaA-exposed 
clams [3]. Also, induction of CYP enzymes in 
PAH-exposed insects has previously been 
reported [31], though smaller PAHs (e.g., 
naphthalene) are apparently better inducers of 
insect CYP enzymes than larger PAHs (e.g., 
BaP) [31]. Furthermore, specific CYP 
enzymes involved in xenobiotic 
biotransformation are often induced by 
substrates upon which they act [4]. 
Benzo(a)pyrene (BaP), for example, 
functions both as substrate and inducer in a 
microsome monooxygenase assay in rats [32]. 
This is in accordance with results from this 
study, where pyrene was substrate in the 
assay and inducer of pyrene hydroxylase 
activity. Even though BaA has previously 
loss. Worms in all other treatments kept their 
weight throughout the experiment (data not 
shown). Contrary to the observation made by 
Lee et al. [3], exposure to 1 μg/g dry weight 
sediment-associated BaA did not induce 
pyrene hydroxylase activity. However, 
differences in both exposure route and 
concentration between the two studies make 
direct comparison difficult.   
     In contrast to the inducibility of pyrene 
hydroxylase activity observed in the present 
study, Driscoll and McElroy [7, 17] were 
unable to detect any induction of BaP 
metabolism in N. virens and N. diversicolor 
after exposure to 3-methylcholanthrene (3-
MC). These authors suggested that 3-MC 
might not be a particularly good inducer of 
polychaete CYPs [17], which is in agreement 
with studies reporting CYP induction by 
PAHs and polychlorinated biphenyls but not 
by 3-MC  [5]. The lack of 3-
been reported to upregulate transcription of 
specific CYP genes in N. virens [2] and 
induce mixed function oxygenase activity [3], 
we did not find induction of pyrene 
hydroxylase activity after BaA treatment. The 
reduced pyrene hydroxylase activity in worms 
exposed to 10 μg/g dry weight sediment-
associated BaA for 7 d, observed in the 
present study, is likely due to toxicity of the 
treatment, indicated by the generally poor 
condition of these worms, judged by weight 
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MC induction of 
CYP enzymes could be due to differences 
between vertebrate and invertebrate species in 
receptors mediating transcriptional 
upregulation. It has been suggested that the 
Ah receptor controlling the expression of 
PAH (including 3-MC) inducible isoforms of 
CYPs in vertebrate species might not exist in 
several invertebrate species including 
polychaetes [33]. This is in agreement with 
the observation that none of the specific CYP 
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 genes isolated thus far from marine 
invertebrate species belongs to the isoforms 
regulated by the aryl hydrocarbon-receptor in 
vertebrate species.  
     None of the three phase II enzymatic 
reactions in this study appeared to be highly 
inducible. This finding is in agreement with 
De Knecht et al. [25], who found phase II 
enzymes in the terrestrial isopods Oniscus 
asellus and Porcellio scaber to be relatively 
constitutively expressed. However, very few 
investigations on phase II enzyme induction 
in invertebrate species are available.  
     To ascertain that the measured pyrene 
hydroxylase activity was due to CYP enzyme 
s found 
 C-labeled 
and phase II metabolites 
activity, CYP specific inhibitors and inducers 
were employed. The measured pyrene 
hydroxylation was induced and inhibited as 
expected for CYP enzymes. Cumene 
hydroperoxide, which has previously been 
reported to support CYP catalyzed reactions 
without involvement of NADPH [25], did in 
fact mediate monooxygenase activity in this 
study. Furthermore, no activity wa
without addition of NADPH. These data 
could also indicate activity of flavin-
containing monooxygenases; however, flavin-
containing monooxygenases catalyze 
hydroxylation reactions only at hetero atoms 
and not at carbon atoms [34], ruling out 
flavin-containing monooxygenase as the 
active enzyme involved in hydroxylation of 
pyrene. Together, these results clearly 
indicate that the pyrene hydroxylation 
observed in vivo in N. virens primarily is 
CYP-mediated, and that it is unlikely that 
other enzymatic reactions considerably 
contribute to the hydroxylation. 
     The very high efficiency of N. virens 
pyrene hydroxylase, glucuronosyltransferase, 
and sulfotransferase enzymes observed in the 
present study (more than 80% of the total 
amount of pyrene or pyrene derived 
compounds present in gut-tissue were 
metabolites of pyrene after 5 d exposure) is in 
accordance with previous studies of PAH 
biotransformation in marine polychaetes 
demonstrating the presence of CYP enzymes. 
Several studies have separated 14
parent compounds into aqueous and polar 
metabolites based on three-phase extraction 
schemes [6, 10, 14, 35-37], thereby offering 
circumstantial evidence for formation of the 
classical phase II metabolites known from 
mammals. Regarding analysis of specific 
metabolites, Christensen et al. [10] identified 
1-hydroxypyrene in tissue from N. 
diversicolor exposed to sediment-associated 
pyrene for 14 d indicating CYP enzyme 
activity. Furthermore, Giessing et al. [11] 
identified 1-hydroxypyrene, pyrene-1-
glucuronide, pyrene-1-sulfate, and pyrene-1-
glucoside also in N. diversicolor using HPLC. 
Also, McElroy [6] observed rapid 
biotransformation of radiolabeled BaA in N. 
virens, with most of the radioactivity 
measured in the water-soluble or 
unextractable fractions. Only small amounts 
of unmetabolized parent compound remained 
in the tissues. Incubation of the aqueous 
extracts with glucuronidase-arylsulfatase 
converted only 2 to 6% of radioactivity to 
nonpolar, solvent extractable metabolites, 
indicating that the water-soluble fraction was 
not conjugated to glucuronic acid or sulfate 
but to another endogenous compound, which 
is not hydrolyzed by glucuronidase-
arylsulfatase [6]. In contrast, we found N. 
virens to primarily form glucuronic acid and 
sulfate conjugates. 
     As far as we know from the present and 
several other studies [25, 38-39], pyrene as a 
model compound has the advantage that it is 
biotransformed to one phase I metabolite 
only, the phenolic metabolite, 1-
hydroxypyrene. This facilitates the 
identification of phase II metabolites 
compared to other substrates as, e.g., BaP that 
is biotransformed to multiple phase I 
metabolites, making identification of 
individual phase I 
difficult. The relative amounts of conjugates 
in gut-tissue of N. virens indicate that 
glucuronidation is the most prominent 
conjugation pathway in this organism. Since 
the amount of 1-hydroxypyrene found in gut 
tissue of pyrene-exposed N. virens was rather 
small in comparison with the amount of 
pyrene conjugates, it is reasonable to believe 
that the rate of conjugating phenolic PAH 
metabolites is relatively high in N. virens. 
This assumption is in accordance with 
Simpson et al. [40], who found that 
conjugation of 1-hydroxypyrene 
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 predominated over further oxidation in two 
species of marine clams (Mya arenaria and 
Protothaca staminea). Also, sulfotransferase 
enzymes and glucuronosyl transferase 
enzymes are known to compete for chemicals 
with phenolic structure [41]. Enzyme kinetics 
investigated in this and other studies indicate 
that Km for sulfation is lower than for 
glucuronidation, and that Vmax is higher for 
glucuronidation compared to sulfation [41]. 
This suggests that, when phase I 
hydroxylation is slow and the substrate 
concentration for the following reaction 
therefore is low, sulfation would dominate 
over glucuronidation. Rapid phase I 
hydroxylation would lead to glucuronidation 
of the substrate due to the higher capacity 
compared to sulfation [42]. However, co-
substrate availability may influence the 
contribution of each competing pathway to 
the conjugation of a compound [43]. Since 
our results indicate that glucuronide 
conjugates are much more abundant than 
sulfate conjugates in N. virens, the amount of 
substrate (1-hydroxypyrene) is unlikely to be 
the limiting factor in the excretion of pyrene.  
     In most vertebrate species investigated, the 
preferred phase II carbohydrate co-substrate 
for conjugation is glucuronic acid, whereas 
glucoside conjugation has been indicated to 
be the most prominent conjugation pathway 
in marine invertebrates [14, 28]. However, 
xenobiotics are rarely biotransformed in the 
same manner by even closely related species 
[14]. Crustaceae are the most intensively 
investigated group of aquatic species 
regarding specific conjugates, and the 
preferred phase II co-substrate is UDP-
glucose, forming glucoside conjugates, but 
sulfate conjugates have also been identified in 
most investigated crustaceans. Comparisons 
of phase II product ratios indicate that 
glucosidation is more efficient than sulfation 
in crustaceans [14, 22, 28]. Biotransformation 
of pyrene in the shore crab Carcinus maenas 
resulted in formation of three major phase II 
metabolites, two of these being glucoside and 
sulphate [39]. The third is unknown, but it 
was not a glucuronide conjugate [39]. The 
relative distribution of conjugates show that 
pyrene-1-glucoside and the unknown pyrene-
1-conjugate dominated in urine from 
Carcinus maenas [39]. Our finding that 
pyrene-1-glucuronide is the most prominent 
metabolite present in gut tissue after pyrene 
exposure, in agreement with the kinetic 
analysis where glucuronidation had the 
highest Vmax(a) of the phase II enzymes, is in 
accordance with Giessing et al. [29], who 
found pyrene-1-glucuronide to be the major 
phase II metabolite in N. virens and N. 
diversicolor, whereas pyrene-1-sulfate and 
pyrene-1-glucoside were the most prominent 
metabolites in Capitella capitata and 
Arenicola marina, respectively [29]. This 
emphasizes the extensive inter-specific 
differences in phase II conjugation pathways 
even among closely related marine 
polychaetes.   
     Pyrene and 1-hydroxypyrene are not 
commonly used as substrates to determine the 
in vitro activity of phase I and II enzymes, 
making it rather difficult to compare our data 
directly with apparent kinetic parameters 
obtained in other marine invertebrates. The 
Vmax(a) for N. virens pyrene hydroxylase 
enzymes was 0.36 nmol/min/mg protein and 
0.86 nmol/min/mg protein for noninduced and 
induced worms, respectively. The Km(a) in 
noninduced individuals was 8.4 µM, and the 
 µKm(a) of the induced enzymes was 1.9 M. 
The smaller Km(a) and the higher Vmax(a) found 
after induction indicate that the relative 
contribution to total CYP protein of the CYP 
enzymes responsible for pyrene hydroxylation 
is increased. In the terrestrial isopods P. 
scaber and O. asellus, enzyme kinetics of 
pyrene hydroxylase was also determined with 
pyrene and 1-hydroxypyrene as substrates 
[25]. The Vmax(a) was for both species 
approximately 0.2 nmol/min/mg protein, 
whereas Km values were not determined, 
indicating that N. virens has a higher pyrene 
hydroxylase capacity compared to P. scaber 
and O. asellus. In N. virens, Vmax(a) for 
glucuronidation with 1-hydroxypyrene as 
substrate was 1.4 nmol/min/mg protein, and 
the Km(a) value was determined to be 31.03 
µM. It is not possible to compare the 
calculated apparent kinetic parameters with 
data from other invertebrate species. In some 
species, including insects and several marine 
invertebrates, glucosidation is the most 
important carbohydrate conjugation pathway, 
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 whereas other marine invertebrates, including 
N. virens, appear to prefer glucuronidation. 
Accordingly, relatively large differences in 
apparent kinetic parameters exist between 
invertebrates regarding capacities and 
affinities, reflecting both differences in 
dominating conjugation pathways and 
differences in enzyme capacity and affinity. 
In N. virens, Vmax(a) for glucosidation was 
determined to 0.46 nmol/min/mg protein, and 
the Km(a) was 73.5 µM. The high Km(a) value 
observed for glucosidation  indicates that 1-
hydroxypyrene is a poor substrate for this 
enzymatic reaction, especially compared to 
glucuronidation in N. virens. Furthermore, the 
capacity for glucosidation is approximately 
three times lower than for glucuronidation. 
These results explain our finding that very 
little 1-hydroxy-glucoside was formed in N. 
virens after exposure to pyrene in the 
sediment. In P. scaber and O. asellus, Vmax(a) 
for glucosidation was 3.2 and 6.2 
nmol/min/mg protein with 1-hydroxypyrene 
as substrate, respectively, and Km(a) was 22 
and 8.1 µM [25]. This indicates that 
glucosidation in both species has a high 
capacity and affinity compared to N. virens.  
     Sulfotransferase enzyme activity has been 
found in almost all aquatic organisms 
investigated for this activity. In this study, 
Vmax(a) for sulfation in N. virens was 
determined to 0.43 nmol/min/mg protein, and 
the Km(a) to 11.6 µM with 1-hydroxypyrene as 
substrate. In O. asellus and P. scaber, the 
Vmax(a) was slightly lower and Km(a) smaller for 
sulfation [25] than observed for N. virens in 
the present study. The relatively high Vmax(a) 
for sulfation found is in accordance with the 
times 
higher than the Km(a) value for 
amount of pyrene-1-sulfate present in N. 
virens gut tissue after pyrene exposure.  
     Comparison of enzyme activities in N. 
virens with those in O. asellus and P. scaber 
indicates that N. virens efficiently 
biotransform large amounts of phenolic 
metabolites (indicated by the relatively high 
Vmax(a)), whereas the two terrestrial isopods 
have low Km(a) values, indicating that they are 
efficient when small amounts of phenolic 
compounds are present. The results from this 
study indicate that in N. virens 
glucuronidation, Km(a) is almost three 
sulfotransferase. This is similar to what is 
found in vertebrates, where Km for 
glucuronidation is normally much higher than 
Km for sulfation [41]. Also, Vmax(a) for 
glucuronidation is high compared to sulfation 
Vmax(a), as expected from vertebrate studies. 
Together, these results indicate that 
glucuronidation and sulfation capacity and 
affinity in N. virens conceivably resemble 
those in vertebrates.  
     The easily defined in vitro parameters Vmax 
and Km can be scaled to provide estimates of 
in vivo metabolic clearance. Intrinsic 
clearance is defined as the Vmax/ Km ratio [44], 
and despite the fact that it is an efficient way 
to compare enzymes [44], the Vmax/ Km ratio 
(μl/min/mg) has not been determined in many 
studies. However, Vmax(a)/ Km(a) ratios were 
calculated for the enzymes in the present 
study. The pyrene hydroxylase activity 
Vmax(a)/Km(a) value was determined to be 42.3 
μl/min/mg and 440 μl/min/mg for control and 
induced animals, respectively, indicating that 
for pyrene hydroxylase, the relative 
contribution to total CYP protein of the CYP 
enzyme responsible for pyrene hydroxylation 
is increased by a factor of 10 due to induction. 
The Vmax(a)/Km(a) ratio for glucuronidation in 
N. virens with 1-hydroxypyrene as substrate 
was 46.0 μl/min/mg. The Vmax/Km for N. 
virens sulfotransferase was 37.1 μl/min/mg, 
which is low compared to calculated Vmax/Km 
values of 2600 μl/min/mg and 960 μl/min/mg 
in O. asellus and P. scaber, respectively [25] 
The Vmax/Km values were re-calculated from 
the unit (nmol/min/mg)/μM to μl/min/mg. It 
is clear that the N. virens sulfotransferase is 
not efficient compared to enzymes from the 
two isopod species. Finally, glucosidation 
enzymes in N. virens had a Vmax(a)/ Km(a) value 
of 6.02 μl/min/mg with 1-hydroxypyrene as 
substrate; in comparison, O. asellus and P. 
scaber glucosidation enzymes have Vmax/Km 
values two orders of magnitude higher than N. 
virens [25], indicating extensively higher 
enzyme efficiency in these organisms. 
     In summary, a biotransformation pathway 
of pyrene in N. virens is proposed (Fig. 4), 
with 1-hydroxypyrene as the only phase I 
metabolite and glucuronidation as the most 
prominent conjugation pathway. Also, our 
results show that phase II metabolism via the 
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 glucuronide conjugation pathway is not 
restricted to vertebrates as indicated by 
Livingstone [14]. Sulfation also appears to be 
an important phase II reaction, whereas the 
small amount of glucoside conjugates 
indicates that glucosidation is not an 
virens (annelida: Polychaeta) 
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enzymes system in marine polychaetes: 
Increa re to aromatic 
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5. . 1981.  
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 by toxics in 
10. 
marina. 
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etry of 1-
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15. 
differences in 
16. 
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important conjugation pathway in this 
organism. Nereis virens most likely possesses 
other phase II enzymes than those 
investigated in this study; however, only five 
peaks were found on HPLC chromatograms 
of gut-tissue samples. The present study 
shows that except for a 3-fold induction of 
pyrene hydroxylase activity after exposure to 
10 µg/g dry weight pyrene, the 
biotransformation enzymes in N. virens do not 
appear to be very inducible by the PAHs, 
concentrations, and exposure periods in this 
experiment. The relatively low regulatory 
capacity in N. virens is in agreement with 
observations for biotransformation enzymes 
in several other marine invertebrates. This 
could be due to a high background expression 
of genes involved in biotransformation, 
caused by a continuous exposure of benthic 
organisms to compounds biotransformed by 
these enzymes. The kinetic experiment 
supported the previously obtained results 
showing that Vmax(a) for glucuronidation was 
high and Km(a) for sulfation was low. 
Furthermore, pyrene hydroxylase activity in 
induced worms had higher Vmax(a) and lower 
Km(a) compared to noninduced worms, 
indicating that the relative contribution to 
total CYP protein of the CYP enzyme(s) 
responsible for pyrene hydroxylation is 
increased. The results presented in this study 
with the suggestion of a biotransformation 
pathway for pyrene in N. virens might 
contribute to the understanding of the 
enzymes involved in excretion of PAHs from 
this organism.  
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CHARACTERISATION OF TWO NOVEL CYP4 GENES FROM THE MARINE  
POLYCHAETE NEREIS VIRENS AND THEIR INVOLVEMENT IN  
PYRENE HYDROXYLASE ACTIVITY 
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Abstract— Cytochrome P450 enzymes (CYP enzymes) catalyse the initial step in biotransformation of xenobiotics like 
polycyclic aromatic hydrocarbons (PAHs). The marine polychaete Nereis virens has a high capacity for 
biotransformation of PAHs. In the present study, the complete cDNA sequences of two novel CYP genes isolated from 
N. virens gut tissue are reported. One named CYP342A1, the first member of a new family and the other named 
CYP4BB1, the first member of a new subfamily. This is the first investigation of specific CYP enzymes from marine 
polychaetes in which catalytic activity have been determined. Both CYP enzymes had monooxygenase activity and 
catalysed hydroxylation of pyrene to 1-hydroxypyrene. Based on the present results it is likely that both CYP4BB1 and 
CYP342A1 are involved in xenobiotic biotransformation. Furthermore, site directed mutagenesis of the conserved 
cysteine residue of the heme binding domain resulted in complete loss of monooxygenase activity of both CYP 
enzymes, indicating that this cysteine residue is indispensable for monooxygenase activity of invertebrate CYP 
enzymes, as has been well documented in vertebrates. Considering the important role of CYP enzymes in 
biotransformation of xenobiotics and the presence of N. virens in estuarine environments that accumulates organic 
xenobiotics, our results are important in understanding the molecular mechanism of biotransformation in marine 
polychaetes.     
 
Keywords—Cytochrome P450, Nereis virens, CYP4BB1, CYP342A1, heterologous expression, pyrene hydroxylase 
activity, site-directed mutagenesis 
 
 
INTRODUCTION∗
 
     The marine polychaete Nereis virens is an 
important species in estuarine sediments, 
which are often impacted by anthropogenic 
persistent compounds including polycyclic 
aromatic hydrocarbons (PAHs). After 
entering the marine environment, the 
lipophilic PAHs primarily associate with 
sediment particles. Therefore, infaunal 
deposit-feeding invertebrates like N. virens 
can be extensively exposed to PAHs due to 
feeding activity and surface contact. The 
degree of systemic accumulation of PAHs 
will depend on intake but also on the 
efficiency of biotransformation and excretion 
                                                 
∗ Corresponding author. E-mail address: 
annejoer@ruc.dk (A.    Jørgensen).  
Fax: +4546743011 
by the organism. N. virens is known to 
extensively biotransform PAHs [1-3] and this 
together with the wide distribution and 
importance of N. virens as food source to 
higher organisms makes it important to 
understand the mechanisms underlying PAH 
biotransformation in this species. Since little 
is known about specific cytochrome P450 
(CYP) enzymes in N. virens and other marine 
polychaetes, the objective of the present study 
was to characterise two specific CYP 
enzymes from N. virens and to determine 
whether they are involved in xenobiotic 
biotransformation as indicated by Rewitz et 
al. [4]. We used pyrene as a model-PAH 
compound for xenobiotic biotransformation in 
N. virens since it has the advantage that 
eukaryotic CYP enzymes catalyse formation 
of one phase I metabolite, 1-hydroxypyrene 
[5-7]. In order to further characterise the two 
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 N. virens CYP enzymes, we investigated the 
importance of the conserved cysteine residue 
in the heme binding domain of the CYP 
enzymes by substituting the cysteine with a 
serine residue. 
     Biotransformation of xenobiotics in 
eukaryotic species is often initiated by 
introduction of a functional group by 
monooxygenation catalysed by (a) CYP 
enzyme(s). Subsequently followed by 
conjugation with an endogenous substrate 
catalysed by enzymes like glucuronosyl 
transferases or sulfotransferases [1, 7, 8] 
whereby lipophilic compounds are 
transformed into hydrophilic conjugates 
easily excreted from the organism. CYP 
enzyme activity was previously demonstrated 
in N. virens [1-3]. The knowledge about 
specific CYP genes in marine invertebrates 
and more specifically in polychaetes and in N. 
virens is very limited, both regarding 
transcriptional regulation of CYP genes as 
well as biochemical activity of specific CYP 
enzymes. The present article reports the full-
length cDNA sequences of the two partial N. 
virens CYP4 genes sequences previously 
described by [4]. Only two full-length CYP 
cDNA sequences CYP301A and CYP4AT1 
from Capitella Sp.I [9] and the two partial 
CYP4 cDNA sequences from N. virens [4] 
have previously been reported from marine 
polychaetes. Expression analysis with the 
CYP genes from Capitella Sp.I and N. virens 
showed that mRNA levels after PAH 
exposure were 2-3 fold transcriptionally 
upregulated [4, 9]. Similar expression levels 
have been reported for CYP genes in other 
marine invertebrates [10-14]. Together, the 
results indicate smaller transcriptional 
upregulation of invertebrate CYP genes 
compared to vertebrates species, where PAH 
interaction with the aryl hydrocarbon-receptor 
(AhR) result in 10-100 fold upregulation of 
the transcription of CYP1A genes [10]. The 
molecular mechanism underlying CYP gene 
transcription regulation has not yet been 
elucidated in invertebrates. However, CYP 
gene expression regulation is likely to 
resemble that in vertebrates as invertebrate 
species possess receptors and corresponding 
response elements e.g. metal responsive 
transcription factor MTF1 [15] and hormone 
receptors [16] similar to those in vertebrates. 
Furthermore, the nuclear receptor nhr-8 from 
Caenorhabditis elegans have been 
demonstrated to contribute to xenobiotic 
resistance [17]. Based on these findings, the 
regulation of invertebrate CYP gene 
expression in invertebrates could conceivable 
resembles that in vertebrates. Sequencing of 
the Drosophila melanogaster and C. elegans 
genomes identified CYP genes belonging to 
family 1 [18], however, sequence analysis of 
invertebrate CYPs suggest that ligand binding 
characteristics are different from those of 
vertebrate [19, 20]. This indicate that other 
CYP families might be involved in PAH 
biotransformation in invertebrate species. For 
example, the CYP6 family in insects have 
been the focus of several investigations and 
insect CYP6 enzymes have been associated 
with insecticide resistance [18, 21-25]. Also, 
it has previously been suggested that CYP4 
enzymes in insects might be involved in 
xenobiotic biotransformation [26, 27] and 
Danielson et al [28] suggested that the 
xenobiotic responsiveness of CYP4 enzymes 
in insects apart them from vertebrate CYP4 
homologs and that insect CYP4 resemble 
drug metabolising CYPs in vertebrates [28]. 
This is supported by the greater number and 
broader sequence diversity of CYP4 in insects 
compared to vertebrates [27]. The CYP 
isoforms responsible for xenobiotic 
biotransformation in marine invertebrates 
have not yet been elucidated and no general 
suggestions about specific CYP isoforms 
mediating xenobiotic biotransformation have 
been made. The large variation in substrate 
specificity of the different CYP isoforms [29] 
and the multiplicity of CYPs with their 
diverse and overlapping substrate specificities 
makes CYP enzymes capable of 
biotransforming a wide variety of endogenous 
and exogenous substrates [30] thereby 
complicating characterisation.  
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      The characterisation of N. virens as an 
abundant estuarine species that are an 
important food source to higher organisms 
and in addition are known to extensively 
biotransform xenobiotics highlights the 
importance of determining the mechanisms 
underlying biotransformation. In order to 
confirm that the two novel N. virens CYP 
enzymes are indeed involved in xenobiotic 
biotransformation as previous indicated [4], 
biochemical characterisation of the CYP 
enzymes is necessary. This will add 
information to elucidate the function of the 
two novel CYP4 genes from N. virens and it 
could indicate if the catalytic activity of CYP 
enzymes from marine invertebrates resembles 
that found in insect and vertebrate CYPs. 
Thereby contributing to the understanding of 
the mechanisms of PAH biotransformation in 
marine polychaetes.  
   
 
MATERIALS AND METHODS 
 
Sequencing of CYP4 genes 
     Two CYP4 genes from N. virens (both 453 
bp) were previously identified and partially 
sequenced [4]. From the partial cDNA 
sequences primers were designed and used to 
obtain the 5´ and 3´ ends of the CYP cDNAs 
by SMART race cDNA amplification 
(Clontech). First strand cDNAs were 
synthesised according to the manufacturers 
instructions. Amplification conditions: 94 ºC 
2 min (94 ºC 15 sec, 68 ºC 30 sec, 72 ºC 4 
min) for 40 cycles followed by a 7 min 
extension period at 72 ºC. PCR products were 
gel purified using the High Pure PCR Product 
Purification Kit (Roche), ligated into pCR II 
vectors and transformed into INVαF´ cells 
according to manufacturers instructions 
(Invitrogen). Positive clones were identified 
on carbenicillin plates (100 ug/ml), validated 
by colony PCR with amplification conditions: 
94 ºC 2 min (94 ºC 30 sec, 50 ºC 30 sec, 72 
ºC 2 min) for 40 cycles followed by a 7 min 
extension period at 72 ºC and sequenced 
using the ABI PRISM BigDye Terminator 
Cycle Sequencing Ready Reaction Kit (Perkin 
Elmer). The cDNA fragments corresponding 
to the full-length mRNA were generated by 
Long Distance PCR (LD-PCR) using specific 
sense primers matching the extreme 5’ 
flanking region of the cDNAs and the 
universal primer hybridising to the adaptor 
region (at the extreme 3’ end). Products were 
cloned and sequenced as previously 
described.  Sequence analyses were carried 
out using WinSeq software (provided by 
Flemming G. Hansen, BioCentrum, DTU, 
Denmark) and multiple alignments were 
performed using ClustalX and 
SeaviewWin95. The two full length 
sequences were submitted to the Cytochrome 
P450 nomenclature committee at D.R. 
Nelson’s homepage 
(http://drnelson.utmem.edu/website) and they 
were named CYP4BB1 and CYP342A1. 
  
Heterologous expression of CYP4 genes  
     To construct full-length CYP4BB1 and 
CYP342A1 for in vitro expression the 
obtained cDNAs for the genes were cloned 
into the expression vector pGEX2TK 
(Amersham Biosciences) via the multiple 
cloning site. To construct GST-
CYP4BB1/CYP342A1 for fusion-protein 
expression in E. coli, restriction sites 
compatible with the pGEX2TK vector were 
introduced in the 5´and 3´ends of both genes 
by PCR. Primers were designed to incorporate 
BamHI restriction sites in both ends of 
CYP4BB1 (fwd primer: 5´- CGGGATCCATGAA 
TTCAGTCACAACATC -3´ and rev primer: 5´- 
CGGGATCCTTATCTTGGATTCATGAAGA -3´) 
and EcoRI restriction sites in both ends of 
CYP342A1 (fwd primer: 5´-CGGAATTCATGG 
GTAATGCAGTAAGCAT-3´ and rev primer 5´-
CGGAATTCTTAGGATCCACTTGTAATTC-3´). 
PCR was performed according to the protocol 
for ExpandTM Long Template PCR system 
(Roche). Amplification conditions were for 
CYP4BB1: 94 ºC 30 sec (94 ºC 15 sec, 65 ºC 
30 sec, 72 ºC 4 min) for 40 cycles followed 
by a 7 min extension period at 72 ºC and for 
CYP342A1:  94 ºC 2 min (94 ºC 30 sec, 60 ºC 
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 2 min, 72 ºC 2 min) for 40 cycles followed by 
a 7 min extension period at 72 ºC. PCR 
product was gel purified as described 
previously. The CYP4BB1 PCR product and 
the pGEX2TK vector were digested with 
BamHI and the CYP342A1 PCR product and 
the pGEX2TK were digested with EcoRI 
according to manufacturers instructions 
(Fermentas). Inserts and pGEX2TK were 
ethanol precipitated and pGEX2TK were de-
phosphororylated using CIAP (Gibco) 
according to manufacturers instructions. The 
CYP genes were ligated into pGEX2TK with 
T4 ligase (Invitrogen) as a continuance of the 
GST reading frame. Transformation into 
TOP10 competent cells (Invitrogen) was done 
according to manufacturers instructions and 
clones were selected by plating on ampicillin 
(100 µg/ml) plates. Plasmids were sequenced 
to confirm the orientation and correct reading 
frame of the insert. 
 
Purification of the fusion proteins 
     Escherichia coli BL21 cells were 
transformed with either of the two expression 
vectors by the CaCl2 method. The 
transformed bacteria were plated on 
ampicillin (100 µg/ml) containing plates and a 
single ampicillin-resistant colony containing 
CYP4BB1 or CYP342A1 were grown 
overnight at 37 ºC, 200 rpm in LB medium 
containing 100 μg ampicillin/ml. A 10 ml 
aliquot was inoculated in 100 ml LB medium 
containing 100 μg ampicillin/ml in a 500 ml 
flask. After 2 hours growth, the tac promoter 
placed upstream of the GST/CYP4BB1 or 
CYP342A1 gene was induced by the addition 
0.1 mM IPTG, and the mixture was incubated 
for 8 hr at 30ºC with vigorous shaking (150 
rpm). Cell-suspensions were harvested and re-
suspended in 1 ml 1×PBS containing protease 
inhibitors (Complete Protease Inhibitor 
Cocktail Tablets, Roche) and lysozym (final 
conc. 1 mg/ml). The samples were incubated 
on ice for 30 min and transferred to new 
eppendorf tubes where DTT and Triton X-100 
were added to final concentrations of 2 mM 
and 0.2%, respectively. Cells were lysed by 
twice freezing in liquid nitrogen and 
subsequent thawing in a 30ºC water bath. 
DNaseI (Roche) treatment with 1 mg/ml was 
conducted on ice until the samples were no 
longer viscous (3 hr). The samples were then 
centrifuged for 30 min at 14.000 × g at 4ºC 
and the cell extracts containing the fusion 
proteins were stored at -80ºC until use.     
     Glutathione Sepharose 4B beads were 
prepared according to the manufacturers 
instructions (Glutathione SepharoseTM 4B, 
Amersham Biosciences) and the cell extract 
was added. Binding of the fusion proteins to 
the GST-beads was achieved by incubation 
for 2 hours at 4 ºC on a rocking platform. The 
protein-bound beads were washed 3 times 
with 1×PBS containing complete protease 
inhibitors. The fusion protein was then eluted 
with GEB buffer (10 mM reduced 
glutathione, 50 mM Tris-HCl, pH 8) by 
incubation for 10 min at room temperature; 
centrifugation 5 min at 1200 rpm at 4ºC, 
saving the supernatant containing the purified 
protein. This step was repeated 3 times, and 
the purified fusion proteins were cleaved with 
trombin according to manufacturers 
instructions (Amersham Biosciences). The 
purified protein was stored at -80ºC with 1 
volume glycerol and 1/20 volume 10×storage 
buffer containing 5 mM DTT and 10% Triton 
X-100. Purified proteins were analysed on a 
12% SDS gel with a ProSieve protein marker 
(Cambrex) to ensure that the proteins were of 
the expected size. 
 
Site-directed mutagenesis 
     Codon 456 of CYP4BB1 and codon 481 of 
CYP342A1 were changed from cysteine to 
serine by site-directed mutagenesis according 
to the method supplied with the QuickChange 
Kit from Stratagene. The sense and antisense 
primers (5´-GCTGGGCCAAGAAATAGCATTGGT 
CAAAATTTTGC-3´ and 5´-GCAAAATTTTGACC 
AATGCTATTTTCTTGGCCCAGC-3´) spanning 
nucleotide 1448-1483 of the CYP4BB1 
cDNA coding exon, contains the appropriate 
base-shift that will introduce the desired 
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 mutation. Accordingly, sense and antisense 
primers (5´-GCTGGTTCAAGAAACAGCATTGGA 
CAAAATTTTGC-3´) and (5´-GCAAAATTTTGTC 
CAATGCTGTTTCTTGAACCAGC-3´) spanning 
nucleotide 1488-1523 of the CYP342A1 
cDNA coding exon were used for 
mutagenesis with PfuTurbo DNA polymerase 
and the following PCR conditions: 95 ºC 30 
sec (95 ºC 30 sec, 55 ºC 1 min, 68ºC 6 min) 
for 16 cycles followed by a 7 min extension 
period at 68 ºC. The reaction product was 
treated with Dpn I and transformed into 
competent XL1-blue cells (Stratagene). The 
mutations were confirmed by sequencing. 
Expression and purification of the mutant 
fusion-protein was as described for the wild 
type proteins except that 0.5 mM δ-amino-
levulinic acid (which is a intermediate in 
heme biosynthesis) was added at the time of 
inoculation and upon induction with IPTG.   
 
Catalytic activity  
     A pyrene hydroxylase assay was designed 
to investigate if the purified CYP enzymes 
were functionally active. A reconstituted in 
vitro system was constructed, containing 
CYP4BB1, CYP342A1, CYP4BB1mut or 
CYP342A1 (0.2 μM), 10 mM MgCl2, 50 mM 
Tris-HCl, 0.5 μM NADPH cytochrome P450 
reductase, 0.5 μM cytochrome b5, 100 μM 
pyrene and 0.5 mM NADPH. The reaction 
was initiated by addition of NADPH and 
reaction tubes were incubated for 30 min at 
30ºC. The reactions were stopped by addition 
of 100 μl acetonitrile. The content of pyrene 
and 1-hydroxypyrene was determined by 
HPLC.      
 
HPLC analysis 
     Pyrene and 1-hydroxypyrene content were 
analysed on a Dionex HPLC system with a 
RF2000 flourescense detector according to 
Giessing et al. (2003). A Supelcosil LC-PAH 
column (25 cm × 4,6 mm inner diameter; 
Supelco, Bellafonte, PA, USA) was used and 
the acetonitrile: buffer (10 mM 
ammoniumacetat, 5 mM triethylamine, pH 5) 
(v/v) gradient profile went from 5:95 linearly 
to 90:10 over 40 min. and then held at 90:10  
for 10 min. at a flow rate of 0,8 ml min-1. 
Detection was by absorbance at 339 nm, and 
fluorescence λEX/EM (i.e. λexcitation/emission) was 
at 346/384 nm for metabolites and at 333/384 
nm for parent compound. Injection volume 
was 50 µl and column temperature was kept 
at 28°C.  
 
RESULTS 
 
CYP cDNA and the deduced amino acid 
sequence analysis  
     Two full-length cDNAs, encoding two 
CYP enzymes, were isolated from the gut 
tissue of the marine polychaete, N. virens, and 
named CYP4BB1 (GenBank accession No. 
XXxxxxxx) and CYP342A1 (GenBank 
accession No. XXxxxxxx) by the Cytochrome 
P450 nomenclature committee. The 
CYP4BB1 cDNA consists of a 508 amino 
acids open reading frame encoding a 
predicted 58.53 kDa protein (Figure 1). A 98 
bp untranslated region precedes the open 
reading frame, which is followed by a 715 bp 
untranslated 3´region containing a 
polyadenylation signal closely followed by a 
poly(A)tail. The CYP342A1 cDNA consists 
of a 508 amino acid open reading frame 
encoding a predicted 58.53 kDa protein 
(Figure 2). A 62 bp un-translated region 
precedes the open reading frame, which is 
followed by a 374 bp untranslated 3´ region 
containing a polyadenylation signal closely 
followed by a poly(A)tail. A comparison of N. 
virens CYP4BB1 and CYP342A1 amino acid 
sequences with those of other CYP4 amino 
acid sequences using NCBI blast, 
demonstrates a high degree of homology. 
Amino acid alignment demonstrated highest 
homology of the deduced amino acid 
sequence of CYP4BB1 with vertebrate 
CYP4F family members. With highest, 41%, 
identity to Mus musculus and 40% identity to 
Rattus norvegicus CYP4F4. It is quite 
interesting that CYP4BB1 was most like 
vertebrate   CYP4F   and   not   insect   or  C.  
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 A 
nt no.                                                                                                                     aa no. 
   1 ACGCGGGGGCAGTGTTACTGTTACTTAAAAAACAACATAACGTAAGACAGCTTGATAAAATTGAAAACATTTAAGATTGGAGCATCATACTACAAGAATGAATTCAGTCACAACATCAAT  
                                                                                                      M  N  S  V  T  T  S  I    8  
 121 AGCAGTGGTGATATTATTACCAGTGCTATACAAGGTTTACCAATACCTCCACTGGATATACAGGACGTGGTTTGTCATTGGGACACAAGTGAATAAATTCCCCGGGGAACCTTTGAAGTG 
      A  V  V  I  L  L  P  V  L  Y  K  V  Y  Q  Y  L  H  W  I  Y  R  T  W  F  V  I  G  T  Q  V  N  K  F  P  G  E  P  L  K  W   48    
 241 GCCATATGGAAATTTGCATCAGAATCCTGGATTCAATGAAAAACTTAATGGCTATCAGAAAAGTATGGCAGCAAAATACAACAGGCTCTGGCGAATGTGGTTTGGTCCTTTTGTTCCTTT 
      P  Y  G  N  L  H  Q  N  P  G  F  N  E  K  L  N  G  Y  Q  K  S  M  A  A  K  Y  N  R  L  W  R  M  W  F  G  P  F  V  P  F   88   
 361 CATCAGCCTTTGTCACCCAGACACCATTAAAATTTTAGTGAAAACAGAGGAGCCAAAATTCACAGATGGTAATGCTGGCTACCTTTTGGCTGAGCCTTGGCTTGGTAATCGACTTTTGTT 
      I  S  L  C  H  P  D  T  I  K  I  L  V  K  T  E  E  P  K  F  T  D  G  N  A  G  Y  L  L  A  E  P  W  L  G  N  R  L  L  L  128    
 481 AAAGTGCTGGACAAAAGTGGAAGAGAAACAGGAGACTCCTGACACCAGCTTTTCATTTTGGCATCCTCAAGAGCTACATTTCTGTCTACAATGCGGAAACAGAAACTCTGATGAAAAAAG 
      K  C  W  T  K  V  E  E  K  Q  E  T  P  D  T  S  F  S  F  W  H  P  Q  E  L  H  F  C  L  Q  C  G  N  R  N  S  D  E  K  S  168    
 601 TGGACAGCAAAAGGATCGAAAGGAGAGAGCTTTGACATTCAGACGGATATTTCGTCTTTGTACACTTAGTATTATACTGCGATGTGCCTTCTCGTATGATGAAAAAATTCAAGAAACTGG 
      G  Q  Q  K  D  R  K  E  R  A  L  T  F  R  R  I  F  R  L  C  T  L  S  I  I  L  R  C  A  F  S  Y  D  E  K  I  Q  E  T  G  208    
 721 TGAGCGACATCCTTATGCTGTAGCTGTGCTGGACCTGTCAAGATTGATGGTCGAAAGAGCATTCAATCCTTTTGTTCGCATGAGTAAGTTTCTGTACGGACTTACTGCAAATGGGCGGAC 
      E  R  H  P  Y  A  V  A  V  L  D  L  S  R  L  M  V  E  R  A  F  N  P  F  V  R  M  S  K  F  L  Y  G  L  T  A  N  G  R  T  248    
 841 ATTTTTCAAGCACTGCGACTATGTTCACAAAGTGGCAGAAACTGTCATTTCTCAAAGGAGGGAAACTTTGCAAGAAAACCCAGATGCGCTGGAAGACAGGAAATATTTGGATTTTCTCGA 
      F  F  K  H  C  D  Y  V  H  K  V  A  E  T  V  I  S  Q  R  R  E  T  L  Q  E  N  P  D  A  L  E  D  R  K  Y  L  D  F  L  D  288    
 961 CATCTTGTTGCAAGCACGGGATGAAGATGGAACTGGGCTTTCTGATTTAGAAATTCGTAATGAGGTCGATACGTTTATGTTCGAAGGGCATGACACCACAGCATCGGGAATATCCTGGGC 
      I  L  L  Q  A  R  D  E  D  G  T  G  L  S  D  L  E  I  R  N  E  V  D  T  F  M  F  E  G  H  D  T  T  A  S  G  I  S  W  A  328    
1081 ACTTTATTCCTTGGCAAAACACCCCGAGTTCCAAAAGAAAGCACAGCAAGAAATTGATGAGCTATTGGCTGACAGAAAAAATAAGTGGATTATGTGGGACGATTTGAATCAGCTACCATA 
      L  Y  S  L  A  K  H  P  E  F  Q  K  K  A  Q  Q  E  I  D  E  L  L  A  D  R  K  N  K  W  I  M  W  D  D  L  N  Q  L  P  Y  368    
1201 CCTGACAATGTGTTTGAAAGAGTCAATGAGACTGTGGTGCCCAGTGCCAGTCATCAGCAGACAACTGTTAAATCCAATAACCATAGATGGGGTGACATTGCCACCACACACCCTCTTTGA 
      L  T  M  C  L  K  E  S  M  R  L  W  C  P  V  P  V  I  S  R  Q  L  L  N  P  I  T  I  D  G  V  T  L  P  P  H  T  L  F  D  408    
1321 CATCAACATTATTGCTCTACATCATAACCCAACAGTGTGGGGAGAAGATCATGATGAATATAAACCTGAAAGATTTCTTCCTGAAAATATCAACAAAATGGACAACTTCGCTTTCCTCCC 
      I  N  I  I  A  L  H  H  N  P  T  V  W  G  E  D  H  D  E  Y  K  P  E  R  F  L  P  E  N  I  N  K  M  D  N  F  A  F  L  P  448    
1441 ATTCTCTGCTGGGCCAAGAAATTGCATTGGTCAAAATTTTGCTTTCAACGAAATGAAAACAACAATAGCAAGGATTATTCAAAGATTTGATCTCTCAGTTGATGAAAGTCACCCAGTGTA 
      F  S  A  G  P  R  N  C  I  G  Q  N  F  A  F  N  E  M  K  T  T  I  A  R  I  I  Q  R  F  D  L  S  V  D  E  S  H  P  V  Y  488    
1561 TCCTCGGCCTGAGGTGGTCACCCGAGCGATTCATGGTATCAAGCTCTTCATGAATCCAAGATAAATATAATAGAATCCTGTCAGCTTTTACATCTGTTGTAGCCTATCATGATATTTGCT 
      P  R  P  E  V  V  T  R  A  I  H  G  I  K  L  F  M  N  P  R  *                                                           508    
1681 AAATGATTTATGGTATATATATATATTATCTTTATTTTGTATGATAAAAGTGTCACTTGAAGTTGCCCAAACATAGTGCCAATGGAAACCTAGGGGAGAAAAGGTAACATGGGCACTACG 
1801 ACCGTAGTAGGCCTACATATACAAAGAATATGTACCAAGAAGCGCCACTCCCAATACTTCACATTCTAAATGCTGCGCCTCCTTCCCCCAGAATTCCCGGCAGGCTGGGCATTCTGGTAG 
1921 TAGCAGATGCACACTTCAATGCCCCTAGTGGATAAAAAATTTTGATATCTATAGCTCTGTCTGGTTCGTAGTTTCTTCAATTTGACTGTTTAAATAGCTAAAATGTCATTTCCAAATAAA 
2041 AACAGTGTCAGCTTGAGTACTATAGTGTGCGAATAAAGTACATTATCACAAATTTCAACGTCAACAAAAGCTGATCAATATTTGAATGTAGGATCGATGCCCAATCAGAGATCCGTATAG 
2161 TATAGAGATTGGTCCGCGAGGGAATATTTCGAGAATCCGGAAGTCAAAAGCCACCCAGCGTTTGGGCGCGAACTAAAATAAACATTATTTGATCTTTTTCTTAAGTCTAGGTTAGGGACA 
2281 TTATCACAAATGCAAAACACATGTTGTTGGAACAGAATAAAAATGTTGAATACCACCGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 2388  
 
Figure 1. (A) Full length CYP4BB1 cDNA sequence and amino acid sequence derived from the open reading frame of the cDNA from N. virens. (B) 
Full length CYP342A1 cDNA sequence and amino acid sequence derived from the open reading frame of the cDNA from N. virens. Nucleotides (nt) 
are numbered on the left and amino acid (aa) on the right. Conserved regions are underlined, conserved amino acids are in bold and the asterisk marks 
the termination codon. The conserved regions are first the proline/glycine rich region, the conserved WxxxR, I-helix, ExxR, PERF, heme binding 
domain and the polyadenylation signal 
 
elegans  CYP4.  The   deduced   amino   acid  
sequence of CYP342A1 shares less than 40% 
identity in overall sequence comparison with 
known CYP enzymes and is therefore 
assigned to a new CYP family (Table 1). The 
highest homology of CYP342A1 was to 
CYP4BB1 and the amino acid sequences 
reveal a 35% identity, indicating that the two 
enzymes are relatively different. Furthermore, 
CYP342A1 was 34% identical with CYP4F14 
from Mus musculus.. Despite their difference 
in amino acid sequence and function, several 
conserved domains exist in most known CYP 
enzymes. In the deduced amino acid 
sequences from CYP4BB1 and CYP342A1 
the following conserved regions have been 
identified: * The absolutely conserved 
signature sequence in CYP enzymes 
FxxGxxxCxxG corresponding to the heme-
binding domain and serving as the fifth ligand 
to the heme iron [30]. * The hydrophobic 
NH2-terminal region followedby a 
proline/glycine rich region are conserved 
among  microsomal  CYP  enzymes   and   are 
 
      
 
Figure 2. SDS-PAGE of the purified CYP proteins from N. virens on 
a 12% SDS gel stained with Coomassie blue. Lane 1: ProSieve 
protein marker. Lane 2: CYP4BB1. Lane 3: CYP342A1. Lane 4: 
CYP4BB1mut. Lane 5: CYP342A1mut. The 58 kDa proteins were 
expected based on the deduced amino acid sequence.  
 
involved in endoplasmic reticulum membrane 
anchoring [30]. * The conserved GxxT motif 
within the I-helix corresponding to the proton 
transfer groove [30]. * The charge pair 
consensus sequence ExxR within the K-helix 
needed to stabilise the core structure of the 
protein [30, 31]. * The PxRF sequence 
present in most CYPs but whose function is 
not yet elucidated. * The WxxxR domain near  
                             1            2          3         4         5 
58 kDa
76 kDa 
47 kDa 
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nt no.                                                                                                                     aa no.  
   1 ACGCGGGGGGACTCTCTGACTTAGTGATTCAAACATAGTTGTACTTACTGGTGCTCTTCAAGATGGGTAATGCAGTAAGCATTGTGAATGAGCAAGTACAACCTCTTTTGGCAAAAGTGT  
                                                                   M  G  N  A  V  S  I  V  N  E  Q  V  Q  P  L  L  A  K  V  S  20    
 121 CAAATCTAACAGCACTGGAGAATGTTAGGAAGAGAGATGTCATATCTGCTATACTTGTTGCATATGGTGTTTATATTGGTGGATCGTTCATTGCCAAGTGCTACAAAATTCATCGATTTC 
       N  L  T  A  L  E  N  V  R  K  R  D  V  I  S  A  I  L  V  A  Y  G  V  Y  I  G  G  S  F  I  A  K  C  Y  K  I  H  R  F  R  60  
 241 GCCAGAAACTTGAAGGAATACCGAACAAACCTAGTGTCGTAATGGGGAATCTTTCAGATTTTCCTGGACCAGGTCCCGAAGTGTTTGGCTGGGTACAAGGCAAAGTTAACCAATACAAGA 
       Q  K  L  E  G  I  P  N  K  P  S  V  V  M  G  N  L  S  D  F  P  G  P  G  P  E  V  F  G  W  V  Q  G  K  V  N  Q  Y  K  K 100   
 361 AATTCTACCAGTTTTGGGTTGGTCCTTTTAGTCCCATGATAAGTCTCTGTCATCCTGAAACAAGTCAAAATCATCCTGAAGTCATCAGAACCAAAGTACACCTTCACAGGATATGGCCAG 
       F  Y  Q  F  W  V  G  P  F  S  P  M  I  S  L  C  H  P  E  T  S  Q  N  H  P  E  V  I  R  T  K  V  H  L  H  R  I  W  P  V 140   
 481 TTATGCTTTTGCTGAAGGAATGGCTAGGAGATGGTCTTCTACTGTCCTCTGGGTCAAAGTGGTTTAGAAACCGAAGACTACTTACTCCTGCTTTTCATTTTCGAGATTCTCAAACCATAC 
       M  L  L  L  K  E  W  L  G  D  G  L  L  L  S  S  G  S  K  W  F  R  N  R  R  L  L  T  P  A  F  H  F  R  D  S  Q  T  I  L 180   
 601 TTAGAGATCTACAGAGTTTCTCGCTGACAAATTCTTTAACAAAATGTCCGCTTAAGGAGAAAATGGCGAAAAGAGTGTGCCCATTTATTCTTTTGTCAGTCTTTTGGCGCTGGATATTAT 
       R  D  L  Q  S  F  S  L  T  N  S  L  T  K  C  P  L  K  E  K  M  A  K  R  V  C  P  F  I  L  L  S  V  F  W  R  W  I  L  F 220   
 721 TTTACGATGTGCGTTCTCAAATGAAAAGGACATACAAGTTCAAGGGGAAAATGACCCATATGTGGCTGCAGTTATTAAGATCACGGACACTCTTGTACAAAGGCTTTTCAATCCTCTCCT 
       Y  D  V  R  S  Q  M  K  R  T  Y  K  F  K  G  K  M  T  H  M  W  L  Q  L  L  R  S  R  T  L  L  Y  K  G  F  S  I  L  S  C 260   
 841 GCACAATACGGTACTATTTTACTTTAGCTCCGTTGGACGTGAGAATCGAAGAGCGCTGTAGTGTGTACACCAAGTATCACAAGAAGTACTACAGAAACGAAAGAAGTCTCTGGCTGAGAA 
       T  I  R  Y  Y  F  T  L  A  P  L  D  V  R  I  E  E  R  C  S  V  Y  T  K  Y  H  K  K  Y  Y  R  N  E  R  S  L  W  L  R  T 300   
 961 CCCAAATGCATCTCAAAAGAGATATCTTGATTTCTTGGACATCCTTCTGGCTGCTCGAGATGAGGACGGAAAAGGTCTGTCTTGATCGTGAAATCAGAGATGAAGTGGATACGTTTATGT 
       Q  M  H  L  K  R  D  I  L  I  S  W  T  S  F  W  L  L  E  M  R  T  E  K  V  C  L  D  R  E  I  R  D  E  V  D  T  F  M  F 340   
1081 TTGAAGGTCACGATACCACAGCTTCTGGCATTTCATGGATCCTGTATGAATTATCAGGGCACCCTGAAGTTCAAGAGCAGGCTGGTCAAGAGGTTATTCGTGTTATTGGAAGCCAAAGTG 
       E  G  H  D  T  T  A  S  G  I  S  W  I  L  Y  E  L  S  G  H  P  E  V  Q  E  Q  A  G  Q  E  V  I  R  V  I  G  S  Q  S  D 380   
1201 ATGGGACTATTGAATGGTCTGATCTCTCCCGCCTGCCATATCTGAGCCAGTGCATAAAGGAGGCCATGAGAGTTCATCCCCCTGTTCCTTTTATTGGTAGACAGTTGTCTCAAGATATAA 
       G  T  I  E  W  S  D  L  S  R  L  P  Y  L  S  Q  C  I  K  E  A  M  R  V  H  P  P  V  P  F  I  G  R  Q  L  S  Q  D  I  I 420   
1321 TCATCAATGGTTGCACCATCCCCAAAGATACCATCTGTGAAGTTTCCATATACGGTGTGCACCATAATCCAGAAGTTTGGGGGAAAGATCATATGGAATTTAAACCTGAGAGATTCCACC 
       I  N  G  C  T  I  P  K  D  T  I  C  E  V  S  I  Y  G  V  H  H  N  P  E  V  W  G  K  D  H  M  E  F  K  P  E  R  F  H  P 460   
1441 CAGACAACATGAAAGACAAAGATGCCTTTGACTACATTCCATTTTCTGCTGGTTCAAGAAACTGCATTGGACAAAATTTTGCTTTGAATGAAGAAAAAGTTGTGATACGCCAAGGTTTTG 
       D  N  M  K  D  K  D  A  F  D  Y  I  P  F  S  A  G  S  R  N  C  I  G  Q  N  F  A  L  N  E  E  K  V  V  I  R  Q  G  F  A 500   
1561 CAGAAGTTCGAATTACAAGTGGATCCTAACCACAAAGTTGAAAAGCATCCAGAAGCAGTTACAAGGACCAACAAATGATATTAAGATATTTTTTAGGCCATTGCATTAATGCTGAACTAA 
       E  V  R  I  T  S  G  S  *                                                                                              508    
1681 TGGCTGTGAGGGCTTTGGCAGGTACCGCACAAGTTTTTTTTCAAACTGACCACACTCAGGCGTAGTCTGCTCCAATTTGGACCACATTATAAGTATCACATGCTTGCAGTAGTCAACCCG 
1801 AGCATTTTCCAACTTGCGTATCTCATCAATGAACATCTTTAAGTTAAACTCACATGCTGTCTTTAAGCAGTATGAGGAGTCATAATTTTGGCTCTATGACTCTTCATGCTTCAGCATGTG 
1921 AAAACTGACCATGGAGCGAATAAAGGGCTGCTAAAGTTACAAAAAAAAAAAAAAAAAAAA 1980    
Figure 1 (continued) 
 
 
the NH2-terminal located in the C-helix and 
considered to neutralise the charge of one of 
the side chains of the heme. * The CYP4 
family consensus sequence of 13-residues 
EVDTFMFEGHDTT [32] within the I-helix 
suggested to be involved in proton transfer 
during monooxygenation (Figure 1). 
Alignments of the conserved I-helix and 
heme-binding domains in CYP4BB1 and 
CYP342A1 with the corresponding regions in 
other CYP4 sequences from other species 
(Figure 3) demonstrate a high degree of 
homology between all the members of the 
CYP4 family. This further indicates that these 
regions in the CYP proteins are involved in 
functions essential for the enzymes and 
therefore highly conserved despite the 
relatively low overall sequence homology. 
    
Expression and purification of the CYP 
proteins 
     The coding sequences of the two N. virens 
CYP genes were subcloned into the 
prokaryotic expression vector pGEX2TK, for  
the expression of CYP4BB1 and CYP342A1  
enzymes in E. coli BL21. Purification of the 
two CYP proteins resulted in a relatively high 
yield 11.6 mg/l culture.   Replacement  of  the  
active site cysteine by serine in CYP4BB1 
and CYP342A1 using site-directed 
mutagenesis resulted in a very low protein 
yield after purification. However, previous 
studies have showed that addition of 0.5 mM 
of the heme precursor δ-amino-levulinic acid 
enabled a many-fold stimulation of expression 
of some forms of CYP proteins [33]. 
Therefore, δ-amino-levulinic acid was added 
during growth of bacteria producing the 
mutated CYP proteins. This resulted in a yield 
of 7,6 mg/l culture making it possible to avoid 
addition of exogenous heme during growth. 
As shown in Figure 2 CYP4BB1, CYP342A1, 
CYP4BB1mut and CYP342A1mut proteins 
were approximately 58 kDa, in agreement 
with the expected size derived from 
calculations based on the deduced amino acid 
sequence.   
 
CYP enzyme activity 
     CYP enzymes require NADPH reductase 
to transfer one or more electrons to CYP in a 
substrate-specific manner and some CYP 
enzymes require cytochrome b5 to either 
donate a second electron or to allosterically 
interact   with   the   CYP   enzyme   complex, 
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Table 1. Amino acid identities of CYP4BB1 and CYP342A1 proteins with other cloned CYP4s from invertebrate and vertebrate 
species. 
Gene Gene Organism Common name Identity Percent 
identity 
Accession 
number 
CYP4BB1 CYP4AT1 Capitella capitata lugworm 164/455 36 AY574044 
 CYP4C39 Carcinus maenas shore crab 150/495 30 AY328467 
 CYP4C15 Orconectes limosus crayfish 145/446 32 AF091117 
 CYP4F15 Mus musculus mouse 209/506 41 BC021377 
 CYP4F4 Rattus norvegicus rat 212/520 40 NM_173123 
 CYP4F8 Homo sapiens human 201/511 39 NM_007253 
CYP342A1 CYP4AT1 Capitella capitata lugworm 117/353 33 AY574044 
 CYP4C39 Carcinus maenas shore crab 114/366 31 AY328467 
 CYP4C15 Orconectes limosus crayfish 120/361 33 AF091117 
 CYP4F14 Mus musculus mouse 149/441 34 BC094016 
 CYP4F4 Rattus norvegicus rat 154/484 31 NM_173123 
 CYP4F8 Homo sapiens human 152/460 33 NM_007253 
 
depending on CYP isoform and substrate 
[25]. For example, CYP6D1 from housefly 
requires cytochrome b5 for aryl hydrocarbon 
hydroxylase activity, but not for 
methoxyresorufin-O-demethylase [34]. We 
used E. coli as expression system for the two 
N. virens CYP4 genes. Since E. coli does not 
contain the co-factors NADPH reductase and 
cytochrome b5 necessary for functional 
monooxygenase  activity,   activities    of   the  
purified N. virens CYP genes were examined 
in a reconstituted system. This system 
contained; purified CYP protein, human 
NADPH-cytochrome P450 reductase, human 
cytochrome b5, NADPH and pyrene as 
substrate. Only one metabolite, 1-
hydroxypyrene, is produced as a result of 
cytochrome  P450  enzyme  activity  with this  
 
substrate (Figure 4) due to the symmetrical 
structure of pyrene. 
     The purified CYP4BB1 and CYP342A1 
proteins were both active enzymes capable of 
catalysing the hydroxylation of pyrene to 1-
hydroxypyrene (Table 2). It appears that 
CYP342A1 is slightly more active in 
hydroxylating pyrene compared to CYP4BB1. 
When CYP4BB1 and CYP342A1 enzyme 
assays were performed in the absence of 
NADPH, no detectable monooxygenase 
activity was found. As expected 
CYP4BB1mut and CYP342A1mut had no 
catalytic activity, due to the mutation in the 
conserved cysteine site in the heme-binding 
domain. 
 
 
Protein  Organism         I-Helix domain      Heme-binding domain 
 
      *  **** *****       ** * ****** * 
CYP4BB1  Nereis virens   EVDTFMFEGHDTT   FSAGPRNCIGQNF  
CYP4C39  Carcinus maenas  EVDTFMFEGHDTT   FSAGPRNCIGQKF 
CYP4C15  Orconectes limosus  EVDTFMFAGHDTT   FSAGPRNCIGQKF 
CYP4AT1  Capitella capitata  EVDTFMFEGHDTT   FSAGPRNCIGQHF 
CYP4D1  Drosophila melanogaster EVDTFMFKGHDTT   FSAGPRNCIGQKF 
CYP4F4  Rattus norvegicus   EADTFMFEGHDTT   FSAGPRNCIGQTF 
CYP4F15  Mus musculus   EADTFMFEGHDTT   FSAGPRNCIGQTF 
CYP4F8  Homo sapiens   EADTFMFGGHDTT   FSAGPRNCIGQKF 
CYP4F7  Dicentrarchus labrax  EANTFMFAGHDTT   FSSGPRNCIGQKF 
CYP342A1 Nereis virens   EVDTFMFEGHDTT   FSAGSRNCIGQNF  
   
Figure 3. Amino acid alignments of the conserved I-helix and heme-binding domains of CYP4BB1 and CYP342A1 with selected CYP4 sequences 
from both invertebrate and vertebrate species. Asterisks at the top mark identical amino acid residues 
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 DISCUSSION 
 
      CYP enzymes involved in 
biotransformation of xenobiotics are 
important for benthic organisms like N. 
virens that are often continuously exposed 
to xenobiotics. A functional CYP response 
mediates the first step in 
biotransformation, which will eventually 
lead to excretion of the xenobiotic [35].  
 
 
Table 2. Pyrene hydroxylase activity of CYP4BB1, CYP342A1, 
CYP4BB1mut and CYP342A1mut in the reconstituted enzyme 
system. Substrate is pyrene and activity was measured as 
formation of 1-hydroxypyrene. N.D.: not detectable formation of 
1-hydroxypyrene. 
 
Enzyme Activity of protein 
 (pmol/min/mg) 
CYP4BB1 58.44 
CYP342A1 70.50 
CYP4BB1mut  N.D. 
CYP342A1mut  N.D. 
 
In order to investigate the biochemical 
activity of the two specific CYP enzymes 
identified in N. virens heterologous 
expression and protein purification were 
conducted. The purified CYP proteins 
were used in a reconstituted enzyme assay 
using pyrene as substrate. Both CYP4BB1 
and CYP342A1 protein from N. virens 
were catalytically active after expression in 
E. coli BL21, as indicated by 
hydroxylation of pyrene to 1-
hydroxypyrene. This indicates that both 
enzymes are likely to be involved in 
xenobiotic biotransformation. The 
activities of CYP4BB1 and CYP342A1 
enzymes were however not particularly 
high compared to purified CYP proteins 
from other invertebrates [22, 34]. 
Comparison of determined catalytic 
activity is difficult due to differences in 
CYP isoform, substrate used and method 
of protein expression between 
investigations. Furthermore, relatively few 
published data are available, especially 
from marine invertebrates. However, the 
enzyme activities determined in this study 
were 58.44 and 70.50 pmol/min/mg for 
CYP4BB1 and CYP342A1, respectively. 
In other studies, for example [36] CYP2L1 
from the spiny lobster Panulirus argus was 
expressed in the yeast Pichia pastoris and 
the activity determined to 2.3 and 3.6 
nmol/min/nmol with testosterone and 
progesterone as substrates, respectively 
(Calculated from nmol/min/nmol using the 
content of 12.8 nmol CYP/mg protein 
stated in figure 1) [36]. Compared to our 
results in N. virens, this activity is quite 
high, which might be due to several 
factors, better expression (folding) in yeast 
than in bacteria, better substrate for the 
specific CYP enzyme, better compatibility 
with yeast NADPH reductase or just higher 
activity of spiny lobster CYP. Also, CYP 
genes from several insects have been 
heterologously expressed and investigated 
with regard to catalytic activity towards 
insecticides. CYP6A2 from Drosophila 
melanogaster was heterologously 
expressed in lepidopteran cells by infecting 
cells with CYP6A2-recombinant 
baculovirus.  
 
 O  H  
P y ren e  1 -h y d ro x y p y ren e  
C Y P 4 5 0  
 
Figure 4. CYP enzyme catalysed phase I biotransformation of 
pyrene in N. virens. CYP450: Cytochrome P450 enzymes. The 
symmetrical structure of pyrene makes it a good model PAH 
since 1-hydroxypyrene is the only phase I metabolite produced 
in eukaryotic species. 
 
The CYP6A2 enzyme activity was 1.04 
and 2.53 nmol/min/mg protein and 
turnover rates of 2.8 and 6.8 min-1 with 
heptachlor and aldrin as substrates, 
respectively [22]. House fly Musca 
domestica CYP6A1 expressed in E. coli 
was active in a reconstituted system with 
aldrin and heptachlor as substrates with 
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 turnover rates of 12 and 34 min-1 [23]. 
Indicating considerable difference in the 
measured catalytic activity of the specific 
insect CYP enzymes investigated, 
however, despite the use of the same 
substrates it is not possible to determine 
whether the difference is due to higher 
activity of one of the CYPs or if it is due to 
the difference in expression systems.   
     The relatively low catalytic activity of 
CYP4BB1 and CYP342A1 could in part be 
due to non-optimal interactions of the two 
CYPs in the reconstituted system with the 
co-factors cytochrome-P450 reductase and 
cytochrome b5 both from human. Despite 
NADPH reductase and cytochrome b5 are 
both highly conserved proteins, CYP 
enzymes of one species will not 
necessarily interact with NADPH 
reductase and cytochrome b5 from another 
species [25]. However, several studies 
have successfully used reconstituted 
systems to investigate the catalytic activity 
of bacterially produced purified CYP 
proteins [37, 38]. Finally, it is also possible 
that these two enzymes are not very active 
altogether or that they are not efficient 
towards the chosen model substrate 
pyrene. N. virens is known to very 
efficiently biotransform pyrene [1] and an 
explanation could be that CYP4BB1 and 
CYP342A1 not usually catalyse the 
hydroxylation of  this type of substrates. 
The low activity is more likely due to lack 
of membrane integration in the 
reconstituted system.  
     The measured catalytic activity of 
purified CYP4BB1 and CYP342A1 
enzymes with pyrene as substrate might 
indicate involvement of the two CYP 
proteins in PAH biotransformation and it 
appears that CYP342A1 is slightly more 
active than CYP4BB1 in this study. The 
same (partial) CYP genes from N. virens 
were previous investigated with regard to 
mRNA expression after exposure to 
xenobiotics [4]. This is in agreement with 
the general consideration that CYP 
enzymes are often transcriptionally 
inducible by the substrates upon which 
they act [39]. Both of these investigations 
individually provide indications of N. 
virens CYP342A1 and CYP4BB1 
involvement in xenobiotic 
biotransformation.    
     Purification of the CYP4BB1 and 
CYP342A1 mutant proteins with the heme 
binding site cysteine replaced by serine 
was difficult, probably due to heme loss 
[40]. However, addition of the heme 
precursor δ-amino-levulinic acid to the 
growth medium made it possible to obtain 
enough protein, without the need for 
reconstitution with exogenous heme and 
the following uncertainty whether this 
would lead to a protein different in some 
respect from the native enzyme. The 
complete loss of monooxygenase activity 
in CYP4BB1mut and CYP342A1mut is in 
agreement with results from previous 
studies. For example, monooxygenase 
activity in CYP2B4 with a similar 
mutation (cysteine to serine in the heme 
binding domain) were undetectable [40]. 
The authors suggested that the cysteine site 
is needed to mediate the cleavage of 
molecular oxygen, explaining why this 
particular cysteine is fully conserved in all 
known CYP enzymes. Also explaining 
why different amino acid substitutions with 
the cysteine residue abolishes 
monooxygenase activity in CYP proteins 
[40-42].  
     In conclusion, the present article 
describes cloning of two functional CYP4s 
from N. virens gut tissue and expression in 
E. coli. This report is the first describing 
heterologous expression of CYP proteins 
from marine polychaetes. The metabolic 
results indicate that the two purified 
proteins are conceivably involved in 
xenobiotic biotransformation and that 
mutation of the conserved cysteine 
residues in the heme binding site resulted 
in complete loss of monooxygsenase 
activity. This indicates that the function of 
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 this cysteine in invertebrate CYP enzymes 
is analogous to the function in vertebrate 
CYP enzymes and adds to explaining its 
indispensable presence in all known CYP 
enzymes. These biochemical data on 
specific CYP enzymes in N. virens 
presented here contribute to the 
understanding of PAH biotransformation 
in this species. This is important in 
attempting to understand and explain the 
differences in sensitivity towards PAHs 
among marine invertebrates.    
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